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Statement of Authorship 
 
I, Ran Zhao confirm that the work presented in this thesis has been 
performed and interpreted solely by myself except where 
explicitly identified to the contrary. 
 
My Master’s thesis includes three published journal papers:  
 
1. Protein aggregate turbidity: Simulation of turbidity profiles for 
mixed aggregation reactions. Damien Hall, Ran Zhao, Ian 
Dehlsen, Nathaniel Bloomfield, Steven Williams, Fumio Ariska, 
Yuji Goto and John Carver. Analytical Biochemistry. 2016, 498: 
78-94. 
 
The genesis of this paper was associated with my attempts at 
analysing a large amount of my own experimental data of protein 
aggregation reactions conducted using the turbidity procedure. 
The gradual realization that the turbidity assay was a non-linear 
descriptor of the underlying extent of aggregated protein led me to 
a post-facto search for robust methods for de-convoluting the 
turbidity signal. For this I first needed a formal means for relating 
aggregation to turbidity. I achieved this by collecting previously 
developed theoretical treatments of light scattering by protein 
aggregates and then used empirical interpolation techniques to 
provide an analytical description in the forms of a unified synthesis. 
In the publication described above I assisted in preparing the draft 
and final versions of the paper. 
 
2. Recognizing and analyzing variability in amyloid formation 
kinetics: Simulation and statistical methods. Damien Hall, Ran 
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Zhao, Masatomo So, Masayuki Adachi, German Rivas, John 
Carver and Yuji Goto. Analytical Biochemistry. 2016, 510: 56-71. 
 
The inspiration for this second paper came from my attempts to 
discern differences between my own aggregation assays 
conducted on a test and control basis. Conducted in parallel with 
the first study this second investigation started on the premise that 
there existed a way to relate the experimental assay measure to the 
underlying aggregation kinetics. Starting with simple methods 
based on average and standard error I soon realized that such 
approaches were not valid due to the highly asymmetric/ long-
tailed distributions of parameters used to describe protein 
aggregation kinetics. Here I looked at what improvements could 
be made in terms of optimal sample size and choice of statistical 
methods used in the analysis of parameters gained from a 
conventional data-reduction approach. I assisted in preparing the 
draft and final versions of the paper. 
 
3. Measurement of Amyloid Formation by Turbidity Assay – 
Seeing Through the Cloud. Ran Zhao, Masatomo So, Hendrik 
Maat, Nicholas Ray, Fumio Arisaka, Yuji Goto, John Carver and 
Damien Hall. Biophysics Review, 8: 445-71. 
 
This review paper represented a summary of the work described 
in papers 1 and 2. The longer review format allowed me to go into 
a lot more detail regarding the non-linear relationship between the 
turbidity signal and the underlying chemical kinetics associated 
with protein aggregation process. In regard to this point I 
examined subtleties associated with signal produced by the 
bundling of amyloid fibres, fibre breakage and end-to-end fibre 
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joining. I wrote the draft and assisted in preparing the final version 
of the paper. 
 
I confirm that this work is submitted in partial fulfilment for the 
degree of Master of Science in Biochemistry and has not been 
submitted elsewhere in any other form for the fulfilment of any 
other degree or qualification. 
 
Word count of “Motivation” and “Future Studies”: 3,036. 
 
 
Signature: 
 
 
Dated: 09/07/2018 
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Motivation 
 
1. My research history 
   Having obtained an undergraduate and a Masters degree from 
Tsinghua University in China I moved to Australia to further my 
postgraduate study at the University of Adelaide at the beginning 
of 2010. My initial research project was concerned with the 
association of the 14-3-3 zeta protein with small heat shock 
proteins (sHsps) and their potential synergistic effects in 
promoting molecular chaperone ability. The aim of the project was 
to find out whether 14-3-3 proteins associate with sHsps, 
especially phosphorylated sHsp forms, and if they do, whether this 
is a synergistic interaction that can enhance the combined 
chaperone ability of the two proteins.  
   To carry out these aims I used recombinant DNA technology to 
produce wild-type 14-3-3zeta, wild-type alpha B-crystallin, S59D 
alpha B-crystallin and S19,45,59D alpha B-crystallin from a 
plasmid transformed into E. coli using previously published 
methods (Williams et al., 2011; Horwitz et al., 1998). I 
successfully expressed and purified these products as 
demonstrated by the positive ion mass spectra obtained for each of 
the four proteins (Figure 1). To investigate the chaperone abilities 
of these proteins I used ADH, insulin and alpha-lactalbumin as 
substrates in a turbidity based light scattering assay (Figure 2). In 
addition to the light scattering turbidity assays I also performed 
Thioflavin T dye binding fluorescence assays to examine the 
amyloid aggregation reaction (Ecroyd et al., 2007). I used circular 
dichroism spectropolarimetry (CD) to investigate the 
conformational change of the proteins upon aggregation (Williams 
et al., 2011). I prepared N15 labeled WT 14-3-3zeta for 
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multidimensional NMR research (Treweek et al., 2010) and used 
TEM imaging to observe the formation of amyloid fibrils and 
amorphous aggregates (Ecroyd and Carver, 2009).  
 
Figure 1. (A) WT alpha B-crystallin mass spectrometry spectrum. Measured 
mass 20157Da vs theoretical mass 20159Da. (B) WT 14-3-3zeta (with 5 
amino acid residues from TEV protease) positive ion electrospray ionization 
mass spectrometry spectrum. Measured mass 28148Da vs theoretical mass 
28174Da. (C) S59D alpha B-crystallin mass spectrometry spectrum. 
Measured mass 20187Da vs theoretical mass 20187Da. (D) S19, 45, 59D 
alpha B-crystallin mass spectrometry spectrum. Measured 20243Da vs 
theoretical mass 20243Da. 
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Figure 2. Turbidity assay based investigation of (A) Chaperone ability of WT 
14-3-3zeta against the amorphous aggregation of 14µM ADH at different 
ADH/14-3-3 molar ratios. (B) Chaperone ability of WT alpha B-crystallin 
against the amorphous aggregation of 14µM ADH at different ADH/crystallin 
molar ratios. (C) Chaperone ability of S59D alpha B-crystallin against the 
amorphous aggregation of 14µM ADH at different ADH/crystallin molar 
ratios. (D) Chaperone ability of S19,45,59D alpha B-crystallin against the 
amorphous aggregation of 14µM ADH at different ADH/crystallin molar 
ratios. 
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  Upon Professor Carver’s acquisition of a new job at the 
Australian National University, in July of 2013 I transferred with 
him to continue my postgraduate research program. Soon after this 
time (February 2014) I have mostly worked under the supervision 
of Dr. Damien Hall, an academic who had just joined the ANU 
Research School of Chemistry. Under his supervision I examined 
some of the fundamental aspects of the turbidity aggregation assay. 
   With regards to this assay technique, solution turbidity can be 
taken as reflecting the total extinction of light passing through 
solution by non-absorptive, scattering based mechanisms. In 
general, throughout the protein aggregation/chaperone literature, 
turbidity is commonly considered as a linear marker of the extent 
of the protein aggregation reaction, however I noted that this 
assumption is frequently made without any experimental or 
theoretical support. In my Masters course I sought to examine the 
basic veracity of this assumption in much greater detail. My 
research involved the following general sequence, 
 
(i) Investigating solution conditions that cause proteins to unfold 
and aggregate.  
(ii) Monitoring the protein aggregation reaction by the 
turbidimetric method. 
(iii) Examining the differential effects of chaperones on the protein 
aggregation reaction as monitored by the recording of turbidity. 
 
  As these three steps constituted the core of my scientific approach 
I briefly introduce the pertinent aspects of each in the following 
sections.  
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2. Protein aggregation and protein conformational diseases 
 
2.1 Protein folding and unfolding 
   All proteins are amino acid polymers. Amino acid molecules are 
linked together by peptide bonds to form polypeptides. After 
peptide synthesis, most proteins need to correctly fold from a 
randomly structured polypeptide coil into a well-defined three-
dimensional globular structure to function (Alberts et al., 2002). 
The protein folding process is generally reversible1. In some 
circumstances, such as mutation or the presence of environmental 
stresses, natively folded proteins may unfold from their functional 
globular formation. This process is called protein unfolding or 
protein denaturation. Denatured proteins can often fold back to 
their native states when the environmental stress reduces or 
vanishes.  
 
2.2 Protein aggregation and protein conformational diseases 
   Sometimes unfolded polypeptides cannot fold into their native 
three-dimensional structure due to errors in the folding process 
(Figure 3). For example, they could enter the off-folding pathways 
via the association of intermediately folded molten globules 
(Ecroyd and Carver, 2008). Misfolded proteins often form 
insoluble amorphous or amyloid fibril aggregates (Ecroyd and 
Carver, 2008). Amyloid fibrils are characterised by highly ordered, 
cross-beta sheet fibrillar structures that are from nanometre to 
micrometer in length (Treweek et al., 2003). 
 
 
1 Reversible within the context of the IEME approximation i.e. the instantaneous 
establishment of microscopic equilibrium. The IEME approximation defines equilibrium time 
periods as an interval sufficiently long for satisfying ergodicity requirements of the particular 
parameter being measured [Hlavacek et al., 1999]. 
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Figure 3: Basic pathways of protein aggregation. In the first pathway, proteins 
form small disordered aggregates, developing into large amorphous 
precipitate. In the second pathway, the protein will form pre-fibrillar 
intermediates, and then amyloid fibrils (taken from Treweek et al., 2003). 
 
   Many diseases, especially neurodegenerative diseases, are 
caused by misfolded proteins. These type of diseases are called 
protein conformational diseases or proteopathies (Ecroyd and 
Carver, 2008). Misfolded proteins are usually degraded by the 
ubiquitin proteasome system and lose their normal functions, 
hence cause protein conformational diseases. Toxic species can 
form during protein misfolding and aggregation, and disrupt the 
functions of cells, tissues and organs, causing protein 
conformational diseases (Cohen and Kelly, 2003). The risk of 
protein conformational diseases increases with age (Walker and 
LeVine, 2000). It is partly because the ability of cells to degrade 
or refold abnormal proteins becomes increasingly poorer as the 
cells grow older (Walker and LeVine, 2000). For example, prions 
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arise from a type of misfolded protein able to form amyloid fibrils 
which then cause Creutzfeldt-Jakob disease (Jarrett and Lansbury, 
1993). Alzheimer’s and Parkinson’s disease are also characterized 
by the formation of plaques/deposits in the brain that contain 
amyloid fibrils (Huang and Mucke, 2012; Jankovic, 2008). Protein 
misfolding and aggregation are also related with cataract, some 
types of cancers, some types of heart diseases and multiple 
sclerosis (Kelly, 1998; Dobson, 2001; Stefani, 2004; Hall and 
Edskes, 2009; Hall and Edskes, 2012). 
 
3. Molecular Chaperones and their role in preventing 
aggregation  
 
3.1 Molecular Chaperones 
   Molecular chaperones are proteins which can assist with other 
proteins’ folding. They are able to identify protein molecules 
which are not correctly folded, and interact with them through 
different mechanisms. Many proteins often cannot fold into their 
native states by themselves and require the assistance of molecular 
chaperones to correctly fold and function (Chaudhuri and Paul, 
2006). Molecular chaperones are considered to be the first 
protective mechanism of cells against various stresses, such as 
elevated temperature, pH shift, oxidative stress and possibly 
changes in the levels of macromolecular crowding (Hall, 2002; 
Hall and Dobson, 2006). In the following sections I provide a short 
summary of the chaperone proteins that formed the basis of the 
experimental systems studied during my postgraduate research.  
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Figure 4: A schematic mechanism of chaperone action of sHsps, which 
selectively interact with target proteins on their off-folding pathways to 
prevent protein aggregation (figure taken from Carver et al., 2003). 
 
3.2 Alpha B-crystallin 
   The crystallins are a protein family which are most prominent in 
the eye lens and cornea. The main function of crystallins is 
maintaining the transparency of said organs by inducing a well-
ordered ‘crystal-like’ arrangement (Andley, 2007). Alpha 
crystallin is the predominant eye lens protein. Aside from their 
structural function, alpha crystallin also functions as a molecular 
chaperone, preventing protein aggregation in the eye lens.  
   Alpha crystallin is composed of two basic subunit types - alpha 
A and alpha B (Ecroyd and Carver, 2009). Alpha B-crystallin is 
also expressed in abundance in other tissues besides the eye lens, 
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such as brain, lung and muscle (Kato et al., 1991). Both alpha A 
and alpha B-crystallin contain flexible C-terminal extensions 
(Carver et al., 1992) and are members of the small heat-shock 
protein (sHsp) family of molecular chaperones (Figure 4, Carver 
et al. 2003). 
 
3.3 14-3-3 proteins 
   The 14-3-3 protein family is highly conserved and expresses in 
abundance in all eukaryotic cells, and also it is one of the most 
abundant cell proteins (Moore and Perez, 1967; Martin et al., 
1994). They are able to bind to and interact with more than 200 
different proteins, suggesting their possible importance as a hub 
interacting protein or chaperone protein (Sun et al., 2009). Muslin 
et al. first discovered 14-3-3 proteins' phosphoserine-binding 
ability (Muslin et al., 1995). Most 14-3-3 protein binding partners 
are phosphorylated proteins that are capable of binding to its 
amphipathic central groove (Fu et al., 2000).  
   The 14-3-3 proteins also exhibit a small heat shock protein like 
chaperone ability, by inhibiting the thermally and chemically 
induced aggregation of several target proteins in vitro (Yano et al., 
2006; Williams et al., 2011). However, this chaperone ability has 
still not been extensively investigated. 
 
4. Protein aggregation turbidity assay 
   To investigate the individual and combined effects of the 
molecular chaperone abilities of both 14-3-3zeta and alpha B-
crystallin on the aggregation of proteins a vital first step is the 
development of a robust and simple assay for examining the 
aggregation of proteins. By far the most common in vitro method 
to monitor protein aggregation is the turbidity assay (Dolado et al., 
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2005; Sant'Anna et al., 2016) (Figure 5).  
 
 
Figure 5: Schematic describing the transmission-based measurement of 
excess solution turbidity of protein aggregates in which the transmitted light 
intensity (IT) is measured in relation to the incident light intensity (I0) using 
a standard spectrophotometer or plate reader (Zhao et al., 2016).  
 
  All protein aggregates scatter light in the visible wavelength 
region since their size ranges from nanometer to micrometers 
(Bohren and Huffman, 2008; Doty and Steiner, 1950; Invernizzi et 
al., 2012; Stoppini and Bellotti, 2015). This characteristic 
combined with a lack of absorption in the visible wavelength 
region makes the low-cost turbidity assay a particularly attractive 
method for monitoring protein aggregation (Andreu and Timasheff, 
1986; Mahler et al., 2009). Colloidal solution turbidity is generally 
considered to exhibit a linear relationship with the aggregation 
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reaction.  However, this assumption is usually not based on 
convincing supporting experiments or theory. The turbidity of a 
colloidal solution is not only determined by the size, but also the 
shape of the particles. As a result, analyzing the relationship 
between solution turbidity and protein aggregation can be quite 
challenging (Camerini-Otero et al., 1978; Garcia-Lopez and 
Garcia-Rubio, 2008; Garcia-Lopez et al., 2006; Hall and Minton, 
2005; Korolevskaya and Khlebtsov, 2010; Mahler et al., 2009; 
Moody et al., 1996; Silver and Birk, 1983). In my postgraduate 
research I examined and developed improved methods for 
simulating and analyzing turbidity profiles of mixed protein 
aggregation reactions (Hall et al., 2016a; Hall et al., 2016b; Zhao 
et al., 2016), which will greatly facilitate the understanding of 
protein aggregation and the effect of molecular chaperone 
reactions. 
 
5. Questions relating to turbidity assay and its quantitative 
interpretation 
 
5.1 Simulating turbidity of protein aggregates of different sizes 
   In my first paper (Hall et al., 2016a), I contributed to developing 
a hybrid method for simulating turbidity of protein aggregates of 
different sizes in the low concentration limit. This simulation 
utilises a combination of the Rayleigh, the Rayleigh-Gans-Debye 
(RGD) and approximate forms of the Mie scattering equations 
(Bohren and Huffman, 2008; Elimlech et al., 1995; Garcia-Lopez, 
2005; Mezzenga and Fischer, 2013; Wickner et al., 2007). This 
hybrid approach was used to generate empirical interpolating 
functions, which may be used for both simulation and analysis of 
turbidity profiles. 
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5.2 Quantifying the variability in the amyloid aggregation 
assay 
   In my second paper (Hall et al., 2016b), I helped to develop a 
method for quantifying the variability in the amyloid aggregation 
assay. We investigated the variability in the amyloid aggregation 
kinetics, and developed methods for its simulation, identification 
and analysis. Rather unexpectedly, such an analysis had not been 
previously developed despite it being the fundamental cornerstone 
of all differential analyses of drug and condition effects upon the 
protein aggregation reaction. 
 
5.3 Physical chemistry of the turbidity signal 
   In my third paper (Zhao et al., 2016), I reviewed the physical 
chemistry of the turbidimetric assay methodology, investigating 
the reviewed information with a series of pedagogical kinetic 
simulations. We particularly focused upon recent literature relating 
to ultra-microscope image analysis (Hall, 2012; Usov and 
Messenga, 2015), light scattering and turbidity development by 
protein aggregates (Garcia-Lopez et al., 2006, 2008; Hall et al., 
2016a), and computer simulation of the kinetics of amyloid and 
other aggregate types (Adachi et al., 2015; Hall et al., 2015; Hall 
et al., 2016a). 
 
 
 
 
 
 
 
18 
 
Paper 1: Protein aggregate turbidity: Simulation of turbidity 
profiles for mixed aggregation reactions 
 
   The first of the three papers published during my studies at the 
Australian National University Research School of Chemistry 
(Hall et al. 2016a) looked at the turbidity signal – which was the 
basis of my assay procedure for looking at the effect of chaperone 
action. In this paper I re-examined the already published 
theoretical relations for describing the turbidity of protein 
aggregates. In this paper I contributed to developing a hybrid 
method for simulating turbidity of protein aggregates of different 
sizes in the low concentration limit. This simulation utilizes a 
combination of the Rayleigh, the Rayleigh-Gans-Debye (RGD) 
and approximate forms of the Mie scattering equations (Bohren 
and Huffman, 2008; Elimlech et al., 1995; Garcia-Lopez, 2005; 
Mezzenga and Fischer, 2013; Wickner et al., 2007). This hybrid 
approach was used to generate empirical interpolating functions, 
which may be used for both simulation and analysis of turbidity 
profiles. 
 
Protein aggregate turbidity: Simulation of turbidity profiles for mixed-
aggregation reactions
Damien Hall a, b, *, Ran Zhao a, Ian Dehlsen a, Nathaniel Bloomfield a, Steven R. Williams a,
Fumio Arisaka c, d, Yuji Goto b, John A. Carver a
a Research School of Chemistry, Australian National University, Acton, ACT 2601, Australia
b Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan
c Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501,
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a b s t r a c t
Due to their colloidal nature, all protein aggregates scatter light in the visible wavelength region when
formed in aqueous solution. This phenomenon makes solution turbidity, a quantity proportional to the
relative loss in forward intensity of scattered light, a convenient method for monitoring protein aggre-
gation in biochemical assays. Although turbidity is often taken to be a linear descriptor of the progress of
aggregation reactions, this assumption is usually made without performing the necessary checks to
provide it with a firm underlying basis. In this article, we outline utilitarian methods for simulating the
turbidity generated by homogeneous and mixed-protein aggregation reactions containing fibrous,
amorphous, and crystalline structures. The approach is based on a combination of RayleigheGanseDebye
theory and approximate forms of the Mie scattering equations.
Crown Copyright © 2015 Published by Elsevier Inc. All rights reserved.
Protein aggregation is a complex phenomenon of major
importance to the fields of medicine [1e3], biology [4,5], and in-
dustry [6,7]. Because protein aggregates span the nanometer to
micrometer size range, they tend to scatter an appreciable amount
of light in the visible region of the spectrum1 [8] (see also chaps. 1
and 5 in Ref. [9]). Their scattering potential, coupled with their
general lack of absorption over this region, has meant that visible
wavelength solution turbidity has been a cornerstone method for
monitoring protein aggregation reaction kinetics [10,11]. However,
because the extent of light scattered by an aggregate is a function of
both the size and shape of the particle, the unambiguous analysis of
the turbidity signal for comparative studies of protein aggregation
can be challenging [11e18]. In the following series of articles, we
describe methods for simulating and analyzing turbidity profiles of
mixed protein aggregation reactions. In this first article of the
series, we develop robust methods for simulating the turbidity
generated by different classes of protein aggregates in the low
concentration limit.2 The simulation approach makes use of a
combination of Rayleigh, RayleigheGanseDebye (RGD), and
approximate forms of the Mie scattering equations [19,20] (see also
chaps. 4e6 in Ref. [9]) as a basis for generating empirical interpo-
lating functions that can be used in a straightforward manner for
both simulation and analysis of turbidity profiles.
Utilitarian approaches to simulating turbidity
Although the topic of aggregate turbidity has been explored
previously [10e18], the range of theoretical approaches used, prior
to the current one, have been either restricted to a single size
regime (e.g., the RayleigheGans limit [9e13]) or lacking of a format
that can be easily adopted by those wanting to translate their
experimentally accessible parameters into useful theory-based
Abbreviations used: RGD, RayleigheGanseDebye; AD, anomalous diffraction.
* Corresponding author. Institute for Protein Research, Osaka University, Suita,
Osaka 565-0871, Japan.
E-mail addresses: damien.hall@anu.edu.au, damienhall30@gmail.com (D. Hall).
1 When formed in a medium having a substantially different refractive index
from them.
2 By low concentration limit, we mean free of significant external interference
effects that allow the system to comport to the single incoherent scattering crite-
rion described in chap. 3 of Ref. [9].
Contents lists available at ScienceDirect
Analytical Biochemistry
journal homepage: www.elsevier .com/locate/yabio
http://dx.doi.org/10.1016/j.ab.2015.11.021
0003-2697/Crown Copyright © 2015 Published by Elsevier Inc. All rights reserved.
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simulations [14e18]. In regard to this point, the major obstacles
have been the following:
1. Lack of a nomenclature for reducing protein aggregates to a
limited number of structural models that correctly relate mass,
refractive index, and shape.
2. Lack of easily calculable turbidity models that are applicable
over a range of aggregate sizes and shapes.
Our primary goal in this article was to develop utilitarian
methods for simulating turbidity profiles of mixed-protein aggre-
gation reactions. By utilitarian, we mean analytical expressions
having relatively few independent variables that can be used for
quantitative/semi-quantitative prediction and analysis of experi-
mental results.
Mesoscopic models of protein aggregates
Depending on the nature of the aggregation pathway, a number
of different classes of protein aggregate structures may be formed
[6,21e23] (Fig. 1). Amorphous aggregates [6,21e23] for which the
internal arrangement of monomers exhibits no long-range struc-
tural ordering [21,24] may be produced. Alternatively, semi-
crystalline structures, such as one-dimensional fibers [6,21e23]
and three-dimensional crystals [6,25], that do display significant
long-range ordering within the aggregate configuration (cf.
Refs. [24] and [26]) may be produced. In this section, we describe a
general system for categorizing the range of possible protein
aggregate structures into a limited subset, with the intention of
using this subset as the basis of quantitative simulation and char-
acterization procedures. Toward this goal, a protein aggregate
Fig.1. (A) Various types of protein aggregatedamorphous, crystalline, and fibrous. (B) Schematic of mesoscopic structural approximations for rod-like and spherical-shaped aggregates in
the scattering experiment. Aggregate packing density is defined by the parameter a. (C) Scattering cross-sectional area as a function of angle of presentation, f, for rods and spheres.
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composed of imonomers may be usefully defined in terms of three
experimentally realizable properties: the molecular weight,Mi, the
shape, Si, and the volume trace, (Vi)TRACE [27,28]. Quantitative de-
scriptions of these three parameters are given in Eq. (1). Two
limiting approximations of the protein aggregate shape [28,29] are
considered: an arbitrarily diffuse rod, defined by a trace length Li
and a trace radius Ri, and an arbitrarily diffuse sphere, singly
characterized by Ri (Eq. (1b) and Fig. 1):
Mi ¼ iM1 (1a)
ðViÞTRACE ¼
iM1y
aiNA
(1b)
Si ¼
(
rod; Li ¼ ðViÞTRACE
.
pR2i

sphere; Ri ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3ðViÞTRACE
ð4pÞ3q : (1c)
In Eq. (1b), NA is Avogadro's number and (Vi)TRACE refers to the
volume of the aggregate approximated by tracing a large body over
the surface to produce an approximately regular shape [27,28]. The
term ai describes the effective packing density of the trace volume
(i.e., the fraction of (Vi)TRACE actually occupied by protein), and y
refers to the protein partial specific volume that, to a first approx-
imation, is taken as having a constant value of approximately
0.73 ml/g [30]. Defining a in the manner outlined by Eq. (1b) allows
it to be used to parameterize the transition between compact and
diffuse states (aDIFFUSE < aCOMPACT  1), with the intention that a
higher value of a would be more appropriate for crystal-like ag-
gregates, whereas a lower value would describe a less dense
amorphous aggregate [6,21e23,31].
As particles get larger and denser, the physics of scattering
becomes less concerned with particle volume and more con-
cerned with the relative orientation of the particle, fi, and the
average area that it presents to the incident light, <Ai> [9,20]. For
the case of a sphere of uniform composition, the scattering
relationship is isotropic, thereby making the average physical
cross-sectional area equal to that defined by its trace volume
radius (Eqs. (2a) and (2b)). For the case of a rod, an estimate of
Fig.2. Schematic of (A) general scattering experiment showing the interaction of non-
polarized light with a molecule located at the origin with an outer sphere (not to scale)
representing all possible points of detection of the scattered light at a set radial dis-
tance and solid angle. (B) The intensity envelope surrounding the scattering molecule
showing the scattering intensity as a function of the sub-apex of the spherical solid
angle.
Fig.3. Schematic of the three general scattering regimes considered in this work. (A)
Rayleigh scattering, where the scattering particle is small in relation to the wavelength of
light (i.e., <Ri> < l/20) (blue arrow represents the magnitude of the electric field). (B)
RayleigheGanseDebye scattering, where the particle can be relatively large in relation to
the wavelength of light sufficient to experience out of phase scattering effects but not so
large as to significantly decrease the intensity of incident light (i.e., l/20 < <Ri> < l/2)
(blue arrow represents the magnitude of the electric field). (C) Mie scattering, where the
particle is sufficiently large to experience out of phase scattering and to diminish the
intensity of incident light moving through the particle. (D) Schematic describing orien-
tation effects on the intra-particle path length of the incident light in the Mie scattering
regime for a variety of shapes. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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<Ai> in terms of Li and Ri can be obtained by first performing
spherical integration to find the area of projection (Eq. (2b)) (e.g.,
Ref. [32]):
AiðfiÞ ¼ pR2i ∴hAii ¼ pR2i for a sphere (2a)
AiðfiÞ ¼ pR2i cos fi þ 2LiRi sin fi for a rod:
∴hAiiz2R2i þ 2=pLiRi
(2b)
With coarse-grained models and formalism suitable for
describing both the physical dimensions and the area of projection
for rod-like fibers, crystals, and amorphous aggregates (conforming
to spherical shape), we now introduce methods for calculating the
wavelength-specific turbidity.
Light scattering and turbidity transformations
The wave model pictures light as a pair of coincident, yet
perpendicular, traveling electric and magnetic vectors oscillating at
a frequency, f, over a wavelength, l [9,33]. Each time a light wave
train encounters some element of matter, the electric field vector
displaces the normal charge distribution, causing it to oscillate at
the characteristic frequency of the light. Conservation laws require
that this accelerated charge re-emit energy in the form of another
light wave of the same wavelength, producing the phenomenon
known as elastic light scattering3 [9,33]. Lord Rayleigh quantified
the relationship between the measured intensity of the scattering
(at a point p ¼ [r,q]) from a single particle (located at the origin) for
the particular case4 where the particle is small in relation to the
wavelength of light (Eq. (3a)) (Fig. 2) [34]. Under these Rayleigh-
limiting conditions, the total amount of light scattered away from
the forward direction, IS, can be calculated by spherical integration
of the angle-specific scattering intensity, i(r,q) (Eq. (3b)):
iðr; qÞ ¼ i0
r2
"
9p2ðViÞ2TRACE
2l4
 
m2i  1
m2i þ 2
!2
1þ cos2 q
#
(3a)
IS ¼ 2pr2
Zp
0
iðr; qÞsinðqÞdq (3b)
Fig.4. Schematic of the RGD approximation for (A) spheres and (B) rods of arbitrary size. (C) Results of RGD calculations (black symbols,C) for different sizes of spheres scaled in relation to
the wavelength of light and the solvent refractive index (x1 ¼ Ri n/l). Solid line represents best fit to empirical equation defined by Eq. (11a), and green symbols (C) represent overlaid data of
Camerini-Otero and Day [12]. (D) RGD output for different lengths and widths of rods relative to solution refractive index and the wavelength of light (x2 ¼ Li n/l). Lines represent best fits to
empirical expression shown as Eq. (11b). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
3 Elastic light scattering refers to the case where the scattered and incident ra-
diation has the same wavelength. Inelastic light scattering refers to the case where
some energy is absorbed, donated, or dissipated by the molecule with subsequent
change in wavelength between incident and scattered radiation.
4 Where q represents the forward scattering apical sub-angle of the solid angle.
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I0 ¼ A0i0 (3c)
IS
I0
¼ 24p
3ðViÞ2TRACE
l4
 
m2i  1
m2i þ 2
!2
1
Ao

(3d)
IS
I0
¼ LCi
24p3ðViÞ2TRACE
l4
 
m2i  1
m2i þ 2
!2
: (3e)
In Eq. (3), i0 refers to the initial forward intensity of light and A0
is the area of illumination by the light beam such that the area
integrated power relation for the incident light is Eq. (3c). For a
single particle, the ratio of power lost to that incident is given by Eq.
(3d). For a solution in which there are multiple particles in the
incident beam, the total relative power loss due to scattering is
shown in Eq. (3e), where Ci is the number density of particle i in
solution and L is the optical path length.
The mi term in Eq. (3) refers to the relative refractive index of the
aggregate (relative to the solvent). A numerical value of mi can be
calculated on the basis of the solvent refractive index, no, and the in-
cremental change in solution refractive indexwith incremental change in
aggregateweight concentration of the particle, dn/dci (Eq. (4a)). Empirical
formulas developed from tabulated data can be used to account for the
wavelength dependence of no and dn/dci [35] (Eqs. (4b) and (4c)):
mi ¼ 1þ ai½ðdn=dcÞð1=yÞ=n0 (4a)
nðlÞ ¼ 1:3403
h
0:9922þ 2:31 1015
.
l2
i
(4b)
dn=dciðlÞ ¼ 0:19 103
h
0:925þ 2:2 1014
.
l2
i
: (4c)
Eq. (3) is valid for particles much smaller than the wavelength
of light (Ri < l/20) when illuminated by an unpolarized source. In
a standard spectrophotometer arrangement, the scattering of
the light beam by the particles in solution decreases the power
of the transmitted light reaching the detector, ID ¼ I0  IS, in a
manner proportional to the length of the solution light path. The
path length-corrected excess turbidity5 is defined as the natural
logarithm of the fractional reduction of the incident power, I0,
due to cumulative scattering outside of the forward direction, IS,
per path length, dL, traveled (Eq. (5a)).6 This logarithmic term
can be expressed as an infinite series (Eq. (5b)) that can be
adequately described by the leading term for values of Is/I0 < 0.1,
that is, for transmittance of greater than 90% (Eq. (5c))7
[9,36,37]:
t ¼ 

1
I

dI
dL
¼ 1
L
loge

1 IS
I0

¼ 2:303ðO:D:Þ (5a)
t ¼ 1
L
X∞
n¼1
1
n

IS
I0
n
(5b)
t
ðlimt/0Þ
z
1
L

IS
I0

: (5c)
Inserting Eq. (3e) into Eq. (5b) and truncating the expansion
at the first term (Eq. (5c)) produces an expression that accurately
describes turbidity values in the low concentration and small
particle size limits (i.e., the Rayleigh limit ~ Ri < l/20, ti / 0). As
the calculated extent of scattered light IS/IO increases beyond
~0.1, the correction described in Eq. (5a) must be performed to
correct for errors introduced by premature truncation of the
series. In the dilute limit,8 the turbidity for a solution of differ-
ently sized and shaped aggregates is equal to the sum of the
contributions to turbidity from each particle (Eq. (6)):
t
ðlimt/0Þ
¼
XN
i¼1
ti: (6)
Fig.5. (A) RGD and AD estimation of Q for sphere-like aggregates for three
different wavelengths (400 nm [blue], 450 nm [red], and 500 nm [green]). Note
the smooth one-dimensional polynomial fitting of Q across the theory juncture
acting to fill missing data points. (B) Results of RGD approximations of Q for rod-
like aggregates. Note the region of extension for Q beyond the RGD theory con-
forming to its earlier characteristic dependence. (For interpretation of the refer-
ences to color in this figure legend, the reader is referred to the Web version of
this article.)
5 By excess turbidity, we mean solvent baseline subtracted.
6 Thereby making it equal to loge(10) z 2.303 multiplied by the solvent-
corrected solution optical density (OD).
7 With a value of IS/I0 < 0.1 corresponding to an error in the turbidity of less than
5%.
8 The dilute limit refers to the concentration range at which we may neglect
significant re-scattering of the scattered light, by other aggregate particles in so-
lution, back into the collimated detection pathway. This re-scattering effect is
sometimes called external interference. The dilute limit is not influenced by in-
ternal interference due to the particles being large in relation to the wavelength of
light; therefore, Eq. (7) can retain its validity across the range of sizes.
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Eq. (6) is an important relation, the veracity of which we
depend on throughout this work and the consecutive articles in
this series.
Calculating turbidity for different particle sizes
Eq. (5) provides us with a general means for understanding
the relationship between the total scattered light and the solu-
tion turbidity. However, as discussed in this section, there are a
range of different theoretical models, of increasing complexity,
for calculating the aggregate turbidity across different particle
size regimes [9,19,20,36,37]. Because a major aim of the current
work was to integrate these different approaches to produce a
useful empirical interpolation, it will prove helpful to recast the
turbidity equation, shown by Eq. (5), in the form outlined by Eq.
(7):
ti
ðlimt/0Þ
¼ CiFiQi: (7)
As formulated by Eq. (7), ti, the turbidity per meter at
limiting dilution, is composed of three terms: Ci, Fi, and Qi. Ci is
the scattering particle concentration (units of molecules m3),
Fi is the idealized turbidity per unit molecular concentration
that would be generated if the particle scattered light as if it
were a point mass (units of m2$molecule1), and Qi is the unit-
less transmittance form factor that modulates the ideal
turbidity to account for the effects of the shape and size of the
particle. In what follows, we consider the appropriate func-
tionalization of Eq. (7) for three particle size regimes of
scattering.
Rayleigh approximation
For particle sizes smaller than l/20 (Fig. 3A), we may describe
the functional form of Eq. (7) in terms of the trace volume radius
described in Eq. (1c):
ðFiÞRAYLEIGH ¼
24ðViÞ2TRACEp3
l4
 
m2i  1
m2i þ 2
!2
(8a)
ðQiÞRAYLEIGH ¼ 1: (8b)
An important distinguishing feature of Rayleigh-type scattering
is that it exhibits an approximately inverse fourth-power depen-
dence of scattering and turbidity on wavelength [19,37] (see also
chap. 5 of Ref. [9]).
RGD approximation
Predicting the extent of light removed from the forward direc-
tion due to scattering becomes progressively harder as the aggre-
gate size increases (in relation to the wavelength of light) for two
reasons (Fig. 3):
1. In large aggregates, different regions of the particle will
sample different phases of the incident light's oscillating
electric field vector, resulting in a complex super-positioning
of scattered light [16,19,37,38] (see also chap. 6 of Ref. [9])
(Fig. 3B).
Fig.6. Smooth two-dimensional polynomial fitting of log10Qi for spherical aggregates
as a function of Ri and ai for three different values of l: (A) l ¼ 400 nm; (B) l ¼ 450 nm;
(C) l ¼ 500 nm. Two-dimensional polynomial was of the form shown by Eq. (14), with
values of the coefficients given in Appendix A.
D. Hall et al. / Analytical Biochemistry 498 (2016) 78e94 83
2. As aggregates grow even larger, there exists a significant dimi-
nution of the intensity of the incident light as it moves through
the aggregate [17,19,20,37] in addition to the phase difference
(Fig. 3C and D).
The RGD formalism addresses the first difficulty but not the
second and so is appropriate for particles of rotationally aver-
aged cross-sectional radius, hRii, approaching half the wave-
length of light, that is, 2hRii < l/no(l) [38] (see also chap. 6 of
Ref. [9]). In the RGD approach, the net scattering intensity
produced by the aggregate is treated as the superposition of the
scattering from N discretized centers within the aggregate
(without correcting for diminution of incident light). The frac-
tional reduction in the scattered light intensity due to intra-
particle interference (i.e., i(r,q)real/i(r,q)ideal) is termed the par-
ticle form factor and is denoted by P(q,l). It can be calculated
based on knowledge of the internal distances separating the
discretized scattering centers, dij, and the magnitude of the
scattering vector, h, through use of the Debye equation (Eq. (9))
[33,36,37]:
Pðq; lÞ ¼ 1
N2
XN
i¼1
XN
j¼1
sin

hdij
	
hdij
(9a)
h ¼ 4pn sinðq=2Þ=l (9b)
dij ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
xi  xj
	2 þ yi  yj2 þ zi  zj	2
r
: (9c)
Insertion of Eq. (9a) into Eq. (3a) along with its subsequent
spherical integration, due to an unpolarized light source, yields Qi,
the transmittance form factor (Eq. (10b)):
ðFiÞRGD ¼ ðFiÞRAYLEIGH (10a)
ðQiÞRGD ¼
Zp
0
Pðq; lÞ

1þ cos2 q

sin qdq: (10b)
Eq. (10b) was solved numerically to generate values of Qi(l) for
discrete approximations of rods and spheres over the RGD regime
[8,12,14,39] (Fig. 4). These data were then empirically fitted using
either a sigmoidal-like function (spheres, Eq. (11a)) or a hybrid
sigmoidal-type inverse function (rods, Eq. (11b)) to re-parameterize
it in terms of the characteristic dimensions of radius or length (or
both). The resultant best-fit equations are shown as Eq. (11a)
(spheres) and (11b) (rods):
Spheres:
ðQiÞRGDðx1Þ ¼ 1 0:955

1 e6:48x1
2:40
for x1 <0:5;
(11a)
where x1 ¼ Rin(l)/l and Qi are defined for x1 ¼ [0, 0.5].
Fig.7. Smooth two-dimensional polynomial fitting of log10Qi for rod-like aggre-
gates as a function of Li and log10Ri for three different values of l: (A) l ¼ 400 nm;
(B) l ¼ 450 nm; (C) l ¼ 500 nm. Two-dimensional polynomial was of the form
shown by Eq. (15), with values of the coefficients given in Appendix A.
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Rods:
where x2 ¼ Lin(l)/l, x1, and Qi are defined for x1 ¼ [0, xR]; x2 ¼ [0, 3].
Mie scattering calculations for spheres
TheMie scattering equation [40] is an exact theoretical solution to
the scattering problem for particles of arbitrary size in relation to the
wavelength of light. Generally speaking, the procedure (Fig. 3C and
D) accounts for change in positional intensity of the incident light as
it travels through the particle in addition to calculation of the mul-
tiple internal scattering superposition effect [9,40]. For nonpolarized
light, the first aspect of this statement can be simply formalized as
Eq. (12), for which the terms have been defined previously:
Iðx; y; zÞ ¼ f ðx; y; z;AiðfÞ; Si;mi; lÞ: (12)
The anomalous diffraction (AD) approximation constitutes a very
accurate and simple closed-form representation of theMie scattering
equations for spherical aggregate geometry [20,37,40] valid for par-
ticles ranging in size from approximately two times the wavelength
to 15 times the wavelength of light (i.e., 2l  hRii  ~15l) that also
have a relative refractive index, mi, less than 1.3 [20]:
ðFiÞAD ¼ ðFiÞRAYLEIGH (13a)
ðQiÞAD ¼


2

4
r

sin rþ

4
r2

ð1 cos rÞ
,"ðFiÞRAYLEIGH
p
D
R2i
E
#
(13b)
r ¼ 4phRiiðmi  1Þ
l
: (13c)
Two notable features of the Mie/AD description Eq. (13) are (i) the
damped decaying sinusoidal nature of the turbidity as the aggregate
size increases and (ii) the lack of uniqueness in the value of the pre-
dicted turbidity against particle size. In relation to aggregate growth,
an interesting extension of these two points is that the turbidity of
spherical aggregates should, after an initial rise, undergo a decrease as
the average aggregate radius exceeds the magnitude of 2l.
For the case of stiff rods of high aspect ratio, the loss of intensity
of the incident light through the rod is significant when the rods lie
parallel to the incident beam, that is, f ¼ 0 [41,42] (see Figs. 1C and
3D). This angular dependence leads to small deviations from the
RGD case for randomly oriented fibers; however, large changes for
nematically ordered fibers can occur, depending on the angle of
fiber alignment relative to the incident light [41,42]. As such, a
suitable approximation for estimating Qi(l) for low concentrations
of randomly oriented rod-like fibers beyond the RGD domain,
where Li > 3l/no(l), involves assuming that the limiting extrapo-
lation over the domain [l/no(l),3l/no(l)] extends indefinitely.
Experimental and theoretical support for this contention was
originally provided by Gaskin and coworkers [43] and Berne [44],
who showed that turbidity generated by solutions composed of
long microtubule rods remained approximately unchanged after
surpassing a size corresponding to Li  3l/no(l).9 The basic cor-
rectness of this approximation is also borne out via more complex
simulations based on numerical evaluations [9,40,42].
Single functions for Q for spheres/rods
We previously outlined three methods for calculating Q over
different and noncontiguous sets of wavelength domains for rod-like
and spherical aggregates of varying internal density. In this section,
we first outline strategies for estimating values of Q in regions not
covered by either theoretical approach (Fig. 5). We then use these
interpolated/padded data sets to develop single empirical functions
that approximate Q over the entire range of aggregate dimensions,
nanometers to tens of micrometers, in the visible wavelength region.
Spheres e padding data/continuous description
To develop a continuous description of Q versus sphere radius, a
one-dimensional interpolating polynomial was first used to fill
values of Q over the intervening region between the RGD and AD
results (Fig. 5A). It can be noted from Eqs. (13b) and (13c) that in the
AD description, Q is dependent on the effective density of protein
[20,41]. As such, a set of data describing the dependence of Q on
sphere radius and aggregate density a was simulated using Eqs.
(11a) and (13), and the resultant collected data set was fitted to a
high-order two-dimensional polynomial. For reasons relating to
improving the goodness of the achieved fit, log10Q was fitted
against a and R (Fig. 6) with the form of the characteristic empirical
equations shown as Eq. (14) (coefficients given in Appendix A for l
equal to 400, 450, and 500 nm):
log10QiðRi;aiÞ ¼
XN
j¼0
XN
k¼0
uj;kðRiÞjðaiÞk: (14)
Rods e padding data/continuous description
Based on the arguments advanced in the preceding section,
values for Q covering a range of amyloid sizes with regard to length
(0 < Li < 30 mm) and radius (0.25 nm < Ri < 15 nm) were calculated
using Eqs. (11a) and (11b). Again a high-order two-dimensional
polynomial was used to find an appropriate interpolation, this time
for log10Q against R and L (Fig. 7). As can be noted from the asso-
ciated residual plot, this fitting procedure provides a suitable
description of the data set within the limits of the specified
ðQiÞRGDðx1; x2Þ ¼
8>>>><
>>>>:
1 0:955

1 e6:48x1
2:40
for x1 < xR
ðQiÞRGDðx1Þ


1 0:995

1 e1:08x2
1:275
for x1 ¼ xR;x2 <1
1
ðQiÞRGDðx1Þ
.
2:40x0:952

for x1 ¼ xR; x2  1
; (11b)
9 Such a finding can be rationalized mathematically by inserting relevant values
of Q from Eq. (10b) for L > 3l/no(l) into the general turbidity expression developed
here (see Appendix A).
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domain.10 The form of the polynomial function is shown as Eq. (15),
with the exact values for these characteristic empirical equations
for l equal to 400, 450, and 500 nm given in Appendix A:
log10QiðLi;RiÞ ¼
XN
j¼0
XN
k¼0
wj;kðLiÞjðRiÞk: (15)
Simulation of total aggregate turbidity
In the preceding sections, we outlined utilitarian approaches for
(i) assigning protein aggregate dimensions in terms of the degree of
polymerization, i, a presumed shape, Si (which we limit to a cy-
lindrical rod or a sphere), and an effective packing density, ai, and
(ii) an empirical interpolation of three forms of light scattering
theory that cover the range of sizes from effective point particles
through to a 10-mm diameter sphere and a 30-mm length, 30-nm
width cylindrical rod. In combination, these approaches can be
used to calculate the turbidity of a solution of mixed protein ag-
gregates using Eqs. (16) and (17) (used with Eq. (5a) for the loga-
rithmic correction):
Spheres: Eq. (16)
where
Ri ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3
4p

iM1y
aiNA

3
s
Rods: Eq. (17)
where
Li ¼ 0;Ri ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3
4p

iM1y
aiNA

3
s
when Ri <Rrod
Li ¼

iM1y
aiNA

pR2rod when Ri ¼ Rrod:
In conjunctionwith the empirical interpolations for Q developed in
Eqs. (14) and (15), the above formulation allows for straightforward
transformation of protein aggregate distributions into turbidity traces
over a wide range of sizes for a limited number of protein aggregate
shapes. Figs. 8 and 9 demonstrate a set of practical numerical examples
of turbidity generated by a 1-mg/ml solution of a protein of monomer
molecular weightM1 ¼ 5000 g/mol for a range of aggregate densities,
a, at three different wavelengths: 400, 450, and 500 nm.
A test simulation was set up to demonstrate the incorporation of
the turbidity transformation procedure into a kinetic simulation of
aggregate growth (Fig. 10). In a similar vein to thework of Yoshimura
and coworkers [22], Hall and coworkers [31], and Adachi and co-
workers [45], two types of protein aggregation reaction, amorphous
and amyloid, were considered to be in competition for a common
monomer pool. A simplified set of equationswas used to describe the
average properties of the two competing polymer types, designated
A for amyloid and G for globular amorphous (Eqs. (18e20)):
Eq. Set (18)
nM!k1 N or bM!k3 B
N þM!k2 Anþ1 or BþM!k4 Gbþ1
Anþ1 þM!k2 Anþ2 or Gbþ1 þM!k4 Gbþ2
…
Ai1 þM!k2 Ai or Gj1 þM!k4 Gj
(18)
dCN
dt
¼ k1ðCMÞn  k2CNCM
d
P
CAi
dt
¼ k2CNCM
d
P
iCAi
dt
¼ ðnþ 1Þk2CNCM þ k2
X
CAiCM (19)
dCB
dt
¼ k3ðCMÞb  k4CBCM
d
P
CGj
dt
¼ k4CBCM
d
P
jCGj
dt
¼ ðbþ 1Þk4CBCM þ k4
X
CGjCM (20)
Each mechanistic pathway is regulated by a set of rate
tiði;M1;Ci;ai; lÞ ¼
24Ci

M21 i
2y2
.h
a2N2A
i
l4
 
m2i  1
m2i þ 2
!2
ðQiÞspherefRi;aig; [16]
tiði;M1;Ci;ai;Rrod; lÞ ¼
24Ci

M21 i
2y2
.h
a2N2A
i
l4
 
m2i  1
m2i þ 2
!2
ðQiÞrodfLi;Rig; (17)
10 Although the residuals are not random and exhibit slight oscillatory behavior,
the associated error is very small.
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constants and a critical nucleus species [A; k1, k2, N], [G; k3, k4, B].
Fig. 10 describes the results of simulations carried out by nu-
merical integration of Eq. Sets (19) and (20), followed by subse-
quent transformation of the simulated aggregate product into
excess solution turbidity by Eqs. (16) and (17). The left-hand
panels of Fig. 10 show the kinetics of the effective weight con-
centration of each aggregate type along with the transformed
turbidity values derived from this time course. The right-hand
panels describe the evolution of the size characteristics of the
aggregates. For the size regime of aggregates described here, the
simulations reveal that the turbidity developed by the spherical
aggregate is much greater than that developed by the same mo-
lecular weight rod-like aggregate, dwarfing it by a roughly 10-fold
ratio.
Discussion
Due to its simplicity, and lack of requirement for specialist
equipment (aside from a spectrophotometer), visible wavelength
turbidity has become the principal assay technique for studying
differential changes in protein aggregation state across a large
number of scientific fields [10,11,20,36]. This ubiquity speaks to
the need for development of a strong understanding11 of the
turbidity assay so as to gain scientific insight into areas as
diverse as the biomedical investigation of proteopathic dis-
eases,12 cell biology research into the cytoskeleton,13 food sci-
ence formulation chemistry,14 pharmaceutical science,15 and
colloid chemistry.16
Our motivation in the current work was to gain a deeper
understanding of the turbidimetric principle. In the current
work, we set ourselves two goals. The first goal was to develop
functional theory capable of approximating the differential
turbidity generated by a heterogeneous protein aggregate dis-
tribution of defined composition. The second goal was to tailor
the theory to a level of complexity sufficient to form the basis of
a future analytical routine. There are a number of competing
aspects of these two goals that constrained the development of
our approach.
The general nature of the first goal (composition / turbidity)
makes its solution, in principle, relatively straightforward. How-
ever, in practice there exist a number of complications that prevent
such a straightforward solution from being attained. The first dif-
ficulty is that polymer heterogeneity in protein aggregation re-
actions often takes on extreme forms with a very large potential
range of aggregate structures, sizes, and densities
[6,14,20,27,39,41]. This wide variation in structural composition
makes judicious assignment of a reduced number of representative
scattering objects (i.e., a relatively few basic structural models of
the scattering components) a nontrivial challenge (e.g., see
Ref. [15]). Similarly, the range of sizes across which the protein
aggregates can span (nm to mm) necessitates the adoption of a
number of different levels of noncontiguous approximations to the
scattering theory [9,20]. Finally, complications induced by inter-
particle scattering effects [9,37,39,56] (seen at high concentra-
tions of scattering particles) restricts any descriptive/analytical ef-
forts to the dilute limit. The opposite nature of the second goal
Fig.8. Calculation of specific turbidity (turbidity per kg/m3 of aggregate) for protein
existing as spherical aggregates. Shown is turbidity for the case of 1 mg/ml total
protein existing as spherical aggregate of a certain radii and internal packing density
for three different wavelengths: (A) l ¼ 400 nm; (B) l ¼ 450 nm; (C) l ¼ 500 nm. Black
symbols represent calculation based on derived empirical relations (Eqs. (14) and (16)),
whereas colored symbols represent calculations based on Eq. (11a). Protein monomer
molecular weight M1 was set at 5000 g/mol. (For interpretation of the reference to
color in this figure legend, the reader is referred to the Web version of this article.)
11 Or at least the gaining of an empirical handle.
12 For example, amyloidosis [1,3,46], clotting [47], and sickle cell disease [48].
13 For example, polymerization of tubulin into microtubules [14,49,50].
14 For example, dairy protein aggregation and stabilization [51], muscle protein
aggregation [13], and efficacy of protein emulsification agents [52].
15 For example, stability of peptide drug formulations [7,11,53].
16 For example, soft matter/colloidal investigations of aggregation kinetics and
non-ideal solution theory [54,55].
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(turbidity / composition) makes for a more complex challenge,
representing an inverse problem typically soluble only upon
application of a number of restraining conditions such as the
assumption of the form of a size distribution [38,57]. Because the
use of such equations in the analysis of experimental data ulti-
mately requires parameter estimation through nonlinear
Fig.9. Calculation of specific turbidity (turbidity per kg/m3 of aggregate) for protein existing as rod-like aggregates. Shown is turbidity for the case of 1 mg/ml total protein existing
as rod-like aggregates of variable length L and radius R for three different values of l: (A) l ¼ 400 nm; (B) l ¼ 450 nm; (C) l ¼ 500 nm. Total packing density was varied such that
a ¼ 1 for left panels and a ¼ 0.2 for right panels. Black symbols represent calculation based on derived empirical relations (Eqs. (15) and (17)), whereas colored symbols represent
calculations based on Eq. (11b). Protein monomer molecular weightM1 was set at 5000 g/mol. (For interpretation of the reference to color in this figure legend, the reader is referred
to the Web version of this article.)
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regression procedures, the chance of affecting a solution is signif-
icantly improved through reduction of the overall number of search
parameters. This future requirement necessarily limited the
complexity of any developed theoretical approach to that involving
a low number of variable parameters.
In the current work, we have taken a utilitarian approach to
achieving the necessary compromise between the two outlined
goalsdone that affords us semi-quantitative understanding, via a
simulation capability, along with the potential for theory-grounded
data reduction. With regard to defining a range of scattering
models capable of accounting forheterogeneous protein aggregation,
Fig.10. Application of the turbidity transform to simulations of competitive growth between rod-like and spherical aggregates. The left panels (A,C,E) describe the reaction progress
curves simulated by numerical integration of Eqs. (18e20), ci (dashed lines), and their associated transformation via Eqs. (14e17) into excess solution turbidity, ti (solid lines),
whereas the right panels (B,D,F) describe the kinetic evolution of the average degree of polymerization <dop> (solid lines) and the average dimensions of each reaction component
for a number of cases of competitive growth, Li or Ri (dashed lines). The top, middle, and bottom panels reflect various cases of aggregate competition between rod-like (red lines)
and spherical (blue lines) aggregate growth. (A,B) Mixed aggregates: Equivalent mixed rod-like and spherical aggregate competitive growth {n ¼ 4; k1 ¼ 0.1 M3 s1,
k2 ¼ 2000 M1 s1, b ¼ 4; k3 ¼ 0.1 M3 s1, k4 ¼ 2000 M1 s1}. Green lines indicate equal rate of growth and development of polymer dop for rod and spherical aggregates, and
black lines describe total turbidity. (C,D) Rod-like aggregates: Exclusive rod-like aggregate formation {n ¼ 4; k1 ¼ 0.1 M3 s1, k2 ¼ 2000 M1 s1, b ¼ 4; k3 ¼ 0 M3 s1,
k4 ¼ 0 M1 s1}. Red lines indicate rod turbidity, blue lines indicate sphere-like turbidity, black line describes total turbidity, and green dotted line indicates concentration of
monomers as either rods or spheres. (E,F) Spherical aggregates: Exclusive spherical aggregate formation {n ¼ 4; k1 ¼ 0 M3 s1, k2 ¼ 0 M1 s1, b ¼ 4; k3 ¼ 0.1 M3 s1,
k4 ¼ 2000 M1 s1}. Note that the maximum average radius in the top panels is 64.5 nm, whereas that in the bottom panels is 71.1 nm. (For interpretation of the references to color
in this figure legend, the reader is referred to the Web version of this article.)
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we selected just two scattering models: isotropic spheres and
isotropic cylindrical rodspossessinga continuumofpotentialpacking
densities from a ¼ 0.2 to 1.0 (Eqs. (1) and (2)). The justification for
adopting this approach was that (i) spheres and rods represent the
extreme cases of scattering behavior (rodeleast and sphereemost
scatteringper unit volume [9,39,41]), (ii) spheres and rods comport to
the type of shape information easily observable from nanoscopic
microscope data such as atomic force microscopy (AFM) and trans-
mission electron microscopy (TEM) [27], and (iii) the assumption of
isotropic character17 for the aggregate (representing a mean field-
type approximation allows for easy factoring into the model of the
relative trace volume, relative packing density, and relative
refractive index of the aggregate [(Vi)TRACE, ai, dn/dci].
To deal with the large range of sizes encountered in protein
aggregation reactions, we employed three different ranges of
already developed light scattering theory corresponding to the
Rayleigh, RGD, and Mie scattering equations [9,20,36,39,40] to
produce a continuous estimate of Q, the particle transmission
dissipation factor, over a defined range of aggregate sizes. We
joined these noncontiguous data sets together using a high-
order one-dimensional polynomial as an interpolating func-
tion to fill in missing regions (Fig. 5). We then described these
completed data sets in the form of high-order two-dimensional
polynomials (spheres: Eq. (15); rods: Eq. (14); see also
Appendix A).
The theoretical accounting of turbidity gets significantly
more difficult at high aggregate concentrations due to the twin
requirements of using higher order terms from the infinite
series in the evaluation of the turbidity (Eqs. (5aec)) and
calculation of the contribution of inter-particle scattering in
addition to the intra-particle scattering contribution computed
using Eq. (5) [9,59]. To cope with the problem associated with
premature truncation of the infinite series (Eq. (5b)), we
instituted a procedure whereby any estimate of the turbidity
was calculated over a sufficiently short path length to ensure
that IS/IO < 5%. The logarithmic correction was then applied to
this value prior to reevaluation of the turbidity per path length.
To cope with the problem associated with inter-particle scat-
tering (occurring at high concentrations), we arbitrarily
imposed the low concentration limit into our theoretical
formulation [9,20]. Such a simplifying assumption can be
experimentally reconciled in practice by serial dilution of the
aggregate, prior to its measurement by turbidity, so as to
identify that the experiment is being conducted in the linear
single scattering region [9].
The competing goal, which tempered the form of our approach,
was to develop a simulation routine containing the least number of
independent variables. This was done with the reason that such a
simplified analytical description could provide the basis of a future
analysis routine. Rapid simulation of postulated turbidity profiles
provides a basis for matching of the parameters to a turbidity
profile derived from an unknown experimental distribution. In
addition, the ready capacity to analytically differentiate a function
to determine maxima andminima criteria is highly desirable in any
prospective analytical function. The ease of simulating and
manipulating explicit two-dimensional polynomials of Qi based on
terms reflecting ai, Ri (for spheres), and Li and Ri (for rods) holds real
possibilities for a semi-empirical analysis of the turbidity derived
from mixed aggregate profilesdsomething we will explore in the
next article of this series.
Although not presenting any new theory in this article, we have
combined and recast the general turbidity relations applicable to
three different size regimes of scattering particles into an excep-
tionally utilitarian form (i.e., a polynomial) that allows for rapid and
straightforward accounting of solution turbidity. The approach
adopted suggests a path forward for development of a rapid
analytical procedure for the interrogation of turbidity profiles. In
this way, our work extends the aims of earlier approaches
[8,12e19,38] that were designed to analyze and predict the size and
molecular weight of homogeneous (of size and shape or both)
protein aggregates. Our work should prove helpful to researchers
performing kinetic studies of protein aggregation reactions that are
entirely, or in part, dependent on a better understanding of the
interplay between turbidity and aggregate composition18 (see, e.g.,
Refs. [13,21e23,45,48,53,61]).
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Appendix A
Coefficients of the approximate interpolating polynomial func-
tions for log10Q for spheres described in terms of radius and
packing density (Eq. (14)) and log10Q for rods described in terms of
length and radius (Eq. (15)) at 400 nm (corresponding coefficients
at 450 and 500 nm are provided in the online supplementary
material)
Coefficients for log10{QSPHERE(Ri,ai)} at l ¼ 400 nm
[e8.9612226eþ142,25,0], [e6.2178673eþ137,24,1],
[4.3219257eþ138,24,0], [1.9681305eþ132,23,2],
[2.9802927eþ133,23,1], [e9.1344692eþ133,23,0],
[e2.0872587eþ127,22,3], [e6.1403387eþ127,22,2],
[e6.5503778eþ128,22,1], [1.0754194eþ129,22,0],
[1.4326259eþ122,21,4], [7.8057605eþ122,21,3],
[5.1240706eþ122,21,2], [8.717724eþ123,21,1],
[e7.0390456eþ123,21,0], [e5.600057eþ116,20,5],
[e6.3051042eþ117,20,4], [e1.102367eþ118,20,3],
[5.7949299eþ117,20,2], [e7.7743739eþ118,20,1],
[1.4478287eþ118,20,0], [e1.6487249eþ111,19,6],
[3.8066915eþ112,19,5], [1.0375059eþ113,19,4],
[5.6493303eþ112,19,3], [e1.8106257eþ113,19,2],
[4.7990097eþ113,19,1], [1.67219eþ113,19,0],
[6.8043805eþ106,18,7], [e1.9191226eþ107,18,6],
17 In certain cases, such as for vesicles, the assumption of an isotropic dispersed
scattering medium has been shown to be a poor approximation [58]. However, for
more evenly dispersed aggregates such as amorphous protein arrangements, this
approximation will have greater validity [54].
18 For a recent semi-historical review of amyloid aggregation kinetics, see
Ref. [60].
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[e6.7824018eþ107,18,5], [e8.5880733eþ107,18,4],
[3.8113954eþ107,18,3], [2.0993804eþ108,18,2],
[e1.971506eþ108,18,1], [e1.7030808eþ108,18,0],
[e4.3711064eþ101,17,8], [e9.3828793eþ101,17,7],
[6.050508eþ102,17,6], [4.5497109eþ102,17,5],
[3.7342016eþ102,17,4], [e9.1514938eþ102,17,3],
[e1.4618403eþ103,17,2], [3.9203551eþ102,17,1],
[6.1809811eþ102,17,0], [1.0031557eþ096,16,9],
[1.2301516eþ097,16,8], [e1.0656749eþ097,16,7],
[e6.4852961eþ097,16,6], [e6.98s42277eþ096,16,5],
[3.2673965eþ095,16,4], [8.2423695eþ097,16,3],
[6.5029863eþ097,16,2], [1.2771041eþ097,16,1],
[8.2402616eþ096,16,0], [e4.7593381eþ089,15,10],
[e4.1968359eþ091,15,9], [e9.2156469eþ091,15,8],
[2.5809873eþ092,15,7], [3.1752629eþ092,15,6],
[e2.7138467eþ091,15,5], [e1.9311451eþ092,15,4],
[e4.4672793eþ092,15,3], [e1.6441195eþ092,15,2],
[e1.631586eþ092,15,1], [e2.19639eþ092,15,0],
[e2.2654694eþ085,14,11], [1.9210622eþ086,14,10],
[2.1232382eþ086,14,9], [1.6506105eþ086,14,8],
[e1.6619091eþ087,14,7], [e1.0248018eþ087,14,6],
[e3.1239481eþ085,14,5], [2.1066011eþ087,14,4],
[1.4494944eþ087,14,3], [1.4612809eþ085,14,2],
[8.9780795eþ086,14,1], [1.3446042eþ087,14,0],
[2.6000854eþ080,13,12], [e9.6418189eþ080,13,11],
[e1.0458066eþ081,13,10], [1.6647952eþ081,13,9],
[e1.1693855eþ081,13,8], [4.2077681eþ081,13,7],
[7.1950842eþ081,13,6], [e1.2000525eþ081,13,5],
[e1.2513165eþ082,13,4], [e1.9196752eþ081,13,3],
[1.8642207eþ081,13,2], [e3.5232504eþ081,13,1],
[e5.1449328eþ081,13,0], [e4.5186753eþ074,12,13],
[e4.930812eþ075,12,12], [3.2790033eþ076,12,11],
[e5.2522596eþ076,12,10], [3.6701297eþ076,12,9],
[e1.4601403eþ076,12,8], [1.3247384eþ076,12,7],
[e6.2401347eþ076,12,6], [2.7873854eþ076,12,5],
[4.5542938eþ076,12,4], [e5.5216856eþ075,12,3],
[e9.4185061eþ075,12,2], [1.0892999eþ076,12,1],
[1.4048427eþ076,12,0], [e4.7509557eþ069,11,14],
[5.5980973eþ070,11,13], [e1.5500089eþ071,11,12,
[6.3068098eþ070,11,11], [2.4366484eþ071,11,10],
[e3.5156078eþ071,11,9], [1.8727398eþ071,11,8],
[e1.1993891eþ071,11,7], [2.8244041eþ071,11,6],
[e1.5692993eþ071,11,5], [e1.1954837eþ071,11,4],
[4.1657839eþ070,11,3], [2.846992eþ070,11,2],
[e2.732297eþ070,11,1], [e2.844044eþ070,11,0],
[4.8488476eþ064,10,15], [e3.1915702eþ065,10,14],
[5.8048465eþ065,10,13], [3.6474845eþ064,10,12],
[e8.7967097eþ065,10,11], [3.4833596eþ065,10,10],
[5.5126089eþ065,10,9], [e3.3361219eþ065,10,8],
[4.1054745eþ064,10,7], [e4.8146114eþ065,10,6],
[2.788692eþ065,10,5], [3.4531377eþ065,10,4],
[e1.6711513eþ065,10,3], [e5.6272472eþ064,10,2],
[5.5350546eþ064,10,1], [4.2863852eþ064,10,0],
[e2.5536597eþ059,9,16], [1.3060273eþ060,9,15],
[e1.7801094eþ060,9,14], [e8.4979954eþ059,9,13],
[3.3909958eþ060,9,12], [e2.0624336eþ060,9,11],
[1.3869602eþ060,9,10], [e3.3300779eþ060,9,9],
[3.432252eþ060,9,8], [e1.9475238eþ060,9,7],
[1.455227eþ060,9,6], [e3.6089797eþ059,9,5],
[e8.9422063eþ059,9,4], [4.7407832eþ059,9,3],
[6.7449981eþ058,9,2], [e8.9075827eþ058,9,1],
[e4.7026428eþ058,9,0], [9.2275768eþ053,8,17],
[e3.9858525eþ054,8,16], [3.7003966eþ054,8,15],
[6.9218668eþ054,8,14], [e1.7588816eþ055,8,13],
[1.7394459eþ055,8,12], [e1.3603213eþ055,8,11],
[6.1410763eþ054,8,10], [1.0000524eþ055,8,9],
[e2.3052824eþ055,8,8], [2.3461508eþ055,8,7],
[e1.5811292eþ055,8,6], [6.1998177eþ054,8,5],
[e1.5238637eþ053,8,4], [e5.1602121eþ053,8,3],
[e9.8295588eþ052,8,2], [1.1823208eþ053,8,1],
[3.4805285eþ052,8,0], [e4.2715205eþ048,7,18],
[2.5002609eþ049,7,17], [e6.5082392eþ049,7,16],
[1.0854905eþ050,7,15], [e1.3859769eþ050,7,14],
[1.3623707eþ050,7,13], [e1.0596883eþ050,7,12],
[1.0045107eþ050,7,11], [e1.2784344eþ050,7,10],
[1.2054274eþ050,7,9], [e5.6259226eþ049,7,8],
[e9.6365845eþ048,7,7], [3.2881831eþ049,7,6],
[e2.1893138eþ049,7,5], [6.7771534eþ048,7,4],
[e1.1700843eþ048,7,3], [3.9439372eþ047,7,2],
[e1.5173035eþ047,7,1], [e1.2010939eþ046,7,0],
[1.8344341eþ043,6,19], [e1.1460602eþ044,6,18],
[2.9201012eþ044,6,17], [e3.4077848eþ044,6,16],
[1.2944621eþ043,6,15], [5.0547818eþ044,6,14],
[e6.1475558eþ044,6,13], [1.2277942eþ044,6,12],
[3.3459425eþ044,6,11], [e1.7895782eþ044,6,10],
[e3.0372074eþ044,6,9], [5.1862997eþ044,6,8],
[e3.6879081eþ044,6,7], [1.4159437eþ044,6,6],
[e2.4124151eþ043,6,5], [e2.3180767eþ042,6,4],
[2.3189526eþ042,6,3], [e8.0207995eþ041,6,2],
[1.8507606eþ041,6,1], [e7.4973474eþ039,6,0],
[e5.2760208eþ037,5,20], [2.9842084eþ038,5,19],
[e5.5649015eþ038,5,18], [e7.368612eþ037,5,17],
[1.9934532eþ039,5,16], [e3.5079662eþ039,5,15],
[2.7065741eþ039,5,14], [e8.5550695eþ038,5,13],
[7.9578629eþ038,5,12], [e2.3374901eþ039,5,11],
[2.7787882eþ039,5,10], [e1.3092327eþ039,5,9],
[e3.4153881eþ038,5,8], [8.6343954eþ038,5,7],
[e5.7280719eþ038,5,6], [2.1308735eþ038,5,5],
[e4.7610813eþ037,5,4], [5.5985893eþ036,5,3],
[4.7929313eþ034,5,2], [e1.2100609eþ035,5,1],
[1.2402605eþ034,5,0], [8.6146332eþ031,4,21],
[e3.6388015eþ032,4,20], [3.333436eþ031,4,19],
[2.5621365eþ033,4,18], [e6.0683368eþ033,4,17],
[4.7351588eþ033,4,16], [3.062306eþ033,4,15],
[e9.2723333eþ033,4,14], [7.1330098eþ033,4,13],
[e1.2707034eþ033,4,12], [e8.043933eþ032,4,11],
[e5.7438818eþ032,4,10], [1.1366916eþ033,4,9],
[e9.3285215eþ031,4,8], [e7.587488eþ032,4,7],
[7.1419871eþ032,4,6], [e3.3877417eþ032,4,5],
[9.7448844eþ031,4,4], [e1.7204173eþ031,4,3],
[1.6692312eþ030,4,2], [e4.9553177eþ028,4,1],
[e4.6522425eþ027,4,0], [e1.9866517eþ026,3,22],
[1.2368348eþ027,3,21], [e3.1210446eþ027,3,20],
[3.9620807eþ027,3,19], [e2.5514036eþ027,3,18],
[1.0388144eþ027,3,17], [e1.8445009eþ027,3,16],
[6.7084785eþ027,3,15], [e1.9774072eþ028,3,14],
[4.0860257eþ028,3,13], [e5.7047765eþ028,3,12],
[5.4581226eþ028,3,11], [e3.6362018eþ028,3,10],
[1.7005739eþ028,3,9], [e5.699677eþ027,3,8],
[1.5498599eþ027,3,7], [e4.7674467eþ026,3,6],
[1.7809808eþ026,3,5], [e5.5799554eþ025,3,4],
[1.1669431eþ025,3,3], [e1.4566339eþ024,3,2],
[9.1222409eþ022,3,1], [e9.7865459eþ020,3,0],
[e1.2753215eþ020,2,23], [2.4384729eþ021,2,22],
[e1.4968714eþ022,2,21], [4.5545238eþ022,2,20],
[e7.2802281eþ022,2,19], [3.4896565eþ022,2,18],
[1.031598eþ023,2,17], [e2.6460921eþ023,2,16],
[3.0693425eþ023,2,15], [e1.797041eþ023,2,14],
[e1.3113554eþ022,2,13], [1.3058726eþ023,2,12],
[e1.3064788eþ023,2,11], [7.0751978eþ022,2,10],
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[e1.8563761eþ022,2,9], [e3.2896387eþ021,2,8],
[5.6333968eþ021,2,7], [e2.8387217eþ021,2,6],
[8.7814651eþ020,2,5], [e1.8348848eþ020,2,4],
[2.6087065eþ019,2,3], [e2.4354957eþ018,2,2],
[1.3652652eþ017,2,1], [e3.696187eþ015,2,0],
[e1.2884138eþ015,1,24], [1.4560902eþ016,1,23],
[e7.665514eþ016,1,22], [2.4598678eþ017,1,21],
[e5.270426eþ017,1,20], [7.7095874eþ017,1,19],
[e7.3933463eþ017,1,18], [3.7941886eþ017,1,17],
[2.3563215eþ016,1,16], [e1.1917975eþ017,1,15],
[e1.0929399eþ017,1,14], [3.5797727eþ017,1,13],
[e3.8199368eþ017,1,12], [2.1742659eþ017,1,11],
[e4.2005832eþ016,1,10], [e4.1111787eþ016,1,9],
[4.6276401eþ016,1,8], [e2.5761581eþ016,1,7],
[9.6541071eþ015,1,6], [e2.5984241eþ015,1,5],
[5.0706653eþ014,1,4], [e7.0331238eþ013,1,3],
[6.5888569eþ012,1,2], [e3.7424662eþ011,1,1],
[9.7428225eþ009,1,0], [86577431,0,25], [e1.3643544eþ009,0,24],
[1.0582414eþ010,0,23], [e5.1364102eþ010,0,22],
[1.6985674eþ011,0,21], [e3.9765133eþ011,0,20],
[6.65372eþ011,0,19], [e7.7386874eþ011,0,18],
[5.4980386eþ011,0,17], [e7.7188377eþ010,0,16],
[e3.0731599eþ011,0,15], [3.2674373eþ011,0,14],
[e3.048412eþ010,0,13], [e2.9639712eþ011,0,12],
[4.3152714eþ011,0,11], [e3.6720244eþ011,0,10],
[2.23716eþ011,0,9], [e1.0358591eþ011,0,8], [3.7237533eþ010,0,7],
[e1.0434499eþ010,0,6][2.2617331eþ009,0,5],
[e3.7208436eþ008,0,4], [44908944,0,3], [e3748279.2,0,2],
[193150.36,0,1], [e4625.8546,0,0]
Coefficients for log10{QROD(Li,Ri)} at l ¼ 400 nm
[6.2194908eþ123,25,0], [1.0246939eþ127,24,1],
[e1.5476224eþ120,24,0], [5.3029801eþ130,23,2],
[e3.4264609eþ123,23,1], [1.5176376eþ116,23,0],
[e8.2090908eþ133,22,3], [e1.5445347eþ127,22,2],
[5.126531eþ119,22,1], [e5.615606eþ111,22,0],
[1.8147228eþ137,21,4], [2.0853884eþ130,21,3],
[2.081173eþ123,21,2], [e4.4721637eþ115,21,1],
[e2.2027218eþ107,21,0], [5.4083333eþ140,20,5],
[e7.4317651eþ133,20,4], [e2.0334348eþ126,20,3],
[e1.7363514eþ119,20,2], [2.4407981eþ111,20,1],
[3.6406581eþ103,20,0], [e3.5309476eþ143,19,6],
[e1.4001085eþ137,19,5], [1.2993372eþ130,19,4],
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[e3.8351324eþ146,16,8], [e5.7296111eþ138,16,7],
[2.0051735eþ132,16,6], [2.0026831eþ124,16,5],
[e3.8302566eþ117,16,4], [4.2764645eþ109,16,3],
[e4.8751088eþ101,16,2], [e5.298464eþ093,16,1],
[e6.8311316eþ085,16,0], [e3.9734793eþ156,15,10],
[8.913005eþ147,15,9], [4.7761405eþ142,15,8],
[e7.509221eþ134,15,7], [e9.941633eþ127,15,6],
[3.9863332eþ119,15,5], [1.1941228eþ113,15,4],
[e1.614181eþ105,15,3], [1.1935721eþ097,15,2],
[1.8802614eþ089,15,1], [3.1124474eþ081,15,0],
[e2.0894894eþ160,14,11], [2.559138eþ153,14,10],
[e8.8405286eþ145,14,9], [e1.9193232eþ138,14,8],
[8.9987814eþ130,14,7], [2.7809221eþ123,14,6],
[e4.6844802eþ115,14,5], [e2.5546162eþ108,14,4],
[4.1695821eþ100,14,3], [e2.2945852eþ092,14,2],
[e4.7645291eþ084,14,1], [e8.748587eþ076,14,0],
[1.7387835eþ162,13,12], [4.0705561eþ156,13,11],
[e4.2051738eþ149,13,10], [1.5527142eþ142,13,9],
[e1.2441068eþ134,13,8], [e3.4245359eþ126,13,7],
[e3.2117534eþ118,13,6], [1.6680818eþ111,13,5],
[3.4479931eþ103,13,4], [e7.3887582eþ095,13,3],
[3.1206821eþ087,13,2], [9.2627485eþ079,13,1],
[1.7739873eþ072,13,0], [4.9159626eþ166,12,13],
[e4.6514806eþ159,12,12], [e1.8644075eþ152,12,11],
[3.0949186eþ145,12,10], [e1.2388464eþ138,12,9],
[1.8780354eþ130,12,8], [e1.8609804eþ121,12,7],
[e2.2935392eþ113,12,6], [e3.3036218eþ106,12,5],
[e1.8610061eþ098,12,4], [8.2720667eþ090,12,3],
[e2.0602351eþ082,12,2], [e1.4280878eþ075,12,1],
[e2.7301097eþ067,12,0], [1.5636597eþ170,11,14],
[e2.3756872eþ163,11,13], [1.4322571eþ156,11,12],
[e2.7254506eþ148,11,11], [e8.3695736eþ140,11,10],
[5.3049839eþ133,11,9], [e1.0273315eþ126,11,8],
[6.9464746eþ117,11,7], [e4.0356061eþ108,11,6],
[4.0117416eþ101,11,5], [e2.9609602eþ093,11,4],
[e3.4540414eþ085,11,3], [e2.2781684eþ077,11,2],
[1.7770569eþ070,11,1], [3.2530757eþ062,11,0],
[3.8031394eþ173,10,15], [e6.4279916eþ166,10,14],
[4.8778109eþ159,10,13], [e2.1064206eþ152,10,12],
[5.0171333eþ144,10,11], [e4.1442248eþ136,10,10],
[e9.6900307eþ128,10,9], [3.041528eþ121,10,8],
[e3.0618215eþ113,10,7], [1.0220923eþ105,10,6],
[e4.3895398eþ096,10,5], [8.5692857eþ088,10,4],
[e6.2136962eþ080,10,3], [8.7989012eþ072,10,2],
[e1.7988655eþ065,10,1], [e3.0189906eþ057,10,0],
[e6.7562032eþ176,9,16], [3.9324903eþ169,9,15],
[1.4771894eþ162,9,14], [e2.3358456eþ155,9,13],
[1.108846eþ148,9,12], [e2.8152458eþ140,9,11],
[3.7200606eþ132,9,10], [e8.0990257eþ123,9,9],
[e5.0944441eþ116,9,8], [7.4357459eþ108,9,7],
[e3.9639963eþ100,9,6], [1.0500939eþ092,9,5],
[e1.2117584eþ084,9,4], [1.4734808eþ076,9,3],
[e1.3645589eþ068,9,2], [1.4800287eþ060,9,1],
[2.1758409eþ052,9,0], [2.5500949eþ180,8,17],
[e2.3456764eþ173,8,16], [9.7392545eþ165,8,15],
[e2.9673554eþ158,8,14], [9.7792177eþ150,8,13],
[e3.131118eþ143,8,12], [7.1899209eþ135,8,11],
[e9.7702791eþ127,8,10], [4.703414eþ119,8,9],
[6.980814eþ111,8,8], [e1.3618509eþ104,8,7],
[9.3606657eþ095,8,6], [e3.0857853eþ087,8,5],
[1.5073841eþ079,8,4], [e1.7020721eþ071,8,3],
[1.366781eþ063,8,2], [e9.8012527eþ054,8,1],
[e1.2055186eþ047,8,0], [1.005261eþ183,7,18],
[e4.1939638eþ176,7,17], [3.9506068eþ169,7,16],
[e1.8383246eþ162,7,15], [5.2274995eþ154,7,14],
[e1.0118554eþ147,7,13], [1.4406986eþ139,7,12],
[e1.5579258eþ131,7,11], [1.0572206eþ123,7,10],
[3.1480443eþ114,7,9], [e2.0173106eþ107,7,8],
[2.6759464eþ099,7,7], [e1.8382101eþ091,7,6],
[7.0086586eþ082,7,5], [e2.1726571eþ074,7,4],
[1.415455eþ066,7,3], [e9.6845028eþ057,7,2],
[5.1310043eþ049,7,1], [5.0439048eþ041,7,0],
[e9.6695418eþ186,6,19], [1.2610056eþ180,6,18],
[e6.209486eþ172,6,17], [1.199626eþ165,6,16],
[1.2189251eþ157,6,15], [e1.23214eþ150,6,14],
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[3.2148279eþ142,6,13], [e4.6845536eþ134,6,12],
[3.8192024eþ126,6,11], [e4.5057734eþ117,6,10],
[e3.5130781eþ110,6,9], [5.7532589eþ102,6,8],
[e5.3032323eþ094,6,7], [3.1585425eþ086,6,6],
[e1.2012248eþ078,6,5], [3.159559eþ069,6,4],
[e1.0389051eþ061,6,3], [5.0846397eþ052,6,2],
[e2.0733119eþ044,6,1], [e1.5501985eþ036,6,0],
[5.0344676eþ189,5,20], [e2.8268137eþ181,5,19],
[e4.603527eþ175,5,18], [3.5902838eþ168,5,17],
[e1.3101017eþ161,5,16], [2.6959849eþ153,5,15],
[e2.9530426eþ145,5,14], [5.8888967eþ136,5,13],
[2.7326092eþ129,5,12], [e2.7728359eþ121,5,11],
[e1.9431105eþ113,5,10], [7.6573437eþ105,5,9],
[e9.7905356eþ097,5,8], [7.7082031eþ089,5,7],
[e4.1000603eþ081,5,6], [1.4740535eþ073,5,5],
[e3.5889718eþ064,5,4], [7.4249615eþ055,5,3],
[e2.1036881eþ047,5,2], [6.3126176eþ038,5,1],
[3.3516109eþ030,5,0], [e6.6155867eþ191,4,21],
[e2.9166738eþ185,4,20], [3.2210323eþ178,4,19],
[e1.1013403eþ171,4,18], [2.1237178eþ161,4,17],
[1.1169568eþ156,4,16], [e3.9374833eþ148,4,15],
[7.121679eþ140,4,14], [e7.6507746eþ132,4,13],
[5.0697303eþ124,4,12], [e3.3004624eþ116,4,11],
[5.3848763eþ108,4,10], [e8.9274473eþ100,4,9],
[9.667674eþ092,4,8], [e6.9864619eþ084,4,7],
[3.4697447eþ076,4,6], [e1.1834047eþ068,4,5],
[2.7315428eþ059,4,4], [e4.5129382eþ050,4,3],
[7.3559324eþ041,4,2], [e1.4275314eþ033,4,1],
[e4.729692eþ024,4,0], [e7.6780977eþ195,3,22],
[1.1751181eþ189,3,21], [e7.2371234eþ181,3,20],
[2.2135472eþ174,3,19], [e2.5665222eþ166,3,18],
[e5.5950062eþ158,3,17], [3.1187139eþ151,3,16],
[e7.3550592eþ143,3,15], [1.1897284eþ136,3,14],
[e1.4999833eþ128,3,13], [1.5159622eþ120,3,12],
[e1.1457808eþ112,3,11], [4.9478093eþ103,3,10],
[1.023715eþ095,3,9], [e3.6414142eþ087,3,8],
[3.1340161eþ079,3,7], [e1.6092594eþ071,3,6],
[5.4421035eþ062,3,5], [e1.2227802eþ054,3,4],
[1.8331319eþ045,3,3], [e2.0813988eþ036,3,2],
[2.3857721eþ027,3,1], [3.6685219eþ018,3,0],
[1.5827018eþ199,2,23], [e2.1849373eþ192,2,22],
[1.3159831eþ185,2,21], [e4.4261539eþ177,2,20],
[8.4742339eþ169,2,19], [e6.3405648eþ161,2,18],
[e1.1491367eþ154,2,17], [4.1695184eþ146,2,16],
[e5.9594365eþ138,2,15], [3.9072608eþ130,2,14],
[1.5396884eþ122,2,13], [e6.6777361eþ114,2,12],
[8.0869557eþ106,2,11], [e5.7549788eþ098,2,10],
[2.3485219eþ090,2,9], [e1.6963874eþ081,2,8],
[e4.4690073eþ073,2,7], [3.1787624eþ065,2,6],
[e1.1737864eþ057,2,5], [2.6855158eþ048,2,4],
[e3.8999507eþ039,2,3], [3.723306eþ030,2,2],
[e2.7519062eþ021,2,1], [e5.1518788eþ011,2,0],
[e2.4567022eþ202,1,24], [3.5649293eþ195,1,23],
[e2.3242433eþ188,1,22], [8.876351eþ180,1,21],
[e2.1440845eþ173,1,20], [3.1724082eþ165,1,19],
[e1.9879667eþ157,1,18], [e2.5480392eþ149,1,17],
[8.0313894eþ141,1,16], [e9.4990484eþ133,1,15],
[4.5754335eþ125,1,14], [3.4467646eþ117,1,13],
[e8.9591231eþ109,1,12], [9.4715316eþ101,1,11],
[e6.694984eþ093,1,10], [3.516689eþ085,1,9],
[e1.4368875eþ077,1,8], [4.685726eþ068,1,7],
[e1.2307613eþ060,1,6], [2.565548eþ051,1,5],
[e4.0635848eþ042,1,4], [4.5841114eþ033,1,3],
[e3.4735732eþ024,1,2], [1.7838465eþ015,1,1], [e1606147.2,1,0],
[e3.1603274eþ205,0,25], [4.9032112eþ198,0,24],
[e3.4548419eþ191,0,23], [1.4523456eþ184,0,22],
[e4.0123348eþ176,0,21], [7.5370022eþ168,0,20],
[e9.6506659eþ160,0,19], [8.8095292eþ152,0,18],
[e9.2672009eþ144,0,17], [2.010042eþ137,0,16],
[e4.4638467eþ129,0,15], [7.212214eþ121,0,14],
[e8.5110815eþ113,0,13], [7.5856919eþ105,0,12],
[e5.2205813eþ097,0,11], [2.8056421eþ089,0,10],
[e1.1810805eþ081,0,9], [3.8812668eþ072,0,8],
[e9.8631626eþ063,0,7], [1.9077199eþ055,0,6],
[e2.7426121eþ046,0,5], [2.8316055eþ037,0,4],
[e1.9969537eþ028,0,3], [8.9277722eþ018,0,2],
[e2.254163eþ009,0,1], [0.25964777,0,0]
Appendix B. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ab.2015.11.021.
References
[1] M. Stoppini, V. Bellotti, Systemic amyloidosis: lessons from b2-microglobulin,
J. Biol. Chem. 290 (2015) 9951e9958.
[2] L.C. Walker, M. Jucker, Neurodegenerative diseases: expanding the prion
concept, Annu. Rev. Neurosci. 38 (2015) 87e103.
[3] D. Hall, H. Edskes, Computational modeling of the relationship between am-
yloid and disease, Biophys. Rev. 4 (2012) 205e222.
[4] R.B. Wickner, H.K. Edskes, F. Shewmaker, T. Nakayashiki, Prions of fungi:
inherited structures and biological roles, Nat. Rev. Microbiol. 5 (2007)
611e618.
[5] G. Invernizzi, E. Papaleo, R. Sabate, S. Ventura, Protein aggregation: mecha-
nisms and functional consequences, Int. J. Biochem. Cell Biol. 44 (2012)
1541e1554.
[6] R. Mezzenga, P. Fischer, The self-assembly, aggregation and phase transitions
of food protein systems in one, two, and three dimensions, Rep. Prog. Phys. 76
(2013) 046601.
[7] S.K. Singh, N. Afonina, M. Awwad, K. Bechtold-Peters, J.T. Blue, D. Chou,
M. Cromwell, H.J. Krause, H.C. Mahler, B.K. Meyer, L. Narhi, D.P. Nesta,
T. Spitznagel, An industry perspective on the monitoring of subvisible parti-
cles as a quality attribute for protein therapeutics, J. Pharm. Sci. 99 (2010)
3302e3321.
[8] P. Doty, R.F. Steiner, Light scattering and spectrophotometry of colloidal so-
lutions, J. Chem. Phys. 18 (1950) 1211e1220.
[9] C.F. Bohren, D.R. Huffman, Absorption and Scattering of Light by Small Parti-
cles, John Wiley, New York, 2008.
[10] J.M. Andreu, S.N. Timasheff, The measurement of cooperative protein self-
assembly by turbidity and other techniques, Methods Enzymol. 130 (1986)
47e59.
[11] H.C. Mahler, W. Friess, U. Grauschopf, S. Kiese, Protein aggregation: pathways,
induction factors and analysis, J. Pharm. Sci. 98 (2009) 2909e2934.
[12] R.D. Camerini-Otero, L.A. Day, The wavelength dependence of the turbidity of
solutions of macromolecules, Biopolymers 17 (1978) 2241e2249.
[13] F.H. Silver, D.E. Birk, Kinetic analysis of collagen fibrillogenesis: I. Use of tur-
bidityetime data, Collagen Relat. Res. 3 (1983) 393e405.
[14] D. Hall, A.P. Minton, Turbidity as a probe of tubulin polymerization kinetics: a
theoretical and experimental re-examination, Anal. Biochem. 345 (2005)
198e213.
[15] T.P. Moody, M.A. Donovan, T.M. Laue, Turbidimetric studies of Limulus coa-
gulin gel formation, Biophys. J. 71 (1996) 2012e2021.
[16] A.C. Garcia-Lopez, A.D. Snider, L.H. Garcia-Rubio, RayleigheDebyeeGans as a
model for continuous monitoring of biological particles: I. Assessment of
theoretical limits and approximations, Opt. Express 14 (2006) 8849e8865.
[17] A.C. Garcia-Lopez, L.H. Garcia-Rubio, RayleigheDebyeeGans as a model for
continuous monitoring of biological particles: II. Development of a hybrid
model, Opt. Express 16 (2008) 4671e4687.
[18] L.B. Korolevskaya, N.G. Khlebtsov, Spectroturbidimetric determination of the
sizes of poly(ethylene glycol)-induced insoluble immune complex particles,
Colloid J. 72 (2010) 504e511.
[19] A. Garcia-Lopez, Hybrid Model for Characterization of Submicron Particles
Using Multiwavelength Spectroscopy (PhD thesis), University of South Flor-
ida, 2005.
[20] M. Elimlech, J. Gregory, X. Jia, R. Williams, Particle Deposition & Aggregation,
Chap. 9, Butterworth Heinemann, Oxford, UK, 1995.
[21] R. Khurana, J.R. Gillespie, A. Talapatra, L.J. Minert, C. Ionescu-Zanetti, I. Millett,
A.L. Fink, Partially folded intermediates as critical precursors of light chain
amyloid fibrils and amorphous aggregates, Biochemistry 40 (2001)
3525e3535.
[22] Y. Yoshimura, Y. Lin, H. Yagi, Y.H. Lee, H. Kitayama, K. Sakurai, M. So, H. Ogi,
H. Naiki, Y. Goto, Distinguishing crystal-like amyloid fibrils and glass-like
D. Hall et al. / Analytical Biochemistry 498 (2016) 78e94 93
amorphous aggregates from their kinetics of formation, Proc. Natl. Acad. Sci.
U. S. A. 109 (2012) 14446e14451.
[23] E.Y. Chi, S. Krishnan, T.W. Randolph, J.F. Carpenter, Physical stability of pro-
teins in aqueous solution: mechanism and driving forces in nonnative protein
aggregation, Pharm. Res. 20 (2003) 1325e1336.
[24] C.H. Bennett, Serially deposited amorphous aggregates of hard spheres,
J. Appl. Phys. 43 (1972) 2727e2734.
[25] S.D. Durbin, G. Feher, Protein crystallization, Annu. Rev. Phys. Chem. 47 (1996)
171e204.
[26] J.P. Sethna, Order parameters, broken symmetry, and topology 1992, arXiv
cond-mat/9204009.
[27] D. Hall, Semi-automated methods for simulation and measurement of amy-
loid fiber distributions obtained from transmission electron microscopy ex-
periments, Anal. Biochem. 421 (2012) 262e277.
[28] D. Hall, A.P. Minton, Effects of inert volume-excluding macromolecules on
protein fiber formation: I. Equilibrium models, Biophys. Chem. 98 (2002)
93e104.
[29] D. Hall, A.P. Minton, Effects of inert volume-excluding macromolecules on
protein fiber formation: II. Kinetic models for nucleated fiber growth, Biophys.
Chem. 107 (2004) 299e316.
[30] O. Kratky, H. Leopold, H. Stabinger, The determination of the partial specific
volume of proteins by the mechanical oscillator technique, Methods Enzymol.
27 (1973) 98e110.
[31] D. Hall, J. Kardos, H. Edskes, J.A. Carver, Y. Goto, A multi-pathway perspective
on protein aggregation: implications for control of the rate and extent of
amyloid formation, FEBS Lett. 589 (2015) 672e679.
[32] A. Shahravan, C. Lucas, T. Matsoukas, Nanowire charging in collisionless
plasma, J. Appl. Phys. 108 (2010) 083303.
[33] K.E. van Holde, W. Cutiss Johnson, P. Shing Ho, Principles of Physical
Biochemistry, Chap. 7, Prentice Hall, 2015.
[34] L. Rayleigh, On the transmission of light through an atmosphere containing
small particles in suspension, and on the origin of the blue of the sky, London,
Edinb. Dublin Philos. Mag. J. Sci. 47 (1899) 375e384.
[35] G.E. Perlmann, L.G. Longsworth, The specific refractive increment of some
purified proteins,, J. Am. Chem. Soc. 70 (1948) 2719e2724.
[36] G. Oster, Light scattering, in: G. Oster, A.W. Pollister (Eds.), Physical Tech-
niques in Biological Research, Vol. 1: Optical TechniquesAcademic Press, San
Diego, 2013 chap. 2.
[37] M. Kerker, The Scattering of Light and Other Electromagnetic Radiation,
Physical Chemistry: a Series of Monographs, vol. 16, Academic Press, San
Diego, 2013 chap. 7.
[38] M.L. Wallach, W. Heller, A.F. Stevenson, Theoretical investigations on the light
scattering of colloidal spheres: XII. The determination of size distribution
curves from turbidity spectra, J. Chem. Phys. 34 (1961) 1796e1802.
[39] P.J. Wyatt, Measurement of special nanoparticle structures by light scattering,
Anal. Chem. 86 (2014) 7171e7183.
[40] W. Hergert, T. Wriedt (Eds.), The Mie Theory: Basics and Applications, vol.
169, Springer, 2012 chap. 2.
[41] E.P. Geiduschek, A. Holtzer, Application of light scattering to biological sys-
tems: deoxyribonucleic acid and the muscle proteins, in: C.A. Tobias,
J.H. Lawrence (Eds.), Advances in Biological and Medical Physics, Academic
Press, 1958, pp. 431e551.
[42] N. Mikati, J. Nordh, B. Norden, Scattering anisotropy of partially oriented
samples: turbidity flow linear dichroism (conservative dichroism) of rod-
shaped macromolecules, J. Phys. Chem. 91 (1987) 6048e6055.
[43] F. Gaskin, C.R. Cantor, M.L. Shelanski, Turbidimetric studies of the in vitro
assembly and disassembly of porcine neurotubules, J. Mol. Biol. 89 (1974)
737e758.
[44] B.J. Berne, Interpretation of the light scattering from long rods, J. Mol. Biol. 89
(1974) 755e758 (Appendix 1).
[45] M. Adachi, M. So, K. Sakurai, J. Kardos, Y. Goto, Supersaturation-limited and
unlimited phase transitions compete to produce the pathway complexity in
amyloid fibrillation, J. Biol. Chem. 290 (2015) 18134e18145.
[46] M.W. Head, J.W. Ironside, CreutzfeldteJakob disease: prion protein type,
disease phenotype, and agent strain [review], Neuropathol. Appl. Neurobiol.
38 (2012) 296e310.
[47] D. Tilley, I. Levit, J.A. Samis, Development of a microplate coagulation assay for
Factor V in human plasma, Thrombosis J. 9 (2011) 1e11.
[48] K. Moffat, Q.H. Gibson, The rates of polymerization and depolymerization of
sickle cell haemoglobin, Biochem. Biophys. Res. Commun. 61 (1974) 237e242.
[49] D. Hall, The effects of tubulin denaturation on the characterization of its
polymerization behaviour, Biophys. Chem. 104 (2003) 655e682.
[50] W.A. Voter, H.P. Erickson, The kinetics of microtubule assembly: evidence for
a two-stage nucleation mechanism, J. Biol. Chem. 259 (1984) 10430e10438.
[51] D.C. Thorn, S. Meehan, M. Sunde, A. Rekas, S.L. Gras, C.E. MacPhee, J.A. Carver,
Amyloid fibril formation by bovine milk k-casein and its inhibition by the
molecular chaperones aS- and b-casein, Biochemistry 44 (2005)
17027e17036.
[52] K.N. Pearce, J.E. Kinsella, Emulsifying properties of proteins: evaluation of a
turbidimetric technique, J. Agric. Food Chem. 26 (1978) 716e723.
[53] F. Salmannejad, N. Nafissi-Varcheh, A. Shafaati, R. Aboofazeli, Study on the
effect of solution conditions on heat-induced aggregation of human alpha
interferon, Iran. J. Pharm. Res. 13 (2014) 27e34.
[54] H. Wu, M. Lattuada, M. Morbidelli, Dependence of fractal dimension of DLCA
clusters on size of primary particles, Adv. Colloid Interf. Sci. 195 (2013) 41e49.
[55] L. Nicoud, M. Owczarz, P. Arosio, M. Morbidelli, A multiscale view of thera-
peutic protein aggregation: a colloid science perspective, Biotechnol. J. 10
(2015) 367e378.
[56] A.P. Minton, Static light scattering from concentrated protein solutions: I.
General theory for protein mixtures and application to self-associating pro-
teins, Biophys. J. 93 (2007) 1321e1328.
[57] J.C. Thomas, The determination of log normal particle size distributions by
dynamic light scattering, J. Colloid Interface Sci. 117 (1987) 187e192.
[58] G. Bryant, T. Mortensen, S. Henderson, S. Williams, W. van Megen, Optical
contrast variation study of nonaqueous suspensions of polymer particles,
J. Colloid Interface Sci. 216 (1999) 401e408.
[59] J.K.G. Dhont, Multiple RayleigheGanseDebye scattering in colloidal systems-
general theory and static light scattering, Phys. A Stat. Mech. Appl. 120 (1983)
238e262.
[60] D. Kashchiev, Kinetics of protein fibrillation controlled by fibril elongation,
Proteins Struct. Funct. Bioinform. 82 (2014) 2229e2239.
[61] D. Hall, L. Huang, On the use of size exclusion chromatography for the reso-
lution of mixed amyloid aggregate distributions: I. Equilibrium partition
models, Anal. Biochem. 426 (2012) 69e85.
D. Hall et al. / Analytical Biochemistry 498 (2016) 78e9494
View publication stats
 
36 
 
Paper 2: Recognizing and analyzing variability in amyloid 
formation kinetics: Simulation and statistical methods 
 
   The second of the three papers published during my postgraduate 
studies at the Australian National University Research School of 
Chemistry (Hall et al. 2016b) was concerned with how to assess 
differences between assays of chaperone action conducted on 
protein aggregation reactions. In this paper, together with Dr. Hall, 
I helped to develop a method for quantifying the variability in the 
amyloid aggregation assay. We investigated the variability in the 
amyloid aggregation kinetics, and developed methods for its 
simulation, identification and analysis. Initially I searched for an 
already developed method in the literature. However, rather 
unexpectedly, such an analysis had not been previously developed 
despite it being the fundamental cornerstone of all differential 
analyses of drug and condition effects upon the protein 
aggregation reaction. 
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We examine the phenomenon of variability in the kinetics of amyloid formation and detail methods for
its simulation, identification and analysis. Simulated data, reflecting intrinsic variability, were produced
using rate constants, randomly sampled from a pre-defined distribution, as parameters in an irreversible
nucleation-growth kinetic model. Simulated kinetic traces were reduced in complexity through
description in terms of three characteristic parameters. Practical methods for assessing convergence of
the reduced parameter distributions were introduced and a bootstrap procedure was applied to deter-
mine convergence for different levels of intrinsic variation. Statistical methods for assessing the signif-
icance of shifts in parameter distributions, relating to either change in parameter mean or distribution
shape, were tested. Robust methods for analyzing and interpreting kinetic data possessing significant
intrinsic variance will allow greater scrutiny of the effects of anti-amyloid compounds in drug trials.
Crown Copyright © 2016 Published by Elsevier Inc. All rights reserved.1. Introduction
The proteinaceous fibrous polymer known as amyloid is much
studied due to its potentially causal association with a number of
fatal amyloidosis [1,2]. Of particular interest to themedical research
community has been the question of what chemical and environ-
mental factors cause normally soluble protein to convert to the
insoluble-polymeric amyloid form [3,4]. The vast majority of prior
in vitro based investigations directed towards this topic have taken
the form of differential kinetic measurements of control and per-
turbed sample groups, i.e. the kinetics are simultaneously
measured in the absence and presence of the component/condition
of interest, and the relative change in kinetics, rather than therd Error; GLV, Gaussian Low
freedom; KS2D, Kolmogorov
stry, Australian National Uni-
en.hall@protein.osaka-u.ac.jp,
roups/physical-biochemistry-
evier Inc. All rights reserved.absolute change, reported [5e7]. In these studies, the time-
dependent change of a suitable experimental measure, such as
thioflavin T dye binding [8e10] or turbidity/light scattering [11,12],
is followed as a proxy marker of fibril formation.
A great variety of amyloid-forming model systems1 are known
in the literature [13], with some directly related to amyloidosis
[14e17], whilst others are studied for their biological significance
[18,19] or potential use as bio/nanotechnology agents [20]. Some
amyloid-forming systems yield kinetic data that are relatively
robust and reproducible [21,22] whilst others seem to lack the
property of reproducibility [16,17,23,24], possibly because of a
strong sensitivity of the reaction rate to initial conditions [25,26] or
the pre-existing potential for diversity of competing reaction
pathways [27e29]. Although a comprehensive understanding as to
why some systems are more difficult to work with than others has
not yet been obtained, such sensitivity may be empirically con-
fronted, and characterized, using a suitable application of statistics.
In this paper, we explore how to deal with intrinsic variability in
amyloid formation kinetics produced by either inherent stochastic1 By amyloid systemwe are referring to the protein, the solution constituents and
the physical parameters.
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e71 57variation [30] or intrinsic non-linear sensitivity to initial conditions
[25,26]. The basic methodology of our approach involves the
following three steps,
(i) Simulate kinetic data of amyloid formation that exhibit
defined extents of intrinsic variation.
(ii) Reduce the primary kinetic data to a set of characteristic
parameters.
(iii) Analyze the parameter distributions to examine when/how
statistically significant conclusions may/or may not be
extracted.
This work represents the first in a two-part series aimed at
developing reliable methods for analyzing amyloid kinetics. Part II
will focus on the experimental application of the concepts outlined
in this paper.
2. Theory and results
The simulation aspect of this work required the generation of
synthetic amyloid kinetic traces, concordant with an irreversible
nucleated-growth scheme, that featuredadefinedextentof intrinsic
variation (Eqn. (1), Fig. 1A and B). Variation, designated by x1 and x2,
was incorporated into the rate constants k1 and k2, respectively
governing the nucleation (Eqn. (1a)) and growth (Eqn. (1b)) stages.
nM !k1±x1 N (1a)Fig. 1. Simulated replicate kinetic data sets showing the fraction of amyloid formed as a func
constants are sampled from distributions affording (A) Low variation (blue) (B) High variati
k1±x1 and k2±x2 along with their mean values (indicated by the arrows) <k1> ¼ 0.1 M1s
sk ¼ 0.15<k>, k2 [<k>6sk, <k>þ6sk,] or a Flat High Variance (FHV) distribution, k 2 [0.1<
used in the data reduction strategy, t10, t50t10 and At/∞. The blue line describes the fractio
nucleus formation. (For interpretation of the references to colour in this figure legend, the2
6666664
N þM !k2±x2 Anþ1
Anþ1 þM !k2±x2 Anþ2
$ $ $
Az1 þM !k2±x2 Az
3
7777775 (1b)
To simulate differing extents of intrinsic variation the rate
constants, k1±x1 and k2±x2, were randomly selected from one of
two general types of distribution, either a Gaussian distribution
with low variance (GLV), or a flat distribution with high variance
(FHV) (Fig. 1C). Using this approach, large data sets exhibiting a
known level of intrinsic variation, were generated for each of the
four possible pairings of rate constant distribution types, through
repeated simulation of the differential equation set pertaining to
Eqn. (1) (Appendix 1). Once simulated, the primary kinetic data
were then reduced using a model-free parameterization strategy
based on a characteristic point analysis (Fig. 1D). The decomposi-
tion of the primary data was carried out using three empirical pa-
rameters, At/∞, the maximal fraction of monomer present as
amyloid, t10, the tenth time, i.e. the time to reach one tenth of the
asymptotic value, and t50t10, the difference between the half-time
and the tenth-time.
Four general cases of amyloid kinetics reflecting intrinsic vari-
ance were simulated from the two types of distribution for each
rate constant.tion of time. Simulations were carried out using Eqns. A1 and A2 whereby the input rate
on (red). (C) Probability distribution describing two disparate types of distribution for
1, <k2> ¼ 1.0 M1s1. The two distribution types were a Gaussian Low Variance (GLV)
k>, 1.9<k>] (D) The three characteristic points measured on the amyloid growth curve
n of amyloid formed as a function of time. The green line describes the time course of
reader is referred to the web version of this article.)
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e7158(i) Low variance Gaussian k1 and low variance Gaussian k2 -
[k1(GLV), k2(GLV)]
(ii) High variance, flat distribution k1 and low variance Gaussian
k2 - [k1(FHV), k2(GLV)]
(iii) Low variance Gaussian k1 and high variance flat distribution
k2 - [k1(GLV), k2(FHV)]
(iv) High variance flat distribution k1 and high variance flat dis-
tribution k2 - [k1(FHV), k2(FHV)].
For each of the above cases, one-thousand simulations wereFig. 2. Raw simulations and histogram analysis of characteristic points, t10, t50t10 and At/
(k1) and growth (k2) rate constants. Row 1: Simulations reflecting [k1(GLV), k2(GLV)] combin
[k1(GLV), k2(FHV)] (magenta background), Row 4: [k1(FHV), k2(FHV)] (orange background).
time. Column 2: Frequency histogram of characteristic t10 times. Column 3: Frequency hist
asymptotic levels of amyloid. All histograms were generated from 1000 simulations. (For int
web version of this article.)generated by appropriate random sampling of the rate constant
distributions [31] (Fig. 2, column 1). Frequency plots for each of the
three characteristic empirical parameters were generated by anal-
ysis of all one-thousand simulations (Fig. 2, columns 2e4) for each
of the four levels of intrinsic variation (rows 1e4). As might be ex-
pected, the well behaved system (Fig. 2 Row 1) yields reduced
parameter distributions reflecting the intrinsically low input vari-
ance that characterizes its rate constants. Similarly predictable, the
poorly defined distribution pairing of k1 and k2 produces charac-
teristic parameter distributionswith the greatest spread (Fig. 2, Row∞, for all four possible combinations of the two types of distribution for the nucleation
ation (yellow background), Row 2: [k1(FHV), k2(GLV)] (light blue background), Row 3:
Column 1: Limited set of 200 overlaid simulations of fractional amyloid formation vs.
ogram of characteristic t50t10 times. Column 4: Frequency histogram of characteristic
erpretation of the references to colour in this figure legend, the reader is referred to the
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e71 594). More interesting, is the comparative failure to see amuch tighter
spread in the distribution of the t10 parameter for the case reflecting
a low-variance Gaussian distribution in k1 and a high-variance flat
distribution in k2 (Fig. 3 Row3 Column2). Thisfinding indicates that
t10 may not necessarily be a good indicator of the magnitude of k1
and that this experimentally derived parameter may be signifi-
cantly determined2 by, or correlated with, the actual value of k2.2.1. A first look at determining parameter convergence
The two most common formats for replicating amyloid kinetic
experiments involve either the sequential replication of an assay in
a single cuvette [32] or the concerted performance of assays using a
multi-well microplate procedure [22e24,33]. In either situation,
the question arises as to whether the number of replicate experi-
ments is sufficiently large to capture the intrinsic variation in the
population. As the only tool available to the experimenter to answer
this question is to simply keep repeating the kinetic assay until a
suitable test signifies parameter convergence, a suitable numerical
indicator of parameter distribution convergence is required [34].
Here we examine three potentially useful measures of parameter
convergence (for a generalized parameter b with total replicate
number N) (Eqn. (2)). The three indicators include the mean plus or
minus a standard error of themean,<b>± SEb (Eqn. (2a)), a reduced
standard deviation, sb (Eqn. (2b)), and a higher moment term, gb,
reflecting a skew-like description of the distribution (Eqn. (2c)).
〈b〉±
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiXN
i¼1
ðbi  〈b〉Þ2
.
ðN½N  1Þ
vuut (2a)
sb ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiXN
i¼1
ðbi  〈b〉Þ2
.
ðN  1Þ
vuut (2b)
gb ¼
PN
i¼1 ðbi  〈b〉Þ3
ðN  1Þ$s3
b
(2c)
All three descriptors provide useful information on the conver-
gence, although for limited sampling, the higher moment terms
(reflecting the standard deviation and the skew of the distribution)
can be seen to be more sensitive indicators. The skew-like term has
the added benefit of showing convergence of the distribution's
asymmetry due to the fact that its positive or negative sign
respectively relates to the existence of a right or left-handed dis-
tribution tail [34]. Fig. 3 describes a particular convergence pathway
of 96 simulated replicates3 for the four cases of intrinsic variability,
generated from the combinations of k1 and k2. From this analysiswe
note that for systems demonstrating greater intrinsic variance the
reduced parameter distributions may not have sufficiently
converged even after 96 replicates have been performed.42 This is a potentially important result as some have interpreted the presence of a
correlation between experimentally derived markers of growth and nucleation
rates as indicating that these two processes share a fundamentally similar depen-
dence upon reaction conditions [17]. This conclusion can be seen to be wholly
derived from the lack of an orthogonal measure of the nucleation rate, i.e. a strong
correlation between experimental markers of nucleation and growth will always be
found when basing the nucleation parameterization on a signal related to fiber
growth, even in the absence of such a correlation at the molecular rate constant
level.
3 As might be generated using a microplate reader [22,24].
4 The potential exists for fitting an empirical function to the marker of conver-
gence and subsequently using this empirical function to estimate the total repli-
cates required for distribution convergence.2.2. A closer look at identifying and analyzing variation
Such a single-shot analysis of convergence, as performed in the
previous section, suffers the consequences of random sampling, i.e.
each convergence series will follow a unique pathway, thus pre-
venting definite conclusions being drawn from a single trace. To
escape this situation, a bootstrap procedure was implemented [35].
Using this method, a fixed number of replicates was randomly
sampled 200 times each from the starting pool of 1000 simulations.
Adapting this approach, we examined the statistical evolution of
each of the three markers of convergence outlined in Eqn. (2), for
the four different cases of intrinsic variance (Fig. 4). In this manner
the bootstrap procedure affords estimation of the likely mean and
standard deviations for the three convergence markers at different
replicate numbers.
2.3. Assessing significance for different scenarios
The majority of medical research into amyloid kinetics is based
on the concept of drug screening, i.e. differential evaluation of the
effect of a ligand or a change in solution conditions on fibril forma-
tion [3e8,18,22]. In such cases two groups of data, the test and
control sets, will be compared and an assessment made as to the
significance of any observed change. In discussing the potential
change in a parameter, it is important to be clear as to what the
potential outcomes for change are. Fig. 5 describes the classes of
change that may be affected within the control distribution, corre-
sponding to changes in themean, variance anddistribution shape. In
this section,we examinemethods for determination of the presence
or absence of significance when comparing data sets featuring
possible variation inparameterdistributions of the typedescribed in
Fig. 5. Two general types of comparative case are examined.
Type 1 Comparison: Test and control sets are drawn from sys-
tems defined by the same fundamental parameter distributions
(therefore possessing the same levels of intrinsic variation).
Type 2 Comparison: Test and control sets are drawn from
different parameter distributions (therefore possessing different
extents of intrinsic variation).
Three statistical methods, having varying degrees of (statistical)
power [34,36,37], were tested in the current work. For each pairing
of test replicates and control replicates, each statistical procedure
was independently carried out two-hundred times with the end
result reported as fractional significance.5 In what follows, we first
provide a short description of the basis of each of these statistical
tests and then present the results of their application to the two
general types of comparative case listed above.
(i) Comparison of averages with standard error
A large majority of published studies simply overlay the data or
alternatively assert significance based on comparison of the5 In the comparison of parameters derived from a set of m group 2 test replicates
against a set of n group 1 control replicates fractional significance is defined as the
fraction of times (out of a total of 200 trials) that test sets were judged to exhibit a
less than 5% critical probability of supporting the null hypothesis, i.e. that they were
no different from the control
Fractional Significance ¼ 1
200
X200
i¼1
j
j ¼ 1 if Pi  Pcriticalð0:05Þ
j ¼ 0 if Pi > Pcriticalð0:05Þ
.
Fig. 3. A single replicate series of convergence indicators corresponding to the distributions of t10 (Row 1), t50t10 (Row 2) and At/∞ (Row 3). Convergence was monitored using
(Column 1) Simple average (< >) plus or minus the standard error (SE), (Column 2) Standard deviation (s), (Column 3) Skew-like parameter (g). The four line colours follow the
same representation as per Fig. 2 i.e. yellow ¼ [k1(GLV), k2(GLV)], light blue ¼ [k1(FHV), k2(GLV)], magenta ¼ [k1(GLV), k2(FHV)], orange ¼ [k1(FHV), k2(FHV)]. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web version of this article.)
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the purposes of this article we will call this the <b> ± 2S.E. test
(Fig. 6a). With certain restrictions,7 this approach is valid for
assessing how likely it may be that a single value is part of a dis-
tribution, but is less correct when comparing two distributions as it
does not properly account for distribution overlap [34]. Fig. 7 de-
scribes the application of the <b> ± 2S.E. test to a type 1 compar-
ison of datawhere each row corresponds to one of the four different6 More often the error envelope is simply approximated as ± 1 S.E. (e.g. [21]) but
we persist here with ~2 S.E. to maintain a ~95% confidence estimate for the two-
tailed test [34].
7 More properly, the confidence interval should be assessed using the 95% critical
t-value for a two-tailed test, t(0.95,N1) ¼ (b<b>)/(sb/√N) for a single distri-
bution (Appendix 2). This value will only approach ~2 (actually 1.96) for replicate
numbers of sixty or greater.cases of intrinsic variance tested against itself (as both sample and
control). The <b> ± 2S.E. test does a fair job of not falsely asserting
significance although some degree of pseudo-significance is seen in
the off-diagonal low replicate regions, especially as the variance
within the sample increases. Fig. 8 shows the application of the <b>
± 2S.E. test to the type 2 comparison inwhich the first three cases of
amyloid kinetic data, featuring increasing levels of variation, are
tested as samples against the control data set possessing the most
intrinsic variance. We see that the <b> ± 2S.E. test is capable of
identifying statistically meaningful differences in the three char-
acteristic parameters, t10, t50t10 and At/∞, between the lowest
intrinsic variance data set and the highest intrinsic variance control
case (Row 1 of Fig. 8). However relatively large replicate numbers of
the low variance sample case are required to identify a significant
difference (i.e. the test is asymmetric with regards to replicate
number of control and sample groups). The simple <b> ± 2S.E. test
Fig. 4. Bootstrap analysis using 200 selections from a pool of 1000 initial simulations of convergence indicators corresponding to the distributions of t10 (Row 1), t50t10 (Row 2)
and At/∞ (Row 3). Convergence was monitored using (Column 1) Average of the bootstrap parameter average (<<b>>) plus or minus the standard deviation of the bootstrap
averages plus the standard deviation of the bootstrap standard error (J), (Column 2) Average of the bootstrap standard deviation (<s>) plus or minus the standard deviation of the
bootstrap standard deviation, (Column 3) Average of the bootstrap skew-like parameter <g> plus or minus the standard deviation of the bootstrap value of g. Colour representation
is as follows, yellow ¼ [k1(GLV), k2(GLV)], magenta ¼ [k1(FHV), k2(GLV)], blue ¼ [k1(GLV), k2(FHV)], orange ¼ [k1(FHV), k2(FHV)]. Error bars reflect plus or minus 1 standard deviation
of the 200 estimates used in the bootstrap series. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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variance sample groups and the high variance control groups (Rows
2, 3 of Fig. 8).
(ii) Comparison using Welch's-t-test
The first alternative test considered is Welch's t-test, a variant of
the standard Student t-test, developed for statistical comparison of
the independence of the means of two groups of normally
distributed data having unequal sizes and unequal variance [34,35].
Welch's t-test is a parametric test as it is based on the assumption
that the parameter distributions have a previously known analyt-
ical form (in this case the normal distribution). Welch's t-test cal-
culates a t value on the basis of difference in group means relativeto grouped standard errors evaluated as a vector sum (Fig. 6b),
rather than as a conventional sum as implied for the previous
procedure. The t-statistic and number of degrees of freedom (dof) is
calculated as per Eqn. (3) [35].
tð0:95;dof Þ ¼ hb1i  hb2iffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
s2
b1
N1
þ s
2
b2
N2
r (3a)
Fig. 5. Some possible changes in distribution of a parameter between control (blue)
and sample (red) groups. (A) Raw histogram describing distributions with changed
averages and variance (note unequal distribution size). (B) Raw histogram describing
distributions with equal averages but with changed variance (for equal distribution
sizes) (C) Normalized histogram reflecting distributions with equal means and vari-
ance but with different distribution shapes. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 6. Critical features of the three statistical tests. (A) <b> ± 2S.E. test (difference in
mean vs. plus or minus two times the standard error) operates on the basis of linear
combination of standard errors. (B) Welch's t-test: Tests the null hypothesis that the
two distributions are the same by comparing the difference in means of the two dis-
tributions against the magnitude of the vector sum of standard errors and uses a
variance weighted degree of freedom for calculation of significance based on a critical
t-distribution. (C) KolmogoroveSmirnov two-sample D-test: Tests the null hypothesis
that the two distributions are the same by comparing the maximum difference in
cumulative distribution plots against a table of critical values from the Kolmogorov
distribution describing likelihood of that distance being achieved via random chance
(for a given number of replicates).
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Importantly, the number of degrees of freedom inWelch's t-test
is weighted such that it penalizes high variance sample or control
data by returning a lower numerical value for the joint degrees of
freedom. A table of critical t-values (Appendix 2) is used forevaluation of the 95% confidence interval in rejecting the null hy-
pothesis that the control and sample groups belong to the same
distribution [34]. Fig. 9 describes the use of Welch's t-test in a type
1 comparison of the data (with each of the four rows describing a
case of intrinsic variance tested against itself as sample and con-
trol). Interestingly Welch's t-test performs about as well as the
simple <b> ± 2S.E. test with some slight tendency for pseudo-
Fig. 7. Application of the <b> ± 2S.E. test to a type 1 comparison of sample and control data as a function of sample and control replicate number. Type 1 comparison - the null
hypothesis that the sample and control distributions are the same is true. Row 1: Control group ¼ Sample group ¼ [k1(GLV), k2(GLV)] Row 2: Control group ¼ Sample
group ¼ [k1(FHV), k2(GLV)] Row 3: Control group ¼ Sample group ¼ [k1(GLV), k2(FHV)], Row 4: Control group ¼ Sample group ¼ [k1(FHV), k2(FHV)]. Column 1: Test applied to t10
values. Column 2: Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e71 63
Fig. 8. Application of the <b> ± 2S.E. test to a type 2 comparison of sample and control data as a function of sample and control replicate number. Type 2 comparison - the null
hypothesis that the sample and control distributions are the same is not true. Row 1: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(GLV)]. Row 2: Control
group¼ [k1(FHV), k2(FHV)], Sample group¼ [k1(FHV), k2(GLV)]. Row 3: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(FHV)] Column 1: Test applied to t10 values.
Column 2: Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
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comparative test (Fig. 10), Welch's test performs noticeably better
than the <b> ± 2S.E. test, as indicated by the clear identification of
significance between the intermediate cases of variance when
compared with the high variance control group (Row 2 of Fig. 10).
This finding suggests a preference for using Welch's t-test over the
<b> ± 2S.E. test. It is worth noting however that Welch's t-test
cannot identify a significant difference when contrasting the
penultimate high variance sample group against the high variance
control group (Row 3 of Fig. 10).
(iii) KolmogoroveSmirnov two-sample D-test
The third test considered is the KolmogoroveSmirnov two-
sample D-test (KS2D) (Fig. 6c). The KS2D-test is a non-parametric statistical test which is capable of identifying signifi-
cant differences in both the mean and shape of the distribution
and therefore is applicable to detecting the type of changes shown
in Fig. 5A, B and C [35,36]. This makes the KS2D test different to
the previously considered simple <b> ± 2S.E. tests and Welch's t-
test, which only test for the differences in means between sample
and control groups. The fundamental measure in the KS2D test is
the parameter D, which is the maximum difference between cu-
mulative frequency distributions of the sample and control groups
over the domain of the measured variable b [35,36]. The process
for calculation of D is shown below [35,37].
(a) Cumulative distributions of frequency plots of the sample,
Csample(b), and control, Ccontrol(b), groups are calculated ac-
cording to Eqn. (4).
Fig. 9. Application of Welch's t-test to a type 1 comparison of sample and control data as a function of sample and control replicate number. Type 1 comparison - the null hypothesis
that the sample and control distributions are the same is true. Row 1: Control group ¼ Sample group ¼ [k1(GLV), k2(GLV)] Row 2: Control group ¼ Sample group ¼ [k1(FHV),
k2(GLV)] Row 3: Control group ¼ Sample group ¼ [k1(GLV), k2(FHV)], Row 4: Control group ¼ Sample group ¼ [k1(FHV), k2(FHV)]. Column 1: Test applied to t10 values. Column 2:
Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
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Fig. 10. Application of Welch's t-test to a type 2 comparison of sample and control data as a function of sample and control replicate number. Type 2 comparison - the null hy-
pothesis that the sample and control distributions are the same is not true. Row 1: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(GLV)]. Row 2: Control
group¼ [k1(FHV), k2(FHV)], Sample group¼ [k1(FHV), k2(GLV)]. Row 3: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(FHV)] Column 1: Test applied to t10 values.
Column 2: Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
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Ximax
i

NðbiÞ
N1

(4a)
Ccontrol

bj

¼
Xjmax
j¼1
0
@N

bj

N2
1
A (4b)(b) The domain is scanned and the ordinate difference at com-
mon abscissa values between b1 and bN is determined. The
maximum value of this difference is termed the Kolmogor-
oveSmirnov D value (Eqn. (5)).D ¼ max
CsampleðbÞ  CcontrolðbÞ (5)(c) The D value is compared against the appropriate critical
value. If D is greater than the critical value, the null hy-
pothesis that sample and control distributions are from the
same distribution is rejected, and the alternative hypothesis
that the samples are statistically different, is accepted. Crit-
ical values for the two-sample D statistic (for rejecting the
null hypothesis that the two distributions are identical) are
provided in Appendix 2.
Fig. 11. Application of the KolmogoroveSmirnov two-sample D-test to a type 1 comparison of sample and control data as a function of sample and control replicate number. Type 1
comparison - the null hypothesis that the sample and control distributions are the same is true. Row 1: Control group ¼ Sample group ¼ [k1(GLV), k2(GLV)] Row 2: Control
group¼ Sample group¼ [k1(FHV), k2(GLV)] Row 3: Control group¼ Sample group¼ [k1(GLV), k2(FHV)], Row 4: Control group¼ Sample group¼ [k1(FHV), k2(FHV)]. Column 1: Test
applied to t10 values. Column 2: Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
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Fig. 12. Application of the KolmogoroveSmirnov two-sample D-test to a type 2 comparison of sample and control data as a function of sample and control replicate number. Type 2
comparison - the null hypothesis that the sample and control distributions are the same is not true. Row 1: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(GLV)].
Row 2: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(FHV), k2(GLV)]. Row 3: Control group ¼ [k1(FHV), k2(FHV)], Sample group ¼ [k1(GLV), k2(FHV)] Column 1: Test
applied to t10 values. Column 2: Test applied to t50t10 values. Column 3: Test applied to At/∞ values.
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e7168Application of the KS2D test to the type 1 and type 2 compar-
ative cases are shown as Figs. 11 and 12 respectively. We note that
the KS2D test does a good job in not falsely identifying significance
in the type 1 comparative case, although the general level of frac-
tional pseudo-significance is slightly greater than for the <b> ±
2S.E. and Welch's t-test (although there is no apparent off-diagonal
dependence). From Fig. 12, we see that the KS2D-test excels in the
type 2 comparative test, identifying significant differences across
the range of low to high variance sample cases when tested against
the highest variance control group (Rows 1e3 of Fig. 12).
3. Discussion
The current paper has considered the topic of inherentvariability in the analysis of amyloid kinetics. Before embarking
upon a discussion of our results, we stress that the type of
variability that we are contemplating is that which would be
observed even with exemplary experimental technique. Although
we used an empirical process for introducing variability into our
data, we first speculate upon the origin of such inherent vari-
ability. One potential cause may be a high-order concentration
dependence of reaction rate coupled with limits on the accuracy
of concentration formulation such as has been observed in sickle
cell hemoglobin polymerization kinetics [38]. Such a statement
may be formalized as Rate f (C1±xC1)g where xC1 is the error in
the monomer concentration and g >> 1. Another potential source
of inherent variation may stem from uncontrolled/unknown
system effects such as the ratio of air/solution interface [39] or
D. Hall et al. / Analytical Biochemistry 510 (2016) 56e71 69potential volumetric effects related to a stochastically rare pro-
cess8 [17,22,30,40]. Other variation-inducing effects may relate to
unique properties of the particular amyloid forming protein
system, such as the potential existence of a condition sensitive
secondary nucleation pathway (as might be realized by fiber
fragmentation or surface nucleation [23e26,41e43]), the poten-
tial existence of a condition-sensitive alternative aggregation
pathway (such as a competitive amorphous pathway [28,29]) or
the sensitivity of the ‘initial conditions’ to protein age and
preparation route [discussed in Ref. [44]]. However irrespective
of the cause, the end result is variation and this is the topic
considered in this paper.
To carry out our study into inherent variability we have had to
develop computational and analytical tools that, if adopted, will
sharpen the field's collective ability to extract substantial infor-
mation from in vitro kinetic assays of amyloid growth. From a
purely practical perspective, we have developed a novel procedure
for simulating inherently noisy amyloid kinetic data possessing a
known level of variation. On a similarly practical note, we have
also demonstrated the systematic application of a data reduction
strategy based on three characteristic points taken from a
sigmoidal amyloid aggregation curve.
The combined ability to both produce (statistically) large
numbers of well-defined synthetic data sets and reduce these data
sets to tabular form, allowed us to ask questions related to sufficient
sampling and evaluation of statistically significant differences be-
tween control and sample groups. With regards to the sampling
question, we examined three markers of parameter distribution
convergence and found a skew-like descriptor to be the most
sensitive of the three markers tested. With regards to the question
of assessing statistical significance, we examined three different
procedures based on parametric and non-parametric analyses. The
three procedures included a test based on comparison of
means ± standard error, Welch's t-test and the Kolmogor-
oveSmirnov two-sample D test. Of the three, the Kolmogor-
oveSmirnov test was found to be the superior method. This may be
largely attributed to the greater flexibility of the Kolmogor-
oveSmirnov test in assessing differences in distribution shape in
addition to differences in mean values. A further major finding of
this aspect of the study was the advantage gained from performing
statistical testing across the range of characteristic parameters
defined by t10, (t50t10) and At/∞. Such a concerted multi-
parameter testing strategy affords maximum opportunity for
identification of significant differences (as can be appreciated from
examination of Row 3 of Fig. 12).
Based on analysis of systems with differing levels of pre-defined
intrinsic variation, we suggest a useful classification of potential-
amyloid forming model systems into four types, those exhibiting
low intrinsic variance in nucleation and growth phases, those dis-
playing significant levels of variation in either nucleation or growth
phases and those afflicted with high levels of intrinsic variance in
both nucleation and growth phases. An interesting caveat to this
suggestion, raised in footnote 2, was based on the observation of an
artificially large apparent variance induced in the nucleation
marker t10 caused by a high variance in k2 growth rate (even when
the k1 nucleation rate had an intrinsically low variance). As such,
the long-held strategy of using t10 as a marker of nucleation
[45e47] may need modification.
The common structural properties of amyloid [48,49] alongwith
the potentially general ability of all proteins to form amyloid [as
discussed in Ref. [50]] has led many researchers to substitute
general amyloid-forming model systems in the place of particular8 i.e. the rare event becomes more common with greater system size.disease-relevant protein model systems when conducting anti-
amyloid inhibitor drug-screening tests [3,5e10,21,22]. Although
often having a practical basis, relating to cost or ease of working,
such decisions may limit appreciation of the potential effects of
anti-amyloid drug treatment due to the fact that the change in a
distribution, as outlined in Fig. 5, may often be more subtle than
simple shift in mean value. Changes in amyloid distribution shape
and variance have potential for modulating disease progression
[51], as outlined in the Two-Hit model of amyloidosis and prion
infection [41,42,51]. Physical demonstration of such changes is yet
to be observed (although methods exist that can potentially mea-
sure these changes [52,53]).
With some notable exceptions [15,22,24], standard experi-
mental approaches formeasuring amyloid kinetics typically involve
performing duplicate or triplicate measurements with subsequent
averaging for comparison [21,32]. In this study, we have stressed
that the kinetics displayed by some amyloid systems may appear
inherently non-reproducible when tackled with such ‘small data’
type approaches. Such a situation invokes the specter of good
versus bad model systems with the natural tendency for experi-
menters to gravitate towards the more well-behaved experimental
models [21]. However, as the present work has shown, knowledge
of variation in the system potentially represents important infor-
mation on the likelihood of amyloid formation and hence also
disease progression [51]. In this paper we have developed an
alternative means for incorporating apparent stochasticity into the
simulation of the aggregation reaction rates. If an analytical
expression for the variability were to arise from either de-
velopments in theory, or directly from empirical measurement,
such variability could be decomposed into distributions of k1* and
k2* via direct fitting of the individual kinetic traces to Eqn. (A1). For
particular aggregation reactions, use of such tailored parameter
distributions in pre-experimental generation of test data sets,
would enable tuning of the experimental design, in terms of
required numbers of trials, to achieve more statistically robust
outcomes. The methods outlined in this paper make a proper
reckoning of these factors possible and therefore should help to
improve analytical efforts aimed at quantifying noisy/seemingly
recalcitrant amyloid kinetic assays. We hope that this work will
supplement the literature directed at the development of anti-
amyloid drugs [51,54].Acknowledgements
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The amyloid kinetic model is an Oosawa type model (Eqn. (A1))
[ref. A1-a] recently used in the exploration of the turbidity gener-
ated by amyloid [ref. A1-b].
dCN
dt
¼ ½k1*ðCMÞn  ½k2*CNCM (A1-1)
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P
CAi
dt
¼ ½k2*CNCM (A1-2)
d
P
iCAi
dt
¼ ðnþ 1Þ½k2*CNCM þ ½k2*
X
CAiCM (A1-3)
where,
k1* ¼ k1±x1 (A1-4a)
k2* ¼ k2±x2 (A1-4b)
For each simulation, the relevant random variables were
sampled from the appropriate distributions just once (at the zero
time point) and then used throughout that particular simulation. A
new sampling procedure was then begun for the next simulation
until a total pool of one-thousand replicates was constructed. The
above equation set was solved by numerical integration using a
modified mid-point adaption of Euler's procedure [ref. A1-c].
Monomer concentration was calculated via mass conservation at
each time point in the numerical integration.
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Paper 3: Measurement of Amyloid Formation by Turbidity 
Assay – Seeing Through the Cloud 
 
      The third of the three papers published during my studies at the 
Australian National University Research School of Chemistry 
(Zhao et al. 2016) was a detailed examination of the relevant 
literature relating to the basic light scattering behaviour of my 
chaperone aggregation functional assay. In this paper I reviewed 
the physical chemistry of the turbidimetric assay methodology, 
investigating the reviewed information with a series of 
pedagogical kinetic simulations. We particularly focused upon 
recent literature relating to ultra-microscope image analysis (Hall, 
2012; Usov & Messenga, 2015), light scattering and turbidity 
development by protein aggregates (Garcia-Lopez et al., 2006, 
2008; Hall et al., 2016a), and computer simulation of the kinetics 
of amyloid and other aggregate types (Adachi et al., 2015; Hall et 
al., 2015; Hall et al., 2016a). 
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Abstract Detection of amyloid growth is commonly carried
out by measurement of solution turbidity, a low-cost assay
procedure based on the intrinsic light scattering properties of
the protein aggregate. Here, we review the biophysical chem-
istry associated with the turbidimetric assay methodology, ex-
ploring the reviewed literature using a series of pedagogical
kinetic simulations. In turn, these simulations are used to in-
terrogate the literature concerned with in vitro drug screening
and the assessment of amyloid aggregation mechanisms.
Keywords Amyloid biophysics . Turbidimetric method .
Amyloid aggregation kinetics . Data reduction . Nonlinear
signal response
Introduction
The word ‘amyloid’ was first coined over 160 years ago to de-
scribe white densities of protein aggregate in autopsied livers, in
the mistaken belief that they represented deposits of starch1
(Virchow 1854). In modern day scientific practice, the meaning
of the term amyloid has extended beyond its original histopath-
ological association with disease, to describe a class of nanofiber
able to be formed by most proteins upon their adoption of an
unfolded structure and subsequent polymerization via intermo-
lecular β-sheet formation (Toyama and Weissman 2011; Tycko
2011) (Fig. 1). From this current perspective, amyloid is
interpreted as a particular tertiary fold, whose structural mainte-
nance is conditional upon its stabilization as part of a higher-
order quaternary assembly.
Regardless of the motivation for its study, the most basic
practical requirement for experimenting with amyloid is an
assay procedure for monitoring its formation. Although
there are numerous techniques that are capable of achieving
this goal (Li et al. 2009; Nilsson 2004), by far the three
most common in vitro assay formats are those based on
turbidity (Dolado et al. 2005; Sant’Anna et al. 2016), in-
duced fluorescence associated with Thioflavin T dye bind-
ing (Dalpadado et al. 2016; Levine 1993; Naiki et al. 1997)
and induced absorbance spectral shift exhibited upon
Congo Red dye binding (Klunk et al. 1989). In this review,
we examine the literature concerned with the underlying
theory and experimental interpretation of the turbidity assay
(Andreu and Timasheff 1986; Moody et al. 1996). As such,
our review differs from many others on the topic of amy-
loid biophysics (Hall and Edskes 2012; Kashchiev 2015;
Ma and Nussinov 2006; Mezzenga and Fischer 2013;
Sasahara and Goto 2013; So et al. 2016; Tycko and
Wickner 2013) by its restriction to matters directly related
to achieving an understanding of the turbidimetric method.
Towards this goal our examination will pay particular at-
tention to recent articles concerned with ultra-microscope
image analysis (Hall 2012; Usov and Mezzenga 2015),
light scattering and turbidity development by protein
1 Latin: amylum; Greek: amylon meaning starch or ground meal
This article is part of a Special Issue on ‘Analytical Quantitative Relations
in Biochemistry’ edited by Damien Hall and Stephen Harding
* Damien Hall
damien.hall@anu.edu.au; damien.hall@protein.osaka-u.ac.jp
1 Research School of Chemistry, Australian National University,
Acton ACT 2601, Australia
2 Institute for Protein Research, Osaka University, 3-1- Yamada-oka,
Suita, Osaka 565-0871, Japan
3 College of Bio-resource Sciences, Nihon University, Chiyoda-ku,
Tokyo 102-8275, Japan
Biophys Rev (2016) 8:445–471
DOI 10.1007/s12551-016-0233-7
aggregates (Garcia-Lopez and Garcia-Rubio 2008; Garcia-
Lopez et al. 2006; Hall et al. 2016a) and simulation of the
kinetics of amyloid (Ghosh et al. 2010; Hall et al. 2016b;
Kaschiev 2015) and other aggregate types (Adachi et al.
2015; Hall et al. 2015). Although placing the focus of the
review on a single type of assay procedure may seem like a
retreat from the bigger questions, such as the relation be-
tween amyloid and disease (Hall and Edskes 2012; Walker
and Jucker 2015), we contend that a thorough understand-
ing of principles associated with the turbidimetric monitor-
ing of amyloid growth will sharpen our collective ability to
make informed judgements about the biological implica-
tions of results gained from in vitro protein aggregation
assays.
In the following sections we outline (1) consensus
physical models of amyloid aggregates to better under-
stand how they might interact with visible wavelength
light, (2) the general physics of the interaction of light
with matter, concentrating on the description of utilitar-
ian mathematical transforms able to estimate the value
of the turbidity on the basis of attainable experimental
quantities and (3) consensus kinetic models of aggregate
development capable of predicting broad features of the
time course of aggregation for various limiting-case re-
gimes of amyloid growth. As a means for summarizing
relevant literature into compact review form, the geo-
metric and turbidimetric transforms discussed in (1)
and (2) are applied to the output of the consensus ki-
netic models presented in (3). These transformed data
sets are then used as aids for the interpretation of liter-
ature related to amyloid aggregation kinetics.
(i) Consensus physical models of protein aggregates
Solid-state nuclear magnetic resonance experiments and vari-
ous electron microscopy techniques have been used, in com-
bination, to determine atomic-level structural models for sev-
eral amyloids (Tycko and Wickner 2013). Figure 1a is a sche-
matic highlighting three consensus features displayed by near-
ly all amyloid structures observed to date (Tycko andWickner
2013; Tycko 2014), namely:
(1) intermolecular β-sheet formation directed parallel to the
long axis of the fibre
(2) hydrophobic stacking ofβ-sheet segments perpendicular
to the long axis of the fibre (if more than one β-sheet
motif is present per polypeptide)
(3) lateral association of protofibrils to form multi-fibre
assemblies
Figure 1b shows an artistic rendering by Goodsell
(Goodsell et al. 2015) of four different amyloid structures
formed from four different proteins, with all structures deter-
mined using hybrid-combination approaches (Apostol et al.
2010; Fitzpatrick et al. 2013; Lu et al. 2013; Van
Melckebeke et al. 2010). Regular arrangements of stacked
β-sheets can be seen in all rendered images. Packing restraints
associated with these bonding patterns induce a differential
diffraction of incident X-rays from fibres aligned perpendicu-
larly to the incident radiation, with this image providing the
Fig. 1 Amyloid structure. a Consensus structural features of the amyloid
fibre. Left Intermolecularβ-sheet stacks are formed between polypeptides
along the direction of the fibre. One or more sections of a polypeptide
may contribute to the longitudinal β-sheet formation. Hydrophobic-
driven lateral packing may occur between the orthogonal faces of the
β-sheet elements within the amyloid fibre. Centre The simplest possible
fibre arrangement is termed a protofibril which can be characterized by a
length, width, persistence length and helical pitch. Right Hydrophobic
packing forces can cause multiple protofibrils to align to yield higher-
order quaternary arrangements of amyloid fibres termed ‘mature fibres’
(figures adapted, with permission, fromHall and Edskes 2012). bArtistic
renderings of the structures of four different amyloids solved by a com-
bination of solid-state nuclear magnetic resonance and various types of
electron microscopy. From left to right amyloid fibres derived from the
human prion protein (Apostol et al. 2010), yeast prion amyloid fibres
formed from the full-length yeast protein HET-s (Van Melckebeke et al.
2010), amyloid formed from a peptide segment of transthyretin
(Fitzpatrick et al. 2013) and amature amyloid fibre, composed ofmultiple
protofibrils, derived from the brain of an Alzheimer’s Disease patient
(Paravastu et al. 2008). Bar in lower left hand corner 5 nm [figures
adapted from painted illustrations by D.G. Goodsell (Goodsell et al.
2015)]
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basis of the ‘cross-β’ structural nomenclature2 often used to
describe internal amyloid bonding patterns (Liu et al. 2016;
Makin and Serpell 2005).
Although atomic models provide maximum structural
information, they are often not representative of the popu-
lation of amyloid fibres in typical in vitro, or in vivo, ex-
periments, for which fibre heterogeneity tends to be the
norm, rather than the exception (Guo and Akhremitchev
2006; Liu et al. 2016; Meinhardt et al. 2009). With regard
to fibre structure, two general classes of variation exist.
The first type of variation is related to heterogeneity in
polymer length/width3 (Hall and Minton 2002, 2004;
Hall et al. 2016b; Szavits-Nossan et al. 2014). Such varia-
tion in fibre length and width is a natural feature of any
polymerization reaction capable of longitudinal growth
and lateral association4 (Hall 2012; Ridgley and Barone
2013; Umemoto et al. 2014). The second type of variation
is generated by intrinsic structural differences in the core
amyloid/aggregate stemming from competing nucleation
pathways available to a single polypeptide sequence
(King and Diaz-Avalos 2004; Paravastu et al. 2008;
Petkova et al. 2005; Tanaka et al. 2004; Toyama and
Weissman 2011; Tycko and Wickner 2013). The availabil-
ity of multiple aggregation pathways is thought to repre-
sent the basis of amyloid polymorphism (also known as
strain formation) (King and Diaz-Avalos 2004; Tanaka
et al. 2004; Tycko and Wickner 2013). Regardless of the
cause of the variation, the end result is a heterogeneous
mixture of fibres and other aggregate products (Hall
2012; Umemoto et al. 2014). Indeed, in order to be used
in high-resolution structural studies, such heterogeneous
fibre distributions must first be carefully treated by either
selective degradation, purification or re-cultivation (via
selection and re-seeding) in a manner analogous to crystal
farming (Qiang et al. 2011; Scherpelz et al. 2016).
Atomic-level differences in amyloid structure are often
invisible, or muted, when coarser assay methods are used
(Li et al. 2009; Nilsson 2004). This is the case for amy-
loid scattering/turbidity experiments conducted using vis-
ible wavelength light (∼400–700 nm) for which the large
wavelength—relative to the aggregate size—makes
anything more than a mesoscopic5 description of amyloid
structure superfluous. The most common and direct
means for such estimations of mesoscopic structures in-
volve the use of ultramicroscopy techniques, atomic force
microscopy (Adamcik et al. 2010; Harper et al. 1997),
transmission electron microscopy (TEM) (Goldsbury
et al. 2011; (Hall 2012) or total internal reflection fluo-
rescence microscopy (Ban et al. 2003, Ban and Goto,
2006)6. A small number of researchers (Hall 2012;
Usov and Mezzenga 2015) have quantitatively reduced
amyloid ultramicroscope images into equivalent hard
particle models based on a description of the aggregates
as spheres (for small amyloid/oligomers and large amor-
phous aggregates) or cylinders (for amyloid fibers) with
the asymmetric bodies assigned a characteristic rigidity
value (Adamcik and Mezzenga 2011; Hall 2012) or a
defined chiral twist (Usov and Mezzenga 2015). In the
study carried out by Hall (2012), semi-automated anal-
ysis software was developed and applied to TEM im-
ages of amyloid formed from bovine insulin under high
temperature and low pH conditions (Fig. 2). In that
work, two algorithms were used to reduce the fibre
images to a table of characteristic values. The first al-
gorithm (Eq. 1a, b, c) enabled deconvolution of the
measured perimeter, P, and area, A, of an individual
fibre (calculated from pixel analysis of the TEM image
bitmap) in terms of an equivalent sphero-cylinder, with
the result that each fibre was reduced to an internal
length L and a fibre width W (Fig. 2c).
P ¼ 2 Lþ πW
2
 
ð1aÞ
A ¼ LW þ πW
2
4
ð1bÞ
−π
4
 
W2 þ P
2
 
W−A ¼ 0 ð1cÞ
The second algorithm (Eq. 2; Hall 2012)– enabled the es-
timation of a quantity, θAV, reflective of the linear persistence
of amyloid fibres (Adamcik and Mezzenga 2011; Cantor and
Schimmel 1980), defined as the average absolute deviation of
the piecewise projection vector I, measured over a
2 Differential diffraction is dependent upon the relative rotation of the fibre
along the cylindrical coordinate.
3 For a reversible process considered in the thermodynamic limit, this can be a
consequence of the statistical/entropic factors associated with a multi-step
reaction pathway (Hall and Minton 2002, 2004). For both reversible and irre-
versible processes considered in the kinetic limit, heterogeneity in reaction
products may also be caused by spatial fluctuations in concentration, molecu-
lar fluctuations in configuration and/or energetic fluctuations brought about
through collisions with the solvent.
4 Lateral association of fibres is an example of a hierarchical mode of aggre-
gation, in which multiple thinner fibres (sometimes termed protofibrils) later-
ally self-associate to form thicker fibres designated as mature fibres (Makin
and Serpell 2002). Other types of hierarchical aggregation products are also
observed (Krebs et al. 2004; Ridgley and Barone 2013).
5 Mesoscopic physics is concerned with materials of an intermediate length,
i.e. from the nanometer to the micrometer range, which roughly spans the
experimental space between the atomic and the macroscopic. Mesoscopic
models do not display atomic/molecular features but tend to be based on
approximate regular structures, such as spheres and hard convex/cylindrical
bodies.
6 Indirect estimates of aggregate shape can also be made from model-based
deconvolution of hydrodynamic (Lomakin et al. 1996; (Rogers et al. 2005) or
molecular weight measurements (Pallitto and Murphy 2001; Nichols et al.
2002).
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Fig. 2 Ultramicroscopy-based analysis of protein aggregates can provide
the necessary mesoscopic-level structural information for estimating tur-
bidity via the methods outlined in the text of this review. a Typical ex-
perimental transmission electron microscopy (TEM) image of amyloid
fibres (made from pig insulin at pH 3.0 and 60 °C, recorded at 6000×
magnification (adapted, with permission, from Fig. 9 of Hall 2012). b
Example of a pseudo-TEM image generated using the Amyloid
Distribution Measurement (ADM) software useful for calibrating and
testing image analysis routines and designing better ultramicroscope ex-
periments (adapted, with permission, from Fig. 2 of Hall 2012). c
Mesoscopic representation of fibre by a sphero-cylinder of variable
internal length (L) and width (W) (adapted, with permission, from
Fig. 8 of Hall 2012). d Average angle of deviation (θav) for an individual
fibre as determined by Hall et al. (2016a) using successive calculation of
the dot product between projection vectors that trace along the backbone
of the amyloid fibre (adapted, with permission, from Fig. 3a of Hall
2012). e Analysis of simulated TEM data yielding two-dimensional his-
tograms of length and width (adapted, with permission, from Fig. 12 of
Hall 2012). f Analysis of simulated TEM data yielding two-dimensional
histogram of width and average deviation (adapted, with permission,
from Fig. 12 of Hall 2012)
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characteristic distance, l, selected as the fibre width7 (Fig. 2d).
θAV ¼ 1N−1ð Þ
XN
j¼2
cos−1
I j:I j−1
l j:l j−1
 
 ð2Þ
As shown in Fig. 2e, f, the analytical software developed by
Hall (2012) is able to decompose fibre images into two-
dimensional histograms of fibre length versus width or width
versus average deviation. This approach was later used to ana-
lyze TEM images of size exclusion chromatography-purified
amyloid fibres, thereby facilitating development of a quantitative
theory of fibre elution by that technique (Hall and Huang 2012).
An extension to this geometrical description, useful for
modelling aggregates in solution (Hall et al. 2016a), involves
representing aggregate geometry in terms of similarly limited
shape possibilities, along with an extra variable relating to the
internal volume packing fraction. Using this approach, amor-
phous, crystalline and fibrous protein aggregates can all be
represented (Fig. 3). In this model, a protein aggregate com-
posed of i monomers is defined by three properties, the mo-
lecular weight, Mi, the shape, Si and the volume trace
(Vi)TRACE (Eq. 3a, b, c). With regards to the shape, Si, protein
aggregates are treated as either arbitrarily diffuse rods, defined
by a trace length Li and a trace radius Ri, or arbitrarily diffuse
spheres, characterized solely by Ri.
Mi ¼ iM 1 ð3aÞ
Við ÞTRACE ¼
iM1υ
αiNA
ð3bÞ
Si ¼
rod; Li ¼ Við ÞTRACE
.
πRi2
 
sphere; Ri ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3 Við ÞTRACE
.
4πð Þ3
r
8><
>: ð3cÞ
In Eq. 3, M1 describes the monomer molecular weight, NA
is Avogadro’s number, αi is the fraction of the trace volume
occupied by protein (Fig. 3b) and υ refers to protein partial
specific volume8 (Lee et al. 2009). As noted (Hall et al. 2016a),
definingαI in the manner outlined by Eq. Eq. 3a, b, c allows it to
be used to parameterize the transition between compact and dif-
fuse aggregate states (αDIFFUSE < αCOMPACT ≤ 1) such that a
higher value of α would be more appropriate for crystal-like
aggregates whereas a lower value would describe a less dense
amorphous9 aggregate (Bennett 1972; Zurdo et al. 2001).
In principle, the geometrical information contained within
an ultramicroscope image can be used to model the
distribution of fibres within the solution from which it was
generated. Although some research groups have made great
strides forward (Arosio et al. 2012; Hall and Huang 2012;
Lomakin et al. 1996; Rogers et al. 2005), this process is as
yet a not fully realized proposition10. Here we take the liberty
of pointing out how fibre shape parameters, derived from
analysis of the ultramicroscope images, can be used to define
a fibre trace volume. In conjunction with an assumed fraction-
al volume packing, αi, the fibre molecular weight and degree
of polymerization can be estimated from Eq. 4a, b, c.
Við ÞTRACE ¼
4
3
πRi3 ‐ for a sphere
LiπRi2 ‐ for a cylinder
8<
: ð4aÞ
Mi ¼ Við ÞTRACEαiNA
.
υ ð4bÞ
i ¼ Mi=M 1 ð4cÞ
To probe macroscopic-level phenomenon, one must be
able to infer the concentration distribution of aggregate in
solution based on knowledge of the number of adsorbed fi-
bres, N, possessing properties within the discrete limits set by
the element of a histogram11. For some techniques, such as7 In the preparation of our review we noticed that the corresponding equation
of Hall (2012) has a typographical error with regard to bracket placement.
a
b
Fig. 3 Coarse structural models of aggregates. a Schematic describing
coarse-grained conceptualization of bonding arrangements seen in vari-
ous types of protein aggregate corresponding to amorphous (left), crys-
talline (middle) and fibrous (right) structures. b Schematic describing
mesoscopic structural groupings of aggregates as either rod-like or spher-
ical with assignment of a volume packing fraction, defined by the param-
eterα, such that a darker colour represents a greater fractional occupancy
of the aggregate trace volume by protein, i.e. a greater internal density
(schematic is adapted, with permission, from Fig. 1 of Hall et al. 2016a, b)
8 To a first approximation υ can be taken as having a constant value of ∼0.73
ml/g although Lee and co-workers (Lee et al. 2009) have shown that this value
may decrease in the amyloid state, i.e. amyloid may be more tightly packed
than normal globular proteins.
9 Amorphous means an aggregate in which the monomeric units constituting
the aggregates possess no regular internal structure (Bennett 1972).
10 In a similar fashion, most solid state NMR structures require determination
of an average density per unit length by scanning TEM experiment (e.g.
Petkova et al. 2005).
11 As a simple example, we might consider the histogram limits as referring to
aggregate degree i, such that we consider the bin elements defined from i→ i +
Δi.
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light scattering (Lomakin et al. 1996; Nichols et al.
2002) or analytical ultracentrifugation (Binger et al.
2008), in which the total signal intensity is defined by
the solution distribution, deconvolution can be attempted
directly. However, for distributions inferred from ultra-
microscope images, ei ther an internal standard
(Kirschner et al. 1975) or an independent measure of
the total mass concentration of aggregate in solution,
caggregate, is required to determine absolute number den-
sities (with caggregate defined as the total concentration of
protein in an oligomeric form having a polymer degree
≥ 2). As shown previously (Borgia et al. 2013;
O’Nuallain et al. 2006), a value of caggregate can be
determined by pelleting or filtration assay, with con-
comitant spectrophotometric analysis of the superna-
tant. With this information available, the ultramicro-
scope image data can be converted into a solution dis-
tribution on the assumption that the derived distribu-
tion is a true representation of the solution state
(Eq.5a, b).
C i→iþΔið Þ ¼ N i→iþΔið ÞXZ
j¼2
N jþΔ jð Þ: jþ Δ j
2
  :caggregate ð5aÞ
C iþ Δi
2
 
¼ C i→iþΔið Þ
Δi
ð5bÞ
Equation 5a, b provides the means for inferring the
solution aggregate distribution from ultramicroscope-
derived histograms. Joining a continuous line between
discrete concentration estimates (such as that provided
by Eq. 5b) allows, in principle, for realization of the
form of the fibre distribution in solution. In the next
section, we examine the literature concerned with the
estimation of the light scattering properties from such
a protein aggregate distribution, summarizing germane
concepts into a set of equations capable of directly
transforming aggregate distributions into turbidity (at a
given wavelength and path length).
Fig. 4 Principles of light scattering. a Schematic describing the
transmission-based measurement of excess solution turbidity of protein
aggregates in which the transmitted light intensity (IT) is measured in
relation to the incident light intensity (I0) using a standard spectropho-
tometer (or plate reader). b Ray diagram of the encounter between light
and the scattering particle in solution. c Simplified schematic of a general
goniometric scattering experiment for non-polarized light (although the
light wave shown has only one polarization!). Scattering intensity for
Rayleigh-type scattering is equivalent when recorded at any point on a
sphere (centre located at the scattering particle) defined by the radius (r)
and the angle θ, whereby θ is defined as the sub-apex of the spherical
solid angle measured from the forward scattering direction (adapted, with
permission, from Fig. 2a of Hall et al. 2016a, b). d Colour plot indicating
the scattering intensity (normalized relative to the scattering recorded at
right angles to the incident beam) as a function of the recording angle θ,
with the system conforming to limiting Rayleigh scattering conditions
described in c (adapted, with permission, from Fig. 2b of Hall et al.
2016a, b)
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(ii) Turbidity of aggregates in the visible region
Turbidity describes the attenuation of the incident beam by
light scattering (Bohren and Huffman 2008; Elimelech et al.
2013) and thus can be evaluated either directly, via measure-
ment of the loss of intensity by transmission measurement
(Fig. 4a, b), or indirectly, by integration of the angle-
dependent scattering at a fixed distance (goniometric static
light scattering) (Doty and Steiner 1950; Wyatt 2014)
(Fig. 4c, d). The relatively straightforward nature of the trans-
mission measurement, requiring only a spectrophotometer or
plate reader, has encouraged adoption of the turbidimetric
method in the absence of more specialist light scattering
equipment (Andreu and Timasheff 1986; Gaskin et al. 1974;
Wyatt 2014). Coupled with ease of performance, the general-
ity of light scattering (due to the lack of a requirement for an
extrinsic label) has made transmission-based turbidimetric as-
says the default ‘basic’ standard for recording protein
aggregation kinetics. Historically speaking, turbidity has been
used to monitor the growth of a range of protein aggregation
reactions, including helical fibre formation by sickle cell
haemoglobin (Ferrone et al. 1985; Moody et al. 1996), cyto-
skeletal fibre formation (Voter and Erickson 1984; Wegner
and Engel 1975; Gaskin et al. 1974), virus capsid formation
(Tachibana et al. 1977), non-specific amorphous polymeriza-
tion (Stranks et al. 2009; Ingham et al. 2011) and of course
amyloid formation (Anzai et al. 2016; Dolado et al. 2005;
Hatters et al. 2001; Necula et al. 2007; Sant’Anna et al.
2016). Although the turbidimetric procedure is a relative-
ly non-demanding experiment to carry out, as with all
scattering methods, the downside is that gaining an un-
derstanding of the underlying physics generally requires
a familiarity with Maxwell’s equations not often in sim-
patico with the background of those performing the
work. It is partly towards this divergence that the next
section is directed.
Table 1 Values of F and Q for the three size regimes and two shape types considered
Approximate size range (for which the description
is valid)
Idealized turbidity per unit molecular
concentrationa (Fi)
Transmittance form factorb (Qi)
Rayleigh 0 ≤ <Ri> ≤ λ/20
Fi ¼ 24 M
2
1 i
2υi2= αi2N2A½ ð Þ
λ4
m2i −1
m2i þ2
 2 Qi = 1
Rayleigh-Gans-Debye 0 ≤ <Ri> ≤ λ/2
Fi ¼ 24 M
2
1 i
2υi2= αi2N2A½ ð Þ
λ4
m2i −1
m2i þ2
 2
Qi ¼ ∫
π
0
P θ;λð Þ: 1þ cos2θ  :sinθ:dθ
Where, P θ;λð Þ ¼ 1
N2
∑
N
i¼1
∑
N
j¼1
sin h:di j
 
h:di j
 
h ¼ 4πnsin θ=2ð Þλ
di j ¼ r!i− r! j
 
For x1 =Rino/λ and x2 = Lino/λ
When x2 < 1;
Qi sphereð Þ ¼ 1−0:955 1−e−6:48x1ð Þ 2:40
Qi rodð Þ ¼ Qi sphereð Þ x1ð Þ
1−0:955 1−e−1:08x2ð Þ½ 1:275
When x2 ≥ 1;
Qi rodð Þ ¼
Qi sphereð Þ x1ð Þ
2:4x20:95
Anomalous diffraction approximationb
2λ ≤ <Ri> ≤ 15λ Fi ¼ 24 M
2
1 i
2υi2= αi2N2A½ ð Þ
λ4
m2i −1
m2i þ2
 2
Qi rodð Þ ¼
Qi sphereð Þ x1ð Þ
2:4x20:95
Qi sphereð Þ ¼
2− 4ρi
 
sin ρið Þþ 4ρi2
 
1−cos ρið Þð Þ
h i
Fið ÞRAYLEIGH=π: Ri2h ið Þ
where, ρi = 4πRi(mi − 1)/λ
All expressions are particular for a non-polarized light source and randomly oriented aggregate. All terms are defined in Eq. 3a, b, c; Eq. 4a, b, c; Eq. 6a,
b, c, d e; Eq. 7a, b, c; Eq. 9
a As defined in Eq. 9 of the text
b The anomalous diffraction equation is a good approximation of the Mie scattering description for spheres (Hergert andWriedt 2012; Kerker 2013; Mie
1908). Arguments have been advanced (Hall et al. 2016a) to suggest that the expression for given for Qi(rod) would retain validity in the Mie scattering
regime (for a discussion see Cassasa, 1955; Bishop 1989; Buitenhuis et al. 1994; Liu et al. 1998)
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The truest understanding of light scattering phenomena re-
quires a quantum-level description of both the system and the
light source (Chu 1974; Loudon 2000). However from the
time of Rayleigh (Rayleigh 1899), theories based on classical
electromagnetism (Bohren and Huffman 2008; Doty and
Steiner 1950; Oster 1955; Penzkofer et al. 2007), coupled with
regular shape approximations of the scattering bodies and
continuum approximations of the solvent, have proven effec-
tive for extracting shape and molecular weight information
from measurement of the angle-dependent intensity of the
scattered light (Geiduschek and Holtzer 1958; Wyatt 2014).
In the classical approach, light is considered to be a
coincident, yet perpendicular pair of travelling electric and
magnetic transverse field vectors, oscillating at a frequency
f, over a wavelength λ (Bohren and Huffman 2008). The
charge distribution associated with any element of matter in
the path of the light beam is perturbed by these fields and
caused to, itself, oscillate. For the case of elastic scattering,
the oscillating (and thus accelerating) charge will produce
another light wave of identical wavelength12 (Bohren and
Fig. 5 Theoretical treatments of scattering. a–c Three general scattering
regimes were considered by Hall et al. (2016a), namely a Rayleigh
limit—where the scattering particle is small in relation to the
wavelength of light [<Ri> < λ/20] (red line light wave, blue arrow
position of the dependent electric field vector). b Rayleigh–Gans–
Debye limit—where the particle can be reasonably large in relation to
the wavelength of light at ∼[0 < <Ri> < λ/2] such that it produces out-of-
phase scattering at different centres of the particle but the light suffers no
appreciable loss of intensity as it passes through the particle. c Mie scat-
tering regime—where the particle is sufficiently large to both generate
out-of-phase scattering and to perturb the intensity of the light as it passes
through the aggregate. For the anomalous diffraction approximation of
the Mie equation used by Hall et al. (2016a) this description is applicable
over the size regime of ∼[2λ < <Ri> < 15λ]. d Schematic highlighting the
potential for orientation effects on both the out-of-phase scattering and
loss of intensity complications accompanying increasing size and asym-
metry of the aggregate. All quantitative descriptions described by Hall
et al. (2016a) assume random orientation of the aggregate. e Continuous
description of the transmittance form factor for a spherical aggregate
[Q(RSPHERE)] at three different wavelengths (blue line 400 nm, red line
450 nm, green line 500 nm). Interpolation based on a polynomial descrip-
tion of spliced simulations from the three characteristic size regimes is
shown in Table 1. f Continuous description of the transmittance form
factor for rods [Q(LROD)] over a large size regime for three different
wavelengths (a–d adapted, with permission, from Fig. 3 of Hall et al.
2016a; e, f adapted, with permission, from Fig. 5 of Hall et al. 2016a)
12 Inelastic light scattering refers to the case where some energy is absorbed,
donated or dissipated by the molecule with subsequent change in wavelength
between incident and scattered radiation.
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Huffman 2008; Kerker 2013). In the late 19th century, Strutt
(Rayleigh 1899) deduced the quantitative relationship be-
tween the characteristics of an illuminated particle and the
scattering intensity measured at a set distance and direction
(Eq. 6a; Fig. 4). That formulation was derived on the basis of a
set of simplifying criteria specifying limiting dilution and
small size for the scattering object relative to the wavelength
of light (Fig 4a). Under these Rayleigh limiting conditions the
total amount of light scattered away from the forward direc-
tion, IS, can be calculated by spherical integration of the angle-
specific scattering intensity, i(r,θ), whereby θ represents the
forward scattering apical sub-angle of the solid angle and r
describes the radial distance from the centre (Kerker 2013;
Oster 1955) (Eq. 6b–e).
i r; θð Þ ¼ i0
r2
9π2 Við Þ2TRACE
2λ4
mi2−1
mi2 þ 2
 2
1þ cos2θ 
" #
ð6aÞ
IS ¼ 2πr2
Zπ
0
i r; θð Þsin θð Þdθ ð6bÞ
I0 ¼ A0i0 ð6cÞ
lo
g 1
0Q
SP
HE
RE
(R
i,
i)
a b
c d
Fig. 6 Utilitarian approach developed by Hall et al. (2016a, b) for esti-
mating turbidity. a Two-dimensional polynomial fit of simulated Q values
for a sphere: fitted values were overlaid onto large sets of the base ten
logarithm of Q calculated for a sphere of arbitrary packing fractionαI and
radius Ri, determined using the interpolation technique describe in Fig. 5e
(at λ = 400 nm). b Specific turbidity (turbidity per kg/m3 of aggregate) for
a spherical protein aggregate of arbitrary αi and Ri, calculated using the
corresponding value of Q shown in a. Protein concentration and mass
were respectively set at 1 mg/ml and 5000 g/mole. c, d Corresponding
plots to a and b, respectively, but this time describing the case for cylin-
drical rods of arbitrary length and radius. Specific turbidity in d was
calculated at the same concentration and mass of the protein monomer
with a value of the specific fractional volume occupancy of α = 1.0
(adapted, with permission, from Figs. 6, 7, 8 and 9 of Hall et al. 2016a, b)
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IS
I0
¼ 24π
3 Við Þ2TRACE
λ4
mi2−1
mi2 þ 2
 2
1
Ao
 
ð6dÞ
IS
I0
¼ LCi 24π
3 Við Þ2TRACE
λ4
mi2−1
mi2 þ 2
 2
ð6eÞ
In Eq. 6a–e, i0 refers to the incident light intensity, A0 to the
cross-sectional area of illumination of the incident light, L to
the optical path length of the transmission measurement and
mi to the relative refractive index of the aggregate (relative to
the solvent). A numerical value of mi can be calculated (Hall
et al. 2016a) on the basis of knowledge of the solvent refrac-
tive index, n0, the aggregate protein refractive increment,
dn/dci, the fractional volume occupation by protein in the trace
volume, αi, and the partial specific volume, υ (Eq. 7a). The
wavelength dependence of the refractive index and refractive
increment can be determined using an empirical formula
(Perlmann and Longsworth 1948) (Eq. 7b, c).
mi ¼ 1þ αi dn
.
dc
 
1
.
υ
 h i.
n0 ð7aÞ
n λð Þ ¼ 1:3403 0:9922þ 2:31 10−15
.
λ2
h i
ð7bÞ
dn
.
dci λð Þ ¼ 0:19 10−3 0:925þ 2:2 10−14
.
λ2
h i
ð7cÞ
The Rayleigh scattering relationship, shown in Eq. 6a–e, is
able to quantitatively account for the scattering of non-
polarized light by a compact solute with average radius of less
than one-twentieth of the wavelength of light Ri < λ/20). In a
standard spectrophotometer arrangement (Fig. 4a), the contin-
ual encounter of incident light with particles in its path leads to
a length-dependent decrease in transmitted light intensity re-
corded at the detector (Kerker 2013). The description of how
the intensity changes with position due to scattering can be
formulated via Eq. 8a, in which turbidity, defined as τ, is the
first-order decay constant of light intensity, I, with path length,
L (Bohren and Huffman 2008; Oster 1955) Rearrangement
and integration yields the central section of Eq. 8a, which in
turn can be simplified by a series expansion to produce Eq. 8b.
When the ratio of scattered light to incident is <0.1, the first
term of the series expansion suffices (Eq. 8c) (Kerker 2013).
τ ¼ − 1
I
 
dI
dL
¼ − 1
L
loge 1−
IS
I0
 
¼ 2:303 O:D:ð Þ ð8aÞ
τ ¼ 1
L
X∞
n¼1
1
n
IS
I0
 n
ð8bÞ
τ
limτ→0ð Þ
≈
1
L
IS
I0
 
ð8cÞ
Insertion of Eq. 6e into Eq. 8a, b, c yields an expression
which accurately describes the path length-corrected turbidity
values of small particles at low concentrations, i.e. Ri < λ/20,
τi →0, Ci → 0).
Although Eq. 8a is capable of predicting the turbidity of
small compact particles in the dilute limit, it becomes less
suitable as the particles increase either in size, concentration
or complexity of their shape13 (Bohren and Huffman 2008;
Garcia-Lopez and Garcia-Rubio 2008; Garcia-Lopez et al. 2006;
Hergert and Wriedt 2012; Kerker 2013). With specific regard to
the size and shape of a particle, we note that deviation from the
ideal Rayleigh case occurs for two reasons (Fig. 5):
1. Different regions of large aggregates will experience differ-
ent phases of the incident light’s electric field, thereby pro-
ducing a complex superposition of the scattered light with a
reduction in overall scattering intensity (Bohren and
Huffman 2008; Geiduschek and Holtzer 1958) (Fig. 5b).
2. In the case of scattering from very large aggregates, the
incident light will be demonstrably reduced in intensity as
it travels through the aggregate, compounding the difficulty
of accounting for any phase difference produced upon scat-
tering (Elimelech et al. 2013; Kerker 2013) (Fig. 5c, d).
The Rayleigh–Gans–Debye (RGD) formalism (Debye
1947; Gans 1925; Zimm and Dandliker 1954) is a theoretical
approach capable of tackling only the first of these two diffi-
culties and is therefore applicable only to particles of averaged
cross-sectional radius, 〈Ri〉, smaller than λ/{2no(λ)} (Bohren
and Huffman 2008). In RGD theory, total scattering intensity
is calculated as the sum of the scattering from N discretized
centres within the aggregate, on the assumption that the inci-
dent light intensity is constant throughout the aggregate
(Fig. 6b). A quantity known as the particle form factor
Pi(θ,λ) reflects the degree to which this type of internal inter-
ference, generated by effective phase difference, diminishes
the scattering recorded for a real particle, i(r,θ)real, relative to
that measured for an idealized scattering particle (same mass,
but point-like dimensions), i(r,θ)ideal, such that Pi(θ,λ) =
13 As issues related to high concentration can be effectively solved experimen-
tally by either using a smaller path length or by serial dilution of the solution
prior to measurement, we focus in this review on the effects related to particle
size and shape complexity. With this point made, we note that the dilute limit
refers to the concentration range at which one may neglect significant re-
scattering of the scattered light by other aggregate particles in solution back
into the collimated detection pathway. This re-scattering effect by other mol-
ecules in solution is sometimes called external interference.We refer the reader
to work describing the effect of external interference on scattering encountered
in the high concentration limit based on virial expansions of the turbidity in
terms of solute concentration (Dhont 1983; Minton 2007). Such factors will be
important to consider if the turbidimetric technique is be used to study aggre-
gation in near cell-like conditions such as those employed in macromolecular
crowding studies (Hall andMinton, 2003; Hall, 2002; Hall and Dobson, 2006;
Hall 2006).
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i(r,θ)real/i(r,θ)ideal (Doty and Steiner 1950; Geiduschek and
Holtzer 1958) (Table 1). The equivalent term for the transmit-
tance measurement, known as the transmittance form factor,
Qi, can be directly obtained from Pi(θ,λ) upon integration to
account for all possible orientations of the aggregate in rela-
tion to all possible polarizations of the light (Table 1). Within
the limits of the approximations inherent in their construction,
these form factors can be calculated for any arbitrary shape
based on knowledge of the centre-to-centre distances of the
discretized scattering centres through use of the Debye equa-
tion (Table 1) (Bohren and Huffman 2008; Debye 1947).
An alternative approach to the Debye approximation, devel-
oped by Gustav Mie for particles of arbitrary size and shape
(Hergert and Wriedt 2012; Mie 1908), accounts for both the
decrease in light intensity as it passes through the aggregate and
the phase difference in scattered light intensity generated by
scattering from widely separated regions of the aggregate mol-
ecule (Hergert and Wriedt 2012; Kerker 2013) (Fig. 5c, d). The
anomalous diffraction (AD) equation (Table 1) developed by
Van de Hulst represents a very accurate simplifying approxima-
tion to the Mie scattering equations for aggregates having
spherical geometry (Elimelech et al. 2013; van de Hulst
1957). The AD approximation for spheres retains validity over
the size regime 2λ ≤ 〈Ri〉 ≤ 15λ for systems having a relative
refractive index, mi, of <1.3 (van de Hulst 1957). Importantly,
this last requirement represents nearly all conceivable cases of
proteins aggregating in standard aqueous buffers. Relatively
simple approximate forms of Mie-type solutions for other
shapes, such as cylindrical rods, have also been developed
and compared to ‘exact’ calculations made using finite element
numerical techniques performed over a large range of particle
sizes relative to the wavelength of light employed (Bishop
1989; Buitenhuis et al. 1994; Liu et al. 1998) (Table 1).
Based on a recasting of the general turbidity expression
into an equation involving three parts, Hall and co-workers
(Hall et al. 2016a) laid the foundation for producing an em-
pirical interpolation of the transmittance particle form factor
Qi over a wide range of sizes and shapes suitable for describ-
ing amyloid growth (Eq. 9) (Fig. 5e, f).
τ i
lim τ→0ð Þ
¼ CiFiQi ð9Þ
As formulated by Eq. 9, τi, the turbidity at limiting dilution,
is composed of three terms, namely Ci, Fi and Qi, whereby Ci
is the scattering particle concentration (units of mole-
cules m−3), Fi is the idealized turbidity per unit molecular
concentration that would be generated if the particle scattered
light as a point mass (units: m2 molecule−1) and Qi is the unit-
less transmittance form factor discussed above. Hall and co-
workers (Hall et al. 2016a) considered the appropriate
functionalization of Eq. 9 for two general shapes, a rod and
a sphere of arbitrary internal density, over the three particle
size regimes of scattering described in Table 1.
Although values of Qi and Fi exist for other shapes (see
Bohren and Huffman 2008; Moody et al. 1996), their evalua-
tion from a turbidity signal is problematic, representing, as it
does, a type of inverse problem (Hall and Minton 2005;
Mroczka and Szczuczynski 2010; Shmakov 2014). Given that
a rod and a sphere respectively demonstrate the least and most
scattering potential of any regular body, Hall et al. (2016a)
suggested that an experimental signal, presumed to reflect am-
yloid growth, might be empirically decomposed into amyloid
(rod-like) and non-amyloid aggregate (assumed spherical)
structures. With this basic premise they went on to provide a
continuous description of F and Q over a size range spanning
the point scattering (R < λ/20) to Mie regime (2λ < R < 15λ) in
the form of two-dimensional polynomial interpolants for
spheres (Eq. 10a) (Fig. 6a) and rods14 (Eq. 10b) (Fig. 6c).
log10Qi Ri;αið Þ ¼
XN
j¼0
XN
k¼0
uj;k Rið Þ j αið Þk ð10aÞ
log10Qi Li;Rið Þ ¼
XN
j¼0
XN
k¼0
wj;k Lið Þ j Rið Þk ð10bÞ
The coefficients for these two polynomials were evaluated
at a series of different wavelengths. With the value of F com-
mon to all three different size regimes (Table 1), the differ-
ences in turbidity due to shape can be seen to be directly
defined by the transmittance particle form factor (Bohren
and Huffman 2008; Kerker 2013). Previously calculated nu-
merical examples (Hall et al. 2016a) describing the specific
turbidity (i.e. turbidity per set mass of scattering component)
produced by a spherical aggregate of arbitrary internal frac-
tional occupancy, and a cylindrical rod for which, αi = 1, are
reproduced in Fig. 6b, d. In the case of multiple aggregate
species, the turbidity for a solution of aggregates of different
sizes and shapes can be calculated as the sum of the contribu-
tions to turbidity from each particle (Eq. 11) (Bohren and
Huffman 2008; Kerker 2013).
τ
lim τ→0ð Þ
¼
XN
i¼1
τ i ð11Þ
The aim of this review is to consider the kinetics of aggre-
gate formation as monitored by the turbidity assay. In the sec-
tion Consensus kinetic models of aggregate growth, we review
different consensus kinetic behaviours of amyloid/aggregate
14 Two important points to note here are (1) QSPHERE in the Mie region was
calculated using the AD approximation and (2) QROD in the Mie region was
calculated by extending the asymptotic form calculated by the RGD approach.
Although not exact, this assumption has been calculated to induce an error of
<15 % in the estimation of scattering of non-polarized light from randomly
oriented fibres extending in length beyond the RGD limit up to an (effectively)
infinite length (Bishop 1989; (Buitenhuis et al. 1994).
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formation, summarizing them into a set of limited basis models
(Table 2). Together with the geometric and turbidimetric trans-
forms reviewed in the previous sections, these consensus ki-
netic models are used to simulate characteristic turbidity sig-
natures associated with particular mechanistic sub-types
(Ghosh et al. 2010; Hall and Edskes 2012; Kashchiev 2015).
(iii) Consensus kinetic models of aggregate growth
An extremely general description of non-specific cluster for-
mation was made over 150 years ago by von Smoluchowski
(1916, 1917). In that approach, for a single isomeric state15,
the rate of formation of an aggregate species is given by the
total balance of all possible formation and breakage events
(Eq. 12a, b),
dCk
dt
 
growth
¼
Xk−1
i¼1
f i;k−iCiCk−i þ
Xz
j¼kþ1
bk;j−kC j ð12aÞ
dCk
dt
 
loss
¼ −
Xz
i¼1
f k;iCkCi−
Xk−1
j¼1
bj;k−jCk ð12bÞ
Within this cluster growth formalism, the concentration of
an aggregate composed of k monomers is denoted by Ck. The
chemical rate constant16 for formation of a species of size k
from two smaller species j and k−j is denoted by fj,k-j.
Similarly, the chemical rate constant describing the breakage
of a species of size k into two species, j and k−j, is denoted by
bk−j,j. With an appropriate choice of rate constants, the
Smoluchowski cluster/condensation rate model can be used
to describe aggregation processes of great complexity
(Aldous 1999). However, despite this potential for diversity,
the kinetics of amyloid formation have repeatedly been shown
to comport to a subset of the possible model space, defined by
Eq. 12a, b, with this subset known as nucleated growth17
(Jarrett and Lansbury 1992; Lomakin et al. 1996; Masel
et al. 1999; Wetzel 2006) (Fig. 7). In its most general form
this mode of aggregation involves the introduction, or slow
production, of a structural nucleus within a pool of monomeric
proteins18 which are themselves capable of joining to the
nucleus and adopting the template structure encoded by
it (Jarrett and Lansbury 1992; Petkova et al. 2005;
Wetzel 2006). As the amyloid reaction proceeds, fibres
can break apart (Hall and Edskes 2009, 2012, 2004; Xue
et al. 2008) or join together (Pallitto and Murphy 2001;
Binger et al. 2008, Michaels and Knowles 2014). Joining
of fibres may occur in either an end-to-end fashion
(Binger et al. 2008), a lateral side-to-side manner
(Pallitto and Murphy 2001; Nichols et al. 2002; Kanno
et al. 2005) or by a random process (Mishra et al. 2011)
to produce a low-density matrix. Irrespective of their
exact form, idealized nucleation–growth models typically
display sigmoidal-type association kinetics if the nucle-
ation step is allowed to occur spontaneously (Jarrett and
Lansbury 1992), or exponential-type association kinetics
without a lag-phase, if nucleation is bypassed by seeding
the system with template (Paravastu et al. 2009; Wetzel
2006). In accordance with Fig. 7, the kinetics can be
parameterized with constants describing the nucleation,
growth and asymptotic stages of the reaction (Hall
et al. 2016b). Alternatively, the kinetic traces may be
fitted to equations derived from mechanistic models of
amyloid growth, to yield the most parsimonious set of
rate constant parameters (Pallitto and Murphy, 2001;
Morris et al. 2009; Smith et al. 2006).
In the following subsections we discuss a number of
potential variants in the nucleated growth model, sum-
marizing the basic kinetic behaviour with an appropriate
chemical rate equation (Table 2). In the formulation and
discussion of kinetic data reflecting the various limiting
cases of aggrega t ion behav ior, we make two
assumptions:
(1) Polymer distributions are approximated by their weight
average. A more formal description of this approxima-
tion for the weight average degree of polymerization, is
shown by Eq. 13:
ih i ¼
Xz
i¼2
Ci:i2
Xz
i¼2
Ci:i
ð13Þ
.
(2) In discussing either breakage, competitive growth or fi-
bre joining, a separation of time scales for the monomer/
polymer mass and polymer mass/polymer distribution
time scales will often be invoked (Bridstrup and Yuan
2016; Hall and Minton 2004). A more formal statement
15 If aggregates are composed of multiple isomeric forms the rate constants
become dependent upon the isomeric state and a new dimension must be
introduced into the specification of the aggregate and rate constants.
16 Corrected for statistical and stoichiometric factors.
17 Also known as templated-growth, nucleated-crystal growth or helical poly-
merization (Oosawa and Asakura 1975).
18 As linear polymers of amino acids, proteins potentially have available to
them a very great number of possible internal configurations of the polymer
chain. Internal bonding preferences for solvent and self often limit this range of
possibilities, leading to a single structural state known as the folded state.
Under conditions of elevated temperature, the presence of a chemical denatur-
ant or other structure-deforming species, the protein can be induced to unfold.
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Table 2 Kinetic equations for six different cases of amyloid aggregation
Kinec Model Kinec Rate Equaons1 Literature
Irreversible Nucleated Growth
MNA
n
MN
N CCfCf
dt
dC
MNA
A CCf
dt
dC
MAAMNA
AM CCfCCfn
dt
dC
)1(
Oosawa and 
Asakura, 1975.
Hall, 2003; Hall et 
al. 2016b.
Powers and 
Powers, 2004.
Fibre Breakage
AAMA
n
MN
A CnCbCf
dt
dC
).1(
AAAMA
n
MN
AM CnbCCfCfn
dt
dC
.
Masel et al. 1999
Hall and Edskes, 
2004, 2009, 2012.
Smith et al. 2005.
Kashschiev, 2015.
Fibre End to End Associaon
MNA
n
MN
N CCfCf
dt
dC
2
AJEEMNA
A CfCCf
dt
dC
MAAMNA
AM CCfCCfn
dt
dC
)1(
Hill, 1983
Pallio and 
Murphy, 2001
Binger et al. 2008
Fibre Lateral Associaon
MNA
n
MN
N CCfCf
dt
dC
2
2 AJLAMNA
A CfCCf
dt
dC
22
AJLA
A Cf
dt
dC
MAAAMNA
AM CCCfCCfn
dt
dC
2
2)1(
Pallio and 
Murphy, 2001
Ghosh et al. 2010.
Amyloid vs Amorphous Compeon2
xCCC tAMtAtA 00;
yCCC tGMtGtG 00 ;
AAMAA
AM CbCCf
dt
dC
xCIf AM
MAA
AM CCf
dt
dC
xCIf AM
GGMGG
GM CbCCf
dt
dC
yCIf GM
MGG
GM CCf
dt
dC
yCIf GM
Naiki et al. 1997
Stranks et al. 2009
Hall et al. 2015
Hall and Minton, 
2004, 2005
Hall, 2003.
Amyloid vs Amyloid Compeon2
As for case above but the subscripts A 
and G should be replaced with the 
symbols A#1 and A#2 represenng two 
different kinds of amyloid growth from 
the same monomeric form.
Naiki et al. 1997
Hall et al. 2015
Hall and Minton, 
2004
Hall, 2003.
1 Monomer was calculated via conservation of mass arguments with terms as appropriate
2 Seeds are regarded as fixed i.e. non-dissociable
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of this conceptual tool is given by the following mecha-
nistic approximation [Eq. 14]:
monomer→
fast
←
polymer mass →
fast or slow
←
polymer distribution ð14Þ
With regard to the first assumption (described in Eq. 13), we
note that a few researchers (Arosio et al. 2012; Ghosh et al.
2010; Hall and Edskes 2004, 2009; Hall et al. 2015) have de-
veloped methods for simulating amyloid kinetics that yield full
distribution information as a function of time. Although these
methods are more informative than the approximation adopted
by Eq. 13, they are also necessarily more complex. Due to the
focus of this review being on the transformation of the distri-
bution by turbidimetric assay procedures, we have opted to
make a trade-off: a level of exactness for ease of discourse19.
In the cases where no literature-derived chemical rate equation
exists (or alternatively no literature derivation possessing a rel-
atively transparent formulation exists), we have cited the rele-
vant literature but put forth an approximate relation.
Of all possible permutations available to Eq. 12a, b, the
following six limiting cases of templated growth are regarded
as having principal importance in this review:
& Irreversible nucleation–growth model
& Nucleation growth with fibre breakage
& Fibre end-to-end association
& Fibre lateral association
& Amyloid versus amorphous competition
& Amyloid versus amyloid competition
Functional kinetic models for each of these limiting cases
have been provided (Table 2). Rate models are presented in
differential equation format due to the straightforward manner
in which ordinary differential equations (ODE) can be related
to mechanism by inspection20. Figs. 8, 9, 10, 11, 12, 13, and
14 show the resultant chemical kinetics and turbidity transfor-
mation for each case.We discuss both the kinetic behavior and
the turbidity transformation (effected through application of
Eqs. 9–11 to the simulated chemical data) to each case in turn.
Irreversible nucleation-growth
Oosawa and colleagues developed the first nucleation–
growth-type kinetic models to describe the polymerization of
helical fibers formed by the cytoskeletal protein actin
(Oosawa and Asakura 1975; Oosawa and Kasai 1962).
Despite potential structural and mechanistic differences21,
others have adapted these Oosawa class of kinetic models to19 Approximation of the distribution by the average prior to estimation of the
turbidity will introduce another type of error into the process.
20 In the modern day computer-based numerical integration of ODE sets
lessens the requirement for the determination of analytical solutions that may
be based on further mathematical approximations (in addition to the already
existing chemical approximations).
21 Interestingly, with regard to this point, it was shown that a nucleation event
could be generated for a linear polymerization process based solely on con-
sideration of the conformational entropy of the unfolded protein—that is an
entropic nucleus (Hall et al. 2005); Hall and Hirota 2009).
a
b c
d e
Fig. 7 Schematic of amyloid kinetics. a Characteristic features of
amyloid nucleation–growth polymerization kinetics include a
characteristic lag/nucleation phase, a steep growth phase and an asymp-
totic endpoint. A simple scheme for reducing the data to parameters
reflecting each of these characteristic features is included. These param-
eters include (1) the kinetic tenth time, t10 (time to reach 10% of reaction),
reflecting the nucleation phase, (2) a composite term reflecting the differ-
ence between half-time, t50, and kinetic tenth time (t50− t10) characteristic
of the growth phase and (3) the time-independent value of the extent of
the monomer incorporated into amyloid, (CM→A)t→∞, characterizing the
asymptotic phase. Blue line Value of CM→A as a function of time, green
line the corresponding concentration of monomer as critical nucleus
(nCN) as a function of time (adapted, with permission, from Fig. 1d of
Hall et al. 2016a, b). b Data reduction and analysis. In the case of drug
screening for amyloid inhibitors, replicate measurements of the measured
growth kinetics are decomposed into a set of characteristic values (such as
the set of parameters described in Fig. 7a), with resultant values repre-
sented as a fractional histogram. c–e Fractional histogram representation
of the surrogate markers of the nucleation (d), growth (c) and asymptotic
(e) regions derived from the simulations shown in b (adapted, with per-
mission from Fig. 2 of Hall et al. 2016b), with simulated results multiplied
by a constant value to more closely reflect the time course and concen-
tration profiles shown in subsequent cases)
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empirically describe the time-course of amyloid formation
(e.g. Morris et al. 2009). To effect simulation of irreversible
nucleation–growth kinetics, all fibre breakage rate constants
in Eq. 12a, b are set equal to zero (i.e. all bi, j = 0). From the
time of the original work by von Smoluchowski (von
Smoluchowski 1917, 1916), many have attempted a first prin-
ciples estimation of association rate constants (fi, j) based on
the component characteristics (e.g. Hall et al. 2005; Hill 1983;
Pallitto and Murphy 2001). On the assumption that amyloid
growth occurs primarily via monomer addition, Hall and
Hirota (2009) calculated a numerical value for all f1,j associa-
tion constants (based on hydrodynamic reasoning) and then
used these parameter values to perform a full distribution sim-
ulation of amyloid growth, exploring effects of peptide posi-
tion and role of peptide flanking sections. As a further
simplification, in the Oosawa-type models all forward associ-
ation rate constants are assigned one of two different values
depending on their positional relation to the polymerization
event featuring the nucleus, considered as possessing a size, n
(Masel et al. 1999; Oosawa and Asakura 1975). In the Oosawa
approximation, association rate constants (fi,j) are set equal to
either fN, denoted as the nucleation rate constant for species i+
j ≤ n, or fA, termed the growth rate constant for association of
species i,j where i+j > n. Kinetics comporting to the nucle-
ation–growth scheme are generated by calculating the rate of
formation and loss of each species on the condition that fA >>
fN (Arosio et al. 2012; Hall 2003). A group of three coupled
ODEs (shown in Table 2) representing the Oosawa–Kasai–
Asakura approximation (Hall 2003; Oosawa and Asakura
1975) is produced upon appropriate summation of the
C M
A
(M
)
a b
c d
Fig. 8 Irreversible nucleation–growth model—effect of fibre width on
the turbidity transform. Simulation of four cases of irreversible amyloid
growth which, although exhibiting identical growth kinetics, differ in the
radius of the amyloid fibre produced, such that RA = 4 nm (black line),
6 nm (red line), 8 nm (blue line) or 10 nm (yellow line). a Concentration
of monomer incorporated into amyloid, CM→A, as a function of time for
four different cases of amyloid radius (single line for all four cases reflects
identical growth kinetics dictated by imposition of identical rate
constants. b Average polymer degree (<i>) of aggregate as a function
of time for the four different cases of amyloid fibre radius (single line for
all four cases is due to identical nucleation and growth kinetics brought
about by use of identical rate constants). (c) Length (L) of amyloid fibres
as a function of time for the four different cases of amyloid fibre radius.
As per volume conservation requirements, fibres of different width
lengthen in a manner proportional to L1/L2 = (RROD2)
2/(RROD1)
2. d
Turbidity (τ) of amyloid fibres as a function of time for the four
different cases of amyloid fibre radius calculated using the transforms
shown in Eqs. 9, 10a, b and 11. For the same average degree of
polymerization, wider fibres of shorter length exhibit much greater
turbidity than narrow fibres of longer length. Common parameters: fA
=10 M−1 s−1, fN = 1 × 10
−7 M−1 s−1, bA = 0 s
−1, n = 2, (CM)tot = 1 ×
10−3M, R1 = 2 nm,M1 = 27.65 kg/mole,υ = 0.73 × 10
−3 m3 kg−1,α = 1.0
Biophys Rev (2016) 8:445–471 459
complete set of ODEs specifying the rate of formation and loss
of each aggregate species (Hall et al. 2015, 2016a, 2016b).
Within this reduced set of equations the nucleus number con-
centration is given by CN and the sum of the number concen-
trations of all amyloid fibre species is described by CA (where-
by CA = ΣCi from n+1 to the maximum amyloid degree). The
number concentration of all monomers within amyloid form is
denoted as CM→A (whereupon CM→A =Σi. Ci from n+1 to the
maximum amyloid degree). On the basis that the signal mea-
sure of amyloid formation reflects CM→A, methods have been
proposed for deducing the nucleus size and the nucleation and
growth rate constants from logarithmic transform plots (Hall
2003; O’Nuallain et al. 2006; Oosawa and Asakura 1975;
Powers and Powers 2006). A noted feature of the irreversible
nucleated growth mechanism is that, dependent upon the
relative rates of nucleation versus growth, a demonstrable
amount of monomer existing as nucleus species can be present
at the reaction end (e.g. see Fig. 7) (Hall et al. 2016b). Another
important feature of the irreversible nucleated growthmodel is
that the end state polymer distribution attains a stationary set
of values at the same instant as the polymer mass end state, i.e.
only the left-hand side equilibrium in Eq. 14 is operative and
therefore no slow rearrangement of the distribution takes place
(Bridstrup and Yuan 2016; Hall 2003; Hall andMinton 2004).
We considered two different cases of the irreversible nucle-
ated growth model with regard to the turbidimetric transform.
The first case (Fig. 8) explores the effects of different fibre
geometry upon the turbidity signal. To examine this, four dif-
ferent examples of fibre radii (4, 6, 8 and 10 nm) are consid-
ered, with all cases following identical growth kinetics
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Fig. 9 Irreversible growth model—effect of nucleation rate on the
turbidity transform. Simulation of three cases of irreversible amyloid
growth which, although rod widths are identical, differ in the rate of
nucleation of amyloid fibre produced such that fN = 1 × 10
−7 M−1 s−1
(thick red line), fN = 1 × 10
−6 M−1 s−1 (intermediate-thick red line) and fN
= 1 × 10−4 M−1 s−1 (thin line). a Concentration of monomer incorporated
into amyloid (CM→A) as a function of time for the three different cases of
amyloid nucleation rate. Faster nucleation rates dictate faster growth
kinetics due to a greater number of extendable nuclei being formed. b
Average polymer degree (<i>) of aggregate as a function of time for three
different cases of amyloid fibre nucleation. Slower nucleation rates lead to
larger average degrees of polymerization. c Length (L) of amyloid fibres
as a function of time for the three different cases of amyloid fibre
nucleation rate. As per the average degree of polymerization, for fixed
fibre geometry, slower nucleation rates lead to longer fibres. d Turbidity
(τ) of amyloid fibres as a function of time for the three different cases of
amyloid fibre nucleation rate. As can be noted from Fig. 6d, the specific
turbidity becomes relatively insensitive to length after the fibres are
longer than ∼2λ. In practice this finding means that for conditions
producing very small fibre distributions, due to rapid nucleation
kinetics, the measured turbidity value reflecting the asymptotic limit
will be lower than that obtained for a system producing the same mass
concentration of amyloid using slower nucleation kinetics. Common
parameters: fA = 10 M
−1 s−1, fN = 1 × 10
−7 M−1 s−1, bA = 0 s
−1, n= 2,
(CM)tot = 1 × 10
−3M, R1 = 2 nm,M1 = 27.65 kg/mole, υ = 0.73 × 10
−3 m3
kg−1. RA = 6 nm, α = 1.0
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(Fig. 8a,b). Due to volume conservation requirements, the
thinner fibres lengthen faster (Fig. 8c), yet it is the shorter,
thicker fibres that show the greatest extent of turbidity
(Fig. 8d). With respect to this point, we note that relatively
short changes in fibre dimension can effect a large change in
the recorded turbidity (Fig. 8d—roughly fivefold for the 4 vs.
10 nm case). The second case considered for the irreversible
nucleated growth scheme (Fig. 9) involves examination of the
effects of slow to fast nucleus production on the chemical
kinetics and accompanying turbidity development of a fibre
with fixed geometry (RA = 6 nm). Faster nucleation is known
to produce a greater number concentration of smaller (Fig. 9b)
and shorter (Fig. 9c) amyloid (Lomakin et al. 1996).
Interestingly, as the fibre length falls below a limit of ∼2λ,
the corresponding turbidity value, taken as reflecting
asymptotic extent, also falls (Fig. 9d) despite there being the
same total amount of monomer in amyloid form for all cases
of the nucleation rate. Such a decrease in turbidity for very
short fibres was first described and theoretically rationalized
for microtubule fibre formation (Berne 1974; Gaskin et al.
1974). This phenomenon was later re-examined (Hall and
Minton 2005) specifically for the case of microtubules and
recently further developed in relation to amyloid and amor-
phous growth (Hall et al. 2016a).
Nucleation–growth with fibre breakage
In this mechanism fibres break—both internally, to produce
two new fibres, and at their extremities, to release non-
amyloid monomers (Hall and Edskes 2004; Masel et al.
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Fig. 10 Reversible growth model—effect of breakage rate on the
turbidity transform. Simulation of three cases of reversible growth with
breakage, in which the fibre width is the same for all cases, but the fibres
differ in their intrinsic tendency towards breakage (or as some have
termed ‘frangible’) such that bA = 0 s
−1 (red line), bA = 1 × 10
−9 s−1
(cyan line) and bA = 1 × 10
−8 s−1 (green line). a Concentration of
monomer incorporated into amyloid (CM→A) as a function of time for
the three different cases of intrinsic breakage rate. Note that faster
breakage rates lead to an effective reduction in both the nucleation and
growth phases with a subsequent faster attainment of the asymptotic
value. b The average polymer degree of aggregate (<i>) as a function
of time for the three different cases of intrinsic breakage rate. Slow
breakage rates, relative to the rate of attainment of the polymer mass
equilibrium, can lead to a slow reduction in the average polymer degree
in a manner effectively temporally decoupled from the time scale of
attainment of the monomer/polymer mass equilibrium (see Eq. 14). c
Length (L) of amyloid fibres as a function of time for the three different
cases of breakage rate. As for the just described case of <i> vs. t, slow
intrinsic breakage rates can lead to an uncoupling between the times
scales of the total mass of protein existing as amyloid and the production
of shorter fibre distributions from longer initial distributions. d Turbidity
(τ) of amyloid fibres as a function of time for three different cases of
amyloid breakage rate. As the fibres shorten below the ∼2λ length limit
the turbidity decreases significantly, even though there is noeffective de-
crease in CM→A. Common parameters: fA = 10 M
−1 s−1, fN = 1 × 10
−7
M−1 s−1, n = 2, (CM)tot = 1 × 10
−3 M, R1 = 2 nm, M1 = 27.65 kg/mol, υ =
0.73 × 10−3 m3 kg−1. RA = 6 nm, α = 1.0
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1999). The consequences of fibre breakage on the progression
of amyloid kinetics have been considered from a number of
different perspectives (Hall and Edskes 2004; Masel et al.
1999; Smith et al. 2006; Tanaka et al. 2004), with a detailed
model of the potential effects of fibre breakage on
amyloidosis-related disease progression being potentially the
most important (Hall and Edskes 2009, 2012). With regard to
this last point, the importance of both fibre breakage rate and
fibre size distributions to aggregate cytotoxicity was demon-
strated using a cell culture model (Xue et al. 2009). More
recently, Nicoud et al. (2015) have considered further compli-
cating effects upon amyloid growth kinetics associated with
potential position dependence of fibre breakage. In the con-
sensus model presented in Table 2, we have reduced Eq. 12a,
b to a more tractable form by assuming that all monomer to
monomer bonds within the amyloid fibre can break at a rate
governed by the first-order rate constant bA (i.e. bi,j = bA for all
i, j). As per the irreversible nucleated growth model, all
second-order association reactions, in which at least one of
the species is assumed to be a monomer, are governed by rate
constants fN and fA, depending upon the size of the reactants.
A summation of the set of rate equations describing the
growth and loss of all species greater than the monomer pro-
duces the set of rate equations described in Table 2 (Hall and
Edskes 2009; Smith et al. 2006). Depending upon the rate of
internal fibre breakage, the collapse of the polymer size distri-
bution may be either temporally coupled or decoupled from
the kinetics of growth of the polymer mass (Hall and Edskes
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Fig. 11 Fibre end-to-end joiningmodel—effect of association rate on the
turbidity transform. Simulation of three cases of the fibre-joining model
in which the amyloid fibre width is kept constant but the fibre joining rate
(fJEE) is set at fJEE = 0 M
−1 s−1 (solid red line), fJEE = 0.3 M
−1 s−1 (dashed
orange line) and fJEE = 1.0 M
−1 s−1 (dashed magenta line). a
Concentration of monomer incorporated into amyloid (CM→A) as a func-
tion of time for the three different cases of joining rate considered. The
relatively low numerical values used for the joining rate constants in these
simulations mean that the polymer redistribution kinetics are effectively
decoupled from the monomer/polymer mass kinetics (see Eq. 14). As
such, no change in the kinetics of monomer incorporation is observed
in the three different cases considered. b Effect of fibre-joining rate on the
average polymer degree (<i>) as a function of time. Faster rates of in-
crease in polymer degree are affected by faster joining rates, but this
occurs slowly in the present case due to the relatively low values of fJEE
specified. c Length (L) of amyloid fbres as a function of time for the three
different cases of fibre-joining rate considered. Note that the fibres slowly
lengthen under the regime of joining rate constants selected. d Turbidity
(τ) of amyloid fibres as a function of time for the three different cases of
fibre-joining rate considered. No change in turbidity is detectable
amongst the three cases of fibre-joining rate considered. This result fol-
lows from relations summarized in Table 1 (represented pictorially in
Fig. 6d) whereby an increase in length, at constant polymer mass concen-
tration, should be largely invisible to detection by turbidity. Common
parameters: fA = 10 M
−1 s−1, fN = 1 × 10
−7 M−1 s−1, n = 2, (CM)tot = 1
× 10−3 M, R1 = 2 nm, M1 = 27.65 kg/mol, υ = 0.73 × 10
−3 m3 kg−1. RA =
6 nm, α = 1.0
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2012). An important consequence of this mode of amyloid
growth is that the end-point size distribution will always ap-
proach—albeit often extremely slowly—the critical nucleus
size (Hall and Edskes 2009).
Three different rates of intrinsic fibre breakage (bA = 0 s
−1,
bA = 1 × 10
−9 s−1 and bA = 1 × 10
−8 s−1) were simulated using
the consensus reversible fibre growth model (shown in
Table 2). Larger values of bA were found to speed up the
incorporation of monomer into the amyloid form (Fig. 10a)
(Hall and Edskes 2004, 2009). Due to the relatively low values
selected for the breakage rate constants, a very slow relaxation
of the fibre distribution is seen (Fig. 10b, c). For constant fibre
geometry (RA = 6 nm), we note that fibre breakage produces
non-ideal turbidimetric kinetic profiles, exhibiting a decrease
in the asymptotic extent of turbidity as the fibre length falls
below the ∼L > 2λ limit (Fig. 10d).
Fibre end-to-end association
The joining of shorter fibres to form longer ones has been directly
observed in some amyloid systems (Binger et al. 2008). Based
on theoretical predictions (relating to differences in number con-
centration22 and intrinsic orientation effects related to the likeli-
hood of two fibre ends meeting (Hill 1983; Pallitto and Murphy
2001), the rate constant governing longitudinal fibre/fibre
22 i.e. the monomer number concentration is higher than the fibre number
concentration nearly throughout the monomer to polymer mass equilibrium.
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Fig. 12 Fibre lateral association model—effect of lateral association rate
on the turbidity transform. Simulation of the fibre lateral association
model in which fibres are able to form laterally-associated ‘mature’ fibres
consisting of fibre dimers, for three cases of the joining lateral association
rate constant (fJLA) are explored, with fJ LA = 0 M
−1 s−1 (solid red line), fJ
LA = 0.3M
−1 s−1 (dashed yellow line) and fJ LA = 10M
−1 s−1 (dashed grey
line). a Concentration of monomer incorporated into amyloid (CM→A) as
a function of time. All three simulated cases of different intrinsic lateral
association rate overlap as the fibre-joining rate is assumed not to influ-
ence the reactivity of the individual fibre ends. bAverage polymer degree
(<i>) as a function of time. The low numerical values selected for the
fibre lateral association rate constants mean that the asymptotic limit of
the average polymer degree is approached very slowly. c Simulated
length (L) of amyloid as a function of time for the three examined cases
of fibre lateral association rate. The coincident behavior is a consequence
of the two simplifying assumptions that fibre size distributions are ap-
proximated by their average, <i>, and that fibre lateral association occurs
at the fibre midpoint (see text on this point for a discussion). d Simulated
turbidity (τ) of amyloid solution as a function of time for the three cases of
fibre lateral association rate. Attainment of an asymptotic limit in the
turbidity profile is delayed (or not apparent) for the cases of faster lateral
association rate. Note that based on relations presented in Table 1 and
Fig. 6d, a change in fibre width, at constant aggregate mass concentration,
will result in an increase in turbidity. Common parameters: fA = 10 M
−1
s−1, fN = 1 × 10
−7 M−1 s−1, n = 2, (CM)tot = 1 × 10
−3 M, R1 = 2 nm, M1 =
27.65 kg/mol, υ = 0.73 × 10−3 m3 kg−1. RA = 6 nm, α = 1.0
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association (fi,j) is assumed to be much smaller than the fibre/
monomer association rate constant (fi,1). As such, the kinetics of
fibre annealing is likely to be relatively slow and decoupled from
the (relatively) faster kinetics of the monomer/polymer mass
reaction. In terms of the equilibrium described by Eq. 14, fibre
joining likely exhibits a slow redistribution phase. In our con-
sensus model, the rate of joining between any two fibres is
specified by a single rate constant, fJEE, such that fJEE << fA.
Three cases of fibre joining rate were simulated using the
consensus fibre end-to-end joining model shown in Table 2.
All simulated cases had the same fibre width, with RA = 6 nm.
Following the asymptotic relation predicted for the transmis-
sion form factor (Q) for rods (Table 1; Fig. 6), the turbidity is
effectively blind to changes in length brought about by join-
ing. In a different kinetic regime (not explored here), fibre
joining could significantly influence the turbidimetric profile
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Fig. 13 Amyloid vs. amorphous competition—effect of relative rates of
amorphous and amyloid growth on the turbidity transform. Simulation of
three cases of competitive reversible-seeded growth in which the rate
constants reflecting amyloid growth are kept constant but the amorphous
growth kinetics are modified by varying the amorphous aggregate asso-
ciation constant (fG), such that fG = 50M
−1 s−1 (thin solid lines), fG = 150
M−1 s−1 (intermediate-thick dashed lines) and fG = 250 M
−1s−1 (thick
solid lines) whereby the red version of the particular line type refers to
the amyloid species and the blue version of the line refers to the amor-
phous species. a Concentration of monomer in amyloid (CM→A) or amor-
phous aggregate (CM→ G) as a function of time for the three different
cases of amorphous relative to amyloid growth. In all cases the choice
of rate constants ensures that the amyloid is ultimately more thermody-
namically stable than the amorphous aggregate. Relatively fast amor-
phous association rates lead to a significant extent of monomer being
initially converted into the amorphous form, prior to its eventual dissoci-
ation and re-incorporation into the amyloid state. b Average polymer
degree of amyloid (<iA>) and amorphous (<iG>) as a function of time
for the different simulated cases of relative rates of amorphous to amyloid
growth. Due to the fact that the simulation model specifies seeded growth
(in which the number concentration of amyloid and amorphous species
are fixed at constant values throughout—see Table 1), <iA> (red lines)
attains the same eventual value for all cases of relative growth. Similarly,
the average degree of polymerization of the amorphous aggregate, <iG>
(blue lines) approaches a value close to the starting value of the amor-
phous seed, <iG>t=0, in all cases. c Average size of aggregate species as a
function of time for three simulated cases of relative rates of amorphous
vs. amyloid growth, with the left y-axis specifying the length (LA) of the
amyloid species and the right y-axis describing the radius (RG) of the
amorphous aggregate species. The faster cases of amorphous growth lead
to aggregates of larger radius (compare ∼32 to 20 nm) whereas LA never
surpasses its maximum value due to a slow approach to equilibrium from
below (i.e. no overshoot is seen). d Turbidity (τ) as a function of time for
the three cases reflecting different relative rates of amorphous to amyloid
growth. Coloured lines Component turbidity generated by the amyloid
(red line) and amorphous (blue line) species. Black lines represent the
total resultant turbidity. Line style is dictated by the different cases
reflecting the rate of amorphous to amyloid growth: solid thick lines
relatively fast amorphous growth, dashed intermediate-thick lines amor-
phous growth, thin solid lines slow amorphous growth. Common param-
eters: fA = 250M
−1 s−1, bA = 1 × 10
−3 s−1, bG = 1 × 10
−2 s−1, (CM)tot = 1 ×
10−3 M, R1 = 2 nm, M1 = 27.65 kg/mol, υ = 0.73 × 10
−3 m3 kg−1. RA = 6
nm, αA = αG = 1.0, (CA)t=0 = 1 × 10
−7M, (CG)t=0 = 1 × 10
−7M, <iA>t=0 =
100, <iG>t=0 = 100
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if it occurred between very small fibres (Hall and Minton
2005) having a length smaller than the L > 2λ limit, (above
this limit, specific turbidity becomes effectively independent
of fibre length (Berne 1974; Buitenhuis et al. 1994; Hall et al.
2016a).
Fibre lateral association
Despite widespread descriptions of laterally associated ‘ma-
ture fibres’ (Fitzpatrick et al. 2013; Kanno et al. 2005; Ridgley
and Barone 2013; Woolfson and Ryadnov 2006; Yamaguchi
et al. 2005) and semi-ordered aggregation of amyloid to form
spherulites (Krebs et al. 2004a; Ruth et al. 2000), there is a
general dearth23 of experimental and theoretical studies which
have considered the effect of lateral association on amyloid
growth kinetics. Three different mechanistic possibilities exist
for the production of laterally associated fibres. The first in-
volves heterogeneous nucleation of a new fibre on the surface
23 With some exceptions (Ghosh et al. 2010; Pallitto and Murphy 2001).
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Fig. 14 Amyloid vs. amyloid competition—effect of relative rates of
growth between two geometric forms of amyloid on the turbidity
transform. Simulations showing two cases of competitive reversible
seeded growth between two amyloid types possessing quite subtle
differences in geometry such that type #1 fibres have a radius RA#1 of
5 nm (dashed lines) and type #2 fibres have a radius of RA#2 = 6nm (solid
lines). Two cases of reversible growth are produced by swapping the sets
of kinetic rate constants. The simulation showing eventual more stable
growth of the narrow type #1 fibres in the thermodynamic limit is defined
by Case A (cyan lines; fA#1 = 150 M
−1 s−1, bA#1 = 0.001 s
−1, fA#2 = 250
M−1 s−1, bA#2 = 0.01 s
−1). The simulation ultimately reflecting more
stable growth of the thicker type #2 fibres is defined by Case B (black
lines; fA#1 = 250 M
−1 s−1, bA#1 = 0.01 s
−1, fA#2 = 150 M
−1 s−1, bA#2 =
0.001 s−1). a Concentration of monomer incorporated into either of the
two types of amyloid (CM→A#1 or CM→ A#2) as a function of time. As the
kinetics are simply reversed between the two different cases, Case A
(cyan lines) and Case B (black lines) are coincident. b Average polymer
degree (<i>) reflecting either type #1 amyloid (<iA#1>) or type #2
amyloid (<iA#2>) as a function of time. As the polymer degree per se is
insensitive to the geometry of the amyloid, these two cases are also
coincident (being simple reversals of the kinetic rate constants). c
Simulated length (L) of amyloid as a function of time for Case A (cyan
lines), whereby the thin fibre (dashed lines) is eventually dominant, and
Case B (black lines) for which the thick fibre (solid line) is eventually
dominant. The differences in width between the two fibre types means
that different lengths are produced between the two cases even though the
average degree of polymerization is identical. d Turbidity (τ) of amyloid
solution as a function of time for two cases of competitive amyloid
growth. The resultant turbidity for both cases is shown by dashed lines
(thin black dashed line Case B, thick cyan dashed line Case A). Note the
unusual kinetics (different to the ideal type shown in Fig. 7a) produced by
very minor differences in fibre geometry. Common parameters: (CM)tot =
1 × 10−3 M, R1 = 2 nm, M1 = 27.65 kg/mol, υ = 0.73 × 10
−3 m3 kg−1.
αA#1 = 1.0, αA#2 = 1.0
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of a pre-existing amyloid fibre (Jeong et al. 2013; Padrick and
Miranker 2002); the second involves lateral association taking
place while the fibres are small, with subsequent extension of
each growing end of the conjoined fibres (Ghosh et al. 2010;
Pallitto and Murphy 2001); the third mechanistic option in-
volves self-association of already formed protofibrils with lat-
eral fibre association governed by rate constants much smaller
than the rate constants governing the monomer/polymer mass
equilibrium (Eq. 14)(Ghosh et al. 2010; Pallitto and Murphy
2001) i.e. (fi,j)LAT << fi,j. There is a great deal of complexity in
the simulation of any of these three cases. To provide a
benchmark kinetic description of the effect of fibre lateral
growth, we have opted to simulate a kinetic case that is
similar in form to the preceding fibre end-to-end joining mod-
el. For simplicity we have limited this to lateral protofibril
addition governed by a rate constant fJLA, with the level of
association fixed to the stage of lateral dimer, denoted as A2
(Table 2). Such a kinetic description dictates a slow
association phase in which the polymers become
progressively thicker on average (Fig. 12). One potentially
misleading assumption in the formulation of the equation set
describing lateral association (Table 2) is the subsuming of a
multitudinous array of possible lateral associations (involving
partial off-centre overlap of fibres) into a single mechanistic
path describing centre-to-centre alignment of the fibres. Such
off-centre association, or indeed point contact formation, may
be responsible for the formation of either extremely long
fibres or the birds’ nest-type clusters of fibres often seen in
amyloid plaques (Merz et al. 1983; Wisniewski et al. 1989)
and in ultra-microscope images (Ban et al. 2003; Mishra et al.
2011; Ogi et al. 2014).
Amyloid versus amorphous growth
When there is no orientation or configurational requirement
to the association reaction, the internal structure of the
aggregate will lack positional order, resulting in the
formation of an amorphous product (Bennett 1972;
Yoshimura et al. 2012; Zurdo et al. 2001) (Table 2). The
production of such amorphous aggregates has been observed
in many amyloid-forming systems and often complicates
simple interpretation of the reaction. Hall et al. (2015) and
Adachi et al. (2015) have treated the case of amyloid growth
in competition with amorphous aggregate using a kinetic rate
scheme that treated the rate of growth and breakage of all
species in an explicit fashion. Here we produce example
simulations describing the competition between the amyloid
and amorphous aggregate based on a fixed-seeded growth
model (Naiki et al. 1997). In this mechanistic format, growth
proceeds reversibly, for both amorphous and amyloid aggre-
gate types, from a fixed (i.e. non-dissociable) seed species of
degree <i>t=0. Here we consider growth and shrinkage as
occurring via monomer addition and monomer loss only,
with no fragmentation or spontaneous nucleation allowed.
For amyloid growth this implies the following boundary
conditions:fi,1 = fA for <iA> ≥ <iA>t=0, else all fi,1 = 0 and bi-
1,1 = bA for <iA> > <iA>t=0, else bi-1,1 = 0; for amorphous
aggregate growth, the following boundary conditions are
implied: fi,1 = fG for <iG> ≥ <iG>t=0, else all fi,1 = 0 and bi-1,1
= bG for <iG> > <iG>t=0, else bi-1,1 = 0. Hall and coworkers
explored the case where amyloid is more thermodynamically
stable than the amorphous aggregate, but slower to initially
form (Hall et al. 2015). This study, along with work byAdachi
et al. (2015), highlighted a potential dependence of the time-
scale of amyloid formation on the dissociation rate of the
amorphous species.
To explore the effects of competing amorphous growth in
extension to that performed previously (Adachi et al. 2015;
Hall et al. 2015), we simulated three cases of competition
between amorphous aggregate and amyloid using the consen-
sus model presented in Table 2 (Fig. 13). The rate constants
were selected to ensure that the amyloid was ultimately more
stable, in the thermodynamic limit, than the amorphous aggre-
gate in all cases (Fig. 13a–c). Despite this preponderance for
amyloid growth, even relatively small amounts of amorphous
aggregate can significantly distort the resultant turbidimetric
kinetic profile (Fig. 13d, black lines).
Amyloid versus amyloid growth—two strains
in competition
Kinetic competition between two types of amyloid has not
yet, to the best of our knowledge, been quantitatively investi-
gated, but it is known to be an important feature of real-case
amyloid growth in which different polymorphic strains are
observed (Hall and Edskes 2004; Paravastu et al. 2008;
Petkova et al. 2005; Tanaka et al. 2004). To explore this be-
haviour in isolation, we modelled two types of amyloid fibre,
both competing for the same monomer pool, using a fixed
seeded reversible growth scheme virtually identical to that
adopted for the amorphous versus amyloid case (reported in
the preceding subsection) with the same requirement that fi-
bres grow or shrink via monomer addition or loss only24
(Table 2). The two fibre types are characterized by different
radii (RA#1 and RA#2). Growth for the type #1 fibre is defined
by the following set of boundary conditions: fi,1 = fA#1 for
<iA#1> ≥ <iA#1>t=0, else all fi,1 = 0 and bi-1,1 = bA#1 for
<iA#1> > <iA#1>t=0, else bi-1,1 = 0; growth for type #2 fibres
is defined by fi,1 = fA#2 for <iA#2> ≥ <iA#2>t=0, else all fi,1 = 0
and bi-1,1 = bA#2 for <iA#2> > <iA#2>t=0, else bi-1,1 = 0.
24 We note that the general behaviour outlined for the two competitive cases
(‘Amyloid vs. amorphous growth’ and ‘Amyloid versus amyloid growth—
two strains in competition’) are also applicable to the description of the growth
and dissolution of different crystal forms (Levi and Kotrla 1997).
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Two different cases of competitive fibre growth were
explored (Fig. 14). The first involved the situation where
a relatively thin type #1 fibre (RA#1 = 5 nm) outcompeted
a slightly thicker type #2 fibre (RA#2 = 6 nm) for mono-
mer resources (Fig. 14a–c). The second case involved the
reverse situation, in which the slightly wider type #2 fi-
bres eventually outcompeted the thinner type #1 fibres for
monomer (Fig. 14a–c). As can be noted (Fig. 14d), even
relatively subtle differences in dimensions between the
dominant and non-dominant fibre types will impart signif-
icant non-ideality to the resultant kinetic profile recorded
via turbidity (dotted black or cyan lines in Fig. 14d).
Towards the future
Concern over the interpretation of potentially non-linear
signal response is a repeating and important theme in
science (Araujo 2009). Pursuing this line of investiga-
tion, we have focussed on literature capable of
informing the reader about the cause and effect relation-
ship between protein aggregates and the turbidity gener-
ated by them in solution. Using a slightly non-
conventional review format we have combined pub-
lished transforms with consensus kinetic models to pro-
duce ‘review-data’, cutting out the requirement for
worded descriptions otherwise necessary for synthesiz-
ing arguments from multiple information streams.
As can be noted from Fig. 6d, straight rod-like fibres
possessing a common width should produce a signal that is
linearly proportional to the mass of monomer in aggregate
form when the fibres are long in relation to the wavelength
(Hall et al. 2016a) (or in the words and symbols of this review,
τ ∝ CM→Awhen LA > 2λ). Outside of this limit a linear rela-
tionship will not necessarily hold and should be either (1)
investigated experimentally (e.g. Borgia et al. 2013;
O’Nuallain et al. 2006), (2) compared against results gained
from an orthogonal technique (Li et al. 2009; Nilsson 2004) or
(3) examined using some of the theoretical and simulation-
based tools highlighted in this review. A fourth option, previ-
ously explored by a number of researchers, involves (4) ex-
perimental interrogation of the wavelength dependence of the
turbidity (Camerini-Otero and Day 1978; Wallach et al. 1961)
to gain clues about dominant aggregate sub-types (Andreu
and Timasheff 1986; Garcia-Lopez and Garcia-Rubio 2008;
Garcia-Lopez et al. 2006; Hall and Minton 2005;
Korolevskaya and Khlebtsov 2010; Mahler et al. 2005;
Moody et al. 1996; Silver and Birk, 1983)). Advances in com-
puter power make re-visitation of this multi-wavelength ap-
proach an attractive area of current and future research
(Mroczka and Szczuczynski 2010; Penzkofer et al. 2007;
Shmakov 2014).
By far, the major focus of amyloid research remains its
association with diseases, collectively termed as amyloidosis,
which are all characterized by the deposition of large amounts
of amyloid into various organs and tissues of the human body
(Symmers 1956; Pepys, 2001; Walker and Jucker 2015).
Potential non-linear effects, which complicate the interpreta-
tion of the turbidity signal, become very important when tur-
bidity is used as an assay for anti-amyloid drug screening
(Anzai et al. 2016; Doig et al. 2004; Dolado et al. 2005;
Necula et al. 2007; Sant’Anna et al. 2016). In such cases,
the use of an orthogonal technique, such as Congo Red or
Thioflavin T dye binding, as a control experimen, should go
a long way towards preventing spurious conclusions from
being drawn.
From its original negative association with disease, am-
yloid has since been found to play potentially beneficial
roles in non-disease-related areas. Two such positive man-
ifestations of amyloid include (1) the discovery of its role
in maintaining the normal biological state as 'functional
amyloid' (Greenwald and Riek 2010) and (2) amyloid’s
potential in biosynthetic applications (Mitraki 2010;
Raynes and Gerrard 2013). In this latter role, amyloid’s
nanometer-scale dimensions (Xu et al. 2016), its inherent
capacity for autonomous self-assembly (Lee et al. 2015;
Sasahara et al. 2010) and the desirable material properties
of the nanofiber product (Paul et al. 2016) all highlight
the potential usefulness of amyloid as a ‘building block’
in nanotechnology applications (Rodina 2012). Due to
their simplicity, turbidity assays will continue to be the
‘go to’ technique for monitoring amyloid formation across
these disparate research areas. A greater familiarity with
the principles of the turbidimetric technique will undoubt-
edly facilitate research progress throughout the wider com-
munity. Hopefully this review has helped to decrease the
foggy nature of turbidity, allowing some metaphorical blue
skies to be seen through the cloud.
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Future Studies 
 
   In my postgraduate studies I initially set out with the aim of 
conducting protein aggregation assays to test the efficacy of the 
molecular chaperones (WT 14-3-3zeta, WT alpha B-crystallin, 
S59D alpha B-crystallin and S19,45,59D alpha B-crystallin). In 
each assay, there was one aggregate substrate (made from either 
ADH, lysozyme, alpha-lactalbumin, RCM alpha-lactalbumin, 
RCM kappa-casein, insulin) and either one chaperone, or two 
chaperones used together in combination. Each of these 
interactions were investigated by use of the turbidimetric assay 
technique. During the course of my studies I realized that I didn’t 
really understand what factors produced the turbidimetric signal. 
As this was the basic measuring stick of my project I decided to 
spend some time digging deeper into the basic physical 
phenomenon underlying this primary assay technique.  
 
   After having looked more closely at the fundamental underlying 
principles of this assay technique I now have a better 
understanding of the biological meaning hidden within these 
assays. In future work I plan to extend the results contained within 
this thesis by developing an assay deconvolution technique which 
uses both data from experiment and the developed equations for 
estimating the turbidity signal to determine the underlying solution 
composition. While such approaches have been tried before I think 
that the Ockham’s razor type simplification in our simulation 
approach, basing the signal on just two components (an amorphous 
and a fibrillar species) will make deconvolution of the signal both 
experimentally meaningful and achievable. To help this process 
we plan on factoring in information relating to the wavelength 
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dependence of the turbidity signal. A future analytical routine will 
take the form of a constrained non-linear least squares approach in 
which the total turbidity at a number of different wavelengths is 
compared to a theoretical estimate of the turbidity generated from 
combinations of the two different types of protein aggregate 
(amorphous or rod-like). I have already made some progress in this 
area by developing an automated diagnostic method for examining 
turbidimetric wavelength dependence of protein aggregation 
reactions that represents an improvement of the methods advanced 
previously (Camerino-Otero and Day, 1978). 
 
   One important aspect of my thesis work was the development of 
statistical measures for discerning meaningful differences in 
protein aggregation kinetics (Hall et al. 2016b) on the condition 
that the signal measure was linear with respect to protein aggregate 
weight concentration. This aspect of my work preceded my 
attempts to correctly/completely de-convolute the turbidity 
spectrum and as such, was slightly premature (as my preference 
was for a linear approach to ironing out the problems inherent in 
the assay field). With this said however the adoption (by the field) 
of the rigorous statistical approaches presented in Hall et al. 2016b 
may turn out to be as, or more, important than the empirical 
equation set for describing the turbidity of mixed aggregation 
reactions. Previously, the assessment of differences in aggregation 
assays has been performed in a very primitive, potentially naïve 
fashion, manly based on the calculation of simple averages. In my 
opinion, this reflects a general lack of appreciation of metrological 
science by the many practicing medical science researchers of the 
protein aggregation community. The relatively straightforward 
solutions to basic assay related questions (e.g. what type of things 
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can provide a measure of difference and how do I measure a 
statistical difference) was, in my opinion, a much required input to 
the field and as such my contribution is something that I will 
remain proud of for a very long time. 
 
   A final aspect of my thesis work which deserves mention is the 
demonstration (and subsequent discussion) of ‘non-regular’ 
amyloid kinetics for different kinetic regimes of protein aggregate 
growth (Zhao et al. 2016). In that Review article I discussed how 
the turbidity generated by protein aggregation would be affected 
by changes in fibre width, fibre breakage, fibre end-to-end joining, 
fibre side-to-side joining, competitive growth between different 
types of fibre species and cases involving fibre species competing 
against amorphous aggregate types. Through the use of 
synthesizing ‘Review simulations’ I managed to show that 
turbidity measurements may produce non-asymptotic kinetic 
forms that defy normal parameterization schemes. In practice, 
such data is often ignored or heavily truncated and treated as if 
something went wrong with the experiment. If nothing else was 
achieved in my thesis the demonstration that such aberrant data is 
actually informative (rather than problematic) would have made 
my postgraduate studies worthwhile. 
 
   As is often the case in science I did not expect my studies to lead 
me to this point. My meandering route has certainly meant that I 
have jumped disciplines (biology, chemistry, physics and 
mathematics). Ultimately though I feel that I am now at a point 
where I (or others continuing on from my efforts/achievements) 
can make meaningful progress into understanding how 
turbidimetric assays can be used to explore just what effects 
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chaperones might play on any protein aggregation reaction 
occurring simultaneously in that chaperone containing solution. 
Ultimately my interest in biological chemistry has been 
strengthened by the path followed and I have developed a real 
appreciation for the non-linear nature of the signals we so often 
interpret in a facile (and potentially incorrect) fashion.  
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